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Abstract 
Commercial production of Atlantic salmon, Salmo solar (L.), in Tasmania is 
becoming increasingly reliant on female stocks for year round production. 
Hatchery production of female monosex stocks uses milt from sex inverted 
females ("neomales") to produce all female offspring. This study was undertaken 
investigate the effects of aromatase inhibitors (Al) on Atlantic salmon and to 
facilitate the development of techniques for their commercial application. 
Dietary treatment for 800 °C days from first feeding, with methyltestosterone at 
doses of 1 or 3 mg kg -1 food or methyldihydrotestosterone (MDHT) at 1 mg kg -1 
food resulted in 100% masculinisation of female Atlantic salmon. Masculinisation 
followed 2 h immersion of alevins in MDHT at 400 p.g 11 during the period 0 to 
28 days post median hatch (DPMH) and complete masculinisation was achieved 
after immersion at 14 and 21 or 14 and 28 DPMH. More sex inverted males with 
patent sperm ducts were produced by immersion than dietary treatments. 
The capacity of five AI: 1,4,6-androstatriene-3,17-dione (ATD); 4-androstene-4- 
ol-3,17-dione (OHA); 142,4-dich1oro-13-([2,4-dichlorobenzyl]oxy)- 
phenethyl]imidazole (miconazole); 3[p-aminopheny1]-3-ethyl-piperidine-2,6- 
dione (aminoglutethimide) and 445,6,7,8-tetra-hydroimidazo-(1,5-a)-pyridin-5- 
yl] benzonitrile monohydrochloride (fadrozole) to reduce estradiol (E2) production 
by Atlantic salmon brain and gonadal tissue was assessed in vitro. Fadrozole was 
the most potent, effective at doses of 0.1-10.0 p.g mr l . ATD, OHA and 
miconazole were also effective on brain and gonadal tissue, but 
aminoglutethimide was only effective on brain tissue. 
Immersion of Atlantic salmon alevins in ATD at a dose of 0.5 mg L -1 on 14 or 14 
and 28 DPMH produced 13% neomales. This incidence was increased to 47 and 
22% following treatment on 7 and 14, or 14 and 21 DPMH respectively and to 51- 
54% with a dose of 5 mg L -1 ATD. Miconazole, aminoglutethimide, fadrozole and 
OHA were all ineffective for sex inversion. Precocious maturation was induced by 
photoperiod manipulation, and 67-88 % of mature neomales had patent sperm 
ducts and fertility (-70%) comparable to normal males. 
ATD was taken up by alevins more readily than OHA; however, tissue levels of 
both declined by 50%, after 24 h and by >90% after 7 days. Uptake levels 
declined with alevin age, but retention rates were similar. Reducing the inter-
treatment interval to 7 days resulted in increased androgen levels following the 
second treatment with ATD. Immersion in fadrozole at doses of 10 and 50 mg U 1 
resulted in tissue levels of 300 and 1000 ng fish -1 which declined by 80% after 3 
days. 
These studies demonstrate the commercial feasibility of androgens and AT for sex 
inversion of Atlantic salmon. The efficacy of immersion treatment with AT is 
dependent on both enzyme inhibition and the uptake and retention characteristics 
of AI. 
DEDICATION 
To Imogen and Isaac 
who provided the inspiration 
and 
Sue 
who gave me the courage to start 
and the strength to finish. 
iv 
Acknowledgements 
Thanks at many levels, goes to my supervisors, Ned Pankhurst and Harry King, 
collectively in the first instance, for having the courage to take an aging fish 
farmer back to the world of research and for introducing me to the world of fish 
endocrinology. 
To Ned, thanks to you for your sage-like guidance throughout the project, 
particularly for patiently setting me straight when I was, at times, determined not 
to see the forest for the trees. Thanks too for your friendship, acceptance of my 
non-PhD commitments, help in the field and instructing me on the finer points of 
Japanese culture. Most recently, for your commitment to balance your major life 
changes of relocation and re-employment with time to re-educate me into 
scientific writing and to get this thesis completed, I am very grateful. 
To Harry, the roles of supervisor, colleague, boss, host, mentor and mate are not 
easy to simultaneously fulfil, but you managed it, as always, with aplomb. You 
have my thanks and gratitude for all you have done, to not only make this project 
a success, but to teach me a great deal, and keep me sane along the way with some 
enjoyable evenings of crib and cabernet. 
I would like to gratefully acknowledge the support of the Cuthbertson Scholarship 
Fund for the provision of a generous scholarship and for their ongoing support of 
aquaculture and agriculture research in Tasmania. In particular I would like to 
thank Mrs. Helen Dickenson for her keen interest in this project. 
This project would not have been possible without the enormous support of 
Saltas. Thanks especially to the management team of Graham Martin and Harry 
for their foresight in proposing this project, supporting it financially, for the in-
kind support of fish, tanks and logistical support, and for enabling me to 
undertake some "real" work too. To the staff of Saltas, for help with fish, systems, 
advice, good humour and Guinness, my gratitude and thanks goes (in no particular 
order) to: Joey, Mark J., Ange J., Ange P., Tim, Gary, Jamie, Dean, Devaya, Julie, 
Dave and especially Jodie and Eoin. 
To my research colleagues in TAFI, in particular those in the Fish Endocrinology 
Group thanks goes to: Quinn, Polly, Sun Biao, Cynthia, Han Kyu, Hannah, Mark 
and Ryan for your company, timely advice and help in the lab and field. Thanks 
also to my colleagues at MRL, especially fellow students Greg, Mark, Mike, Phil, 
Andrew, Anthony, Simon, Michel and Jenny for good company and wide ranging 
discussions, some of them even scientific. Special thanks to Jayson Semmens for 
advice on all things histological and to Natalie Moltschaniwskj for sorting out 
some statistical issues. Sincere thanks also to Dr Noel Davies, Central Science 
Laboratory, University of Tasmania for developing the LC MS/MS protocol for 
fadrozole analysis. 
Thanks, somewhat belatedly, to Dr. Mike Loughead and Dr. David Hill, without 
whose dedication and skill, I may not have had the chance to achieve this goal. 
To my parents, thank you for instilling in me not only a long abiding interest of 
all things that live in the water but also for showing me the joy of learning. 
Special thanks to Mum for your constant love and support over many years of 
study, and to my wonderful friends and extended families in spread across the 
country, thanks to: Dave, Judy, David, Donna, Andy, Paul, Kathy, Steve, Phil, 
Louise, Dave, Sharon, Helene, Louise and Fillipp for your friendship, love and 
support along the way. 
Above all I thank my family. To my children, Imogen and Isaac, for reminding 
me what is truly important in life, and yes, I will get a real job when I grow up! 
To my wife Sue, without whom this would never have come to pass, and who has 
sacrificed much over the past four years to help me reach my goal, this belongs to 
you as much as me. Your love, support and generosity of spirit has seen us all 
through an extraordinary few years and helped me get through this and many 
other challenges. I love you deeply. 
vi 
Table of Contents 
Declaration 	  
Authority of Access 	  
Abstract 	 ii 
Dedication 	 iv 
Acknowledgements 	  
Table of Contents 	 vii 
List of Figures 	  
List of Tables 	 xiii 
List of Abbreviations 	 xv 
Chapter 1. General Introduction 	  1 
	
1.1 	The Tasmanian Atlantic salmon farming industry 	  1 
1.2 	Sex determination and sex differentiation in fishes 3 
1.3 	Production of monosex female populations 	  5 
1.4 	Estrogen and aromatase (cytochrome P450arom)  7 
1.5 	Aromatase inhibitors 	  9 
1.6 	Sex control using Al  12 
1.7 	The present study 	  13 
1.8 	References 	  15 
Chapter 2. Preliminary assessment of sex reversal of farmed Tasmanian 
Atlantic salmon (Salmo salar) by dietary and immersion 
androgen treatments. 26 
2.1 	Introduction 	 26 
2.2 	Materials and Methods 	 28 
2.2.i 	Stock and Husbandry 28 
2.2.ii 	Experimental protocols 	 29 
Experiment 1 	 29 
Experiment 2 31 
2.2.iii Gonadal examination 	 32 
2.2.iv 	Statistical Analysis 32 
2.3 	Results 	 32 
vii 
2.3.i 	Experiment 1 	 32 
2.3.ii 	Experiment 2 33 
2.4 	Discussion 	 34 
2.5 	References 38 
Chapter 3. Effects of aromatase inhibitors on in vitro steroidogenesis in 
Atlantic salmon (SaImo solar) gonadal and brain tissue 	42 
3.1 	Introduction 	 42 
3.2 	Materials and Methods 	 45 
3.2.i 	Fish 	 45 
3.2.ii 	Follicle preparation and incubation 	 45 
3.2.iii Brain tissue preparation and incubation 	 46 
3.2.iv Experimental protocols 	 46 
Experiment 1 — Gonadal tissue incubation 	 46 
Experiment 2 — Efficacy of Al on ovarian E2 production 	46 
Experiment 3- Brain tissue incubation 	 47 
Experiment 4- Solvent extraction of steroids 	 47 
Experiment 5 — Efficacy of Al on E2 production by brain tissue 	 48 
3.2.v 	Steroid measurement 	 49 
3.2.vi Statistical Analyses 49 
3.3 	Results 	 49 
3.3.ii 
3.3.iii 
3.3 .iv 
3.3.v 
3.3.vi 
3.4 
3.5 
Experiment 1 — gonadal tissue incubation 	 50 
Experiment 2 — Efficacy of Al on ovarian E2 production 	57 
Experiment 3 - Brain tissue incubation 	 58 
Experiment 4 - Solvent extraction of steroids 	 62 
Experiment 5 — Efficacy of Al on E2 production by brain tissue 	 62 
Discussion 	 65 
References 71 
Chapter 4. Efficacy of aromatase inhibitors for sex inversion of farmed 
Atlantic salmon. 	  79 
	
4.1 
	
Introduction 	  79 
4.2 
	
Materials and Methods 	  82 
4.2.i 
	
Stock and Husbandry  82 
4.2.ii 
	
Immersion protocol 	  86 
4.2.iii Experiment 1: 2000-01  86 
4.2.iv Experiment 2: 2001-02 	  87 
4.2.v 	Population assessment  87 
4.2.vi Sperm quality 	  88 
4.2.vii Histological procedures 	  89 
4.2.viii Statistical Analyses  89 
4.3 	Results 	  90 
viii 
4.3.i 	Experiment 1: 2000-01 	 90 
4.3 . ii 	Experiment 2: 2001-02 99 
4.4 	Discussion 	  109 
4.5 	References  117 
Chapter 5. Uptake and retention of aromatase inhibitors by Atlantic 
salmon alevins following immersion treatments 	 126 
5.1 	Introduction 	  126 
5.2 	Materials and Methods 	  130 
5.2.i 	Stock and Husbandry 130 
5.2.ii 	Immersion protocol 	  130 
5.2 .iii Aromatase inhibitor uptake and retention 	  130 
5.2.iv Experiment 1: 2000-01 	  130 
5.2.v 	Experiment 2: 2001-02  131 
5.2.vi ATD and OHA assay 	  131 
5.2.vii Fadrozole assay 	  131 
5.2.viii Statistical analyses  132 
5.3 	Results 	  133 
5.3.i 	RIA validation 	  133 
5.3.ii 	Fadrozole assay validation 	  133 
5.3.iii Experiment 1: 2000-01  133 
5.3.iv Experiment 2: 2001-02 	  140 
5.4 	Discussion 	  146 
5.5 	References  151 
Chapter 6. General Discussion 	 155 
6.1 	The present study  155 
6.2 	Sex differentiation in Atlantic salmon 	  155 
6.3 	Sex inversion with Al 	  156 
6.4 	Commercial implications  158 
6.5 	Future studies 	  160 
6.6 	Concluding remarks 	  161 
6.7 	References 	  162 
Appendix I Atlantic salmon milt extender and activator solutions 	 169 
Appendix Ia Extender solution for Atlantic salmon milt 	  169 
Appendix lb Activator solution for Atlantic salmon milt  169 
Appendix II Histological procedures 	 170 
Appendix Ha Infiltration regime — Tissue Tek VIP 4617 	  170 
Appendix Ilb Haematoxylin and eosin staining procedure  170 
ix 
List of Figures 
Chapter 1. 
Figure 1.1 Diagram of the procedure for indirect feminisation of species 
having heterogametic males. 	 6 
Figure 1.2 Mechanism of the aromatisation of testosterone 	 8 
Figure 1.3 Representative non-steroidal aromatase inhibitors  10 
Figure 1.4 Representative steroidal aromatase inhibitors 	  11 
Chapter 2. 
Figure 2.1 Percentage masculinisation in immersion and dietary treatment 
groups used in Experiment 1. 	 33 
Figure 2.2 Percentage masculinisation and open sperm ducts in immersion 
and dietary treatment groups used in Experiment 2. 	34 
Chapter 3. 
Figure 3.1 E2 production by follicles from Fish 1, after a) 6 hours b) 18 
hours or c) 42 hours incubation, at 5, 10 or 15 °C, with steroid 
precursors added as shown 51 
Figure 3.2 E2 production by follicles from Fish 2, after a) 6 hours b) 18 
hours or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. 	53 
Figure 3.3 T production by follicles from Fish 1, after a) 6 hours b) 18 
hours or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. 	54 
Figure 3.4 T production by follicles from Fish 2, after a) 6 hours b) 18 
hours or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. 	55 
Figure 3.5 E2 production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C 	 56 
Figure 3.6 T production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C 	 56 
Figure 3.7 Basal E2 production by follicles from a) Fish 1 and b) Fish 2, 
after 18 hours incubation at 10 °C with Al added as shown. 	59 
Figure 3.8 E2 production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C with T and Al added as shown 	60 
Figure 3.9 E2 levels in incubation medium from 20, 50, 100 or 200 mg 
mU l brain tissue incubated for 18 hours at 10 °C. 	 61 
Figure 3.10 T levels in incubation medium from 20, 50, 100 or 200 mg mL 
1 brain tissue incubated for 18 hours at 10 °C 	 61 
Figure 3.11 E2 levels in ether-extracted homogenate of 20, 50, 100 or 200 
mg mL-1 brain tissue incubated for 18 hours at 10 °C. 	63 
Figure 3.12 T levels in ether-extracted homogenate of 20, 50, 100 or 200 
mg mL-1 brain tissue incubated for 18 hours at 10 °C. 	63 
Figure 3.13 E2 production by brain tissue homogenate following 18 or 42 h 
incubation with or without added T 	 64 
Figure 3.14 Effects of Al on E2 production by brain tissue homogenate 
following 42 h incubation with added T 	 64 
Chapter 4. 
Figure 4.1 Arrangement of six 1m3 tanks used for first feeding of juvenile 
Atlantic salmon, indoors at Saltas' Florentine facility. 	84 
Figure 4.2 Four m3 tanks used for ongrowing of Atlantic salmon parr, 
outdoors at Saltas' Wayatinah facility. 	 84 
Figure 4.3 Mean weekly water temperature for a) December 2000 to June 
2001 and b) December 2001 to June 2002 in outdoor tanks at 
Wayatinah. 85 
Figure 4.4 Manipulated photoperiod used in Experiments 1 and 2 	85 
Figure 4.5 Atlantic salmon alevins undergoing immersion treatment in 
mesh boxes, in stainless steel containers. 	 86 
Figure 4.6 Percentage masculinisation following single or double 
immersion with MDHT or aromatase inhibitors. 	 93 
Figure 4.7 Proportions of sperm duct status of mature fish, expressed as a 
percentage of mature sex inverted male fish produced by 
immersion in either MDHT or ATD in Experiment 1  93 
Figure 4.8 Percent frequency of pooled data of: a) whole weight; b) fork 
length; c) condition factor and d) GSI, for fish from 
Experiment 1 94 
Figure 4.9 Sections of testis showing spermatocytes (Sp), from individuals 
treated with a) MDHT b)ATD c) aminoglutethimide and d) 
miconazole  95 
Figure 4.10 Sections of ovotestis, from individuals treated with a) and b) 
miconazole c) aminoglutethimide, showing oocytes, male 
gonadal tissue, spermatogonia and secondary spermatocytes  96 
Figure 4.11 Sections of ovaries, from a) control b) aminoglutethimide c) 
miconazole and d) OHA treated individuals. 	 97 
Figure 4.12 Sections of gonads containing a small cluster of oogonia 
amongst testis and sterile connective tissue from a) MDHT 
treated and b) Control individuals. 98 
xi 
Figure 4.13 Percentage masculinisation following immersion with MDHT 
or AI 	 102 
Figure 4.14 Proportions of sperm duct status of mature fish, expressed as a 
percentage of mature sex inverted male fish produced by 
immersion in either MDHT or ATD in Experiment 2 102 
Figure 4.15 Percent frequency of pooled data of: a) whole weight; b) fork 
length; c) condition factor and d) GSI, for fish from 
Experiment 2 103 
Figure 4.16 Sections of testis from a) control or individuals treated with, b) 
ATD, c) fadrozole and d) MDHT. 	 105 
Figure 4.17 Ovotestis from individuals treated with a) and b) fadrozole at 
10 mg L-1 c) ATD at 5 mg L-1 	 106 
Figure 4.18 Sections of ovaries from individuals treated with a) ATD at 
5mg L-1 b) ATD at 0.5mg Cc) and d) MDHT. 	 107 
Figure 4.19 Sections of gonads containing predominantly testis tissue , with 
a cluster of oocytes. Animals treated with a) and d) AID, b) 
and c) MDHT 108 
Chapter 5 
Figure 5.1 
Figure 5.2 
Figure 5.3 
Figure 5.4 
Figure 5.5 
Figure 5.6 
RIA binding curves for a) ATD and b) OHA showing 
displacement curves for T, ATD and OHA standards, and serial 
dilutions of tissue extract, in assays using 3H-T tracer and a T 
antibody.  134 
Chromatograms of fadrozole and internal standard from a 
representative a) standard and b) sample 135 
Standard curves constructed using alevins spiked with 
fadrozole, with miconazole as an internal standard. Values are 
a) fadrozole curve area:miconazole curve area and b) fadrozole 
curve area  136 
Tissue levels of a) AID and b) OHA in Atlantic salmon 
alevins following 120 minutes immersion in solutions of Al of 
4, 20, 100 or 500 1.ig on 14 and 28 DPMH 137 
Tissue levels of AID in Atlantic salmon alevins, following 120 
minutes immersion in solutions of ATD at 0.5 or 5 mg L -1 at a) 
7 and 14 DPMH or b) 14 and 21 DPMH 141 
Tissue levels of fadrozole in Atlantic salmon alevins, following 
120 minutes immersion in solutions of fadrozole at 10 or 50 
mg U l at a) 7 and 14 DPMH or b) 14 and 21 DPMH 145 
xii 
List of Tables 
Chapter 2 
Table 2.1 	Immersion and dietary treatment groups used in Experiment 1.... 30 
Table 2.2 	Immersion and dietary treatment groups used in Experiment 2.... 31 
Chapter 3 
Table 3.1 Effective E2 equivalence due to cross reactivity of AI with E2 
antibody 	 48 
Table 3.2 	Fish whole weight, ovary weight, GSI and oocyte diameter for 
animals used in Experiments 1 and 2. 	 50 
Table 3.3 	Coefficient of variation of E2 production following incubation 
at 10 °C for 18 h, of either five or ten follicles per well. 	57 
Table 3.4 	T levels in incubation media following incubation for 18 hours 
at 10 °C of 20, 50, 100 or 200 mg mL -I brain tissue with 100 
ng T mU l added  	58 
Chapter 4. 
Table 4.1 Sperm motility criteria used in sperm activity assessment 	88 
Table 4.2 	Percent mortality of Atlantic salmon alevins immersion treated 
in different doses of the aromatase inhibitors ATD, OHA, 
miconazole and aminoglutethimide. 	 90 
Table 4.3 	Production parameters for Atlantic salmon, immersion treated 
in either MDHT or the aromatase inhibitors ATD, OHA, 
miconazole or aminoglutethimide. 	 91 
Table 4.4 	Sperm activity parameters and fertility of sex inverted and 
normal male fish in Experiment 1. 	 99 
Table 4.5 	Production parameters for Atlantic salmon, immersion treated 
in either MDHT or the aromatase inhibitors AID or fadrozole 
in Experiment 2 	 100 
Table 4.6 	Sperm activity parameters and fertility of sex inverted and 
normal male fish from Experiment 2   104 
Chapter 5 
Table 5.1 Uptake and tissue levels of the AT ATD and OHA by Atlantic 
salmon alevins, following 120 min immersion in solutions of 
AI at 4, 20, 100 or 500 Kg  138 
Table 5.2 	Percentage uptake and tissue levels of the Al ATD by Atlantic 
salmon alevins, following 120 mm immersion in solutions of 
ATD at 0.5 or 5.0 mg 1: 1 , at either 7 and 14 or 14 and 21 
DPMH 142 
Table 5.3 	Percentage uptake and tissue levels of the Al fadrozole by 
Atlantic salmon alevins, following 120 mm immersion in 
solutions of fadrozole at 10 or 50 mg 1: 1 at either 7 and 14 or 
14 and 21 DPMH. 144 
xiv 
List of Abbreviations 
17,20-3P 17a-20P-dihydroxy-4-pregen-3-one 
17HSD 	17-hydroxysteroid-dehydrogenase 
AGT 	aminoglutethimide 
Al 	aromatase inhibitor 
ATD 	1,4,6-androstatriene-3,17-dione 
DD 	°C days 
DPMH 	days post-median hatch 
ESD 	environmental sex determination 
FAD 	fadrozole 
GSD 	genetic sex determination 
MCZ 	miconazole 
MDHT 	17a-methyldihydrotestosterone 
OHA 	4-androstene-4-o1-3, 1 7-dione 
OSS 	out-of-season smolt 
TSD 	temperature sex determination 
XV 
Chapter 1 
General Introduction 
Of all the animals, the boy is the most unmanageable. 
Plato 
General Introduction 
	
1. 	General Introduction 
1.1 	The Tasmanian Atlantic salmon farming industry 
The first introductions of Atlantic salmon, Salmo salar (L.), to Tasmania occurred 
in the 1860s, with the importation of ova collected from Scotland, England and 
Wales. The first release of Atlantic salmon occurred in 1865, but populations 
failed to establish in Tasmanian waters from this, and a number of subsequent 
releases, and it would be 120 years before a breeding population of Atlantic was 
established in Tasmania, albeit in captivity (Jungalwalla, 1991a). In 1981 the 
Tasmanian Fisheries Development Authority commenced a program to establish a 
salmonid farming industry in the state. Owing to the existencecat the time, of a 
ban on importation of fresh salmonid products into Australia, ova for the 
Tasmanian industry were sourced from an established landlocked population of 
Atlantic salmon in Gaden, New South Wales. This population originated from ova 
imported from Nova Scotia in the 1960s, and had been maintained through a 
hatchery assisted breeding program since that time (Jungalwalla, 1991a). Ova 
from Gaden were transferred to Tasmania in 1984, 1985 and 1986, and these were 
ongrown to become the original Tasmanian Atlantic salmon broodstock cohorts, 
of 1987,1988 and 1989 (Jungalwalla, 1991a). 
The Tasmanian state government established the Atlantic salmon farming industry 
with a high level of regulation, under the auspices of the Salt-Water Salmonid 
Culture Act, in 1985. The act established a company, Salmon Enterprises of 
Tasmania Pty. Ltd. (Saltas), formed as a partnership between the Tasmanian 
government and commercial sector. Among the objectives of Saltas were the 
establishment and operation a hatchery capable of producing 1 million Atlantic 
salmon smolts per annum, and the responsibility to undertake research to improve 
breeding stocks and to benefit the developing marine farming sector (Jungalwalla, 
1991a). Currently Saltas operates two hatcheries, utililising state-of-the-art 
recirculation systems (Anonymous, 1999) to produce in excess of 3 million smolts 
per annum (H.R. King, personal communication). The Tasmanian Atlantic salmon 
farming industry now comprises 5 hatchery companies, supplying 8 independent 
marine farming companies, (Tasmanian Salmonid Growers Association, 
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unpublished data). Industry production has increased from 53 T in 1985/86 to 
15000 T, valued at A$170 million in 2001/02 (Battaglene, 2002) 
Farmed Tasmanian Atlantic salmon reach full maturity over autumn (March to 
May), with spawning occurring in May. Most (97%) Tasmanian Atlantic salmon 
smoltify as 'Si', that is in the second spring after hatching, and are transferred to 
sea during the spring, September-November (Jungalwalla, 1991a). A high 
proportion of farmed Atlantic salmon in Tasmania reach maturity after their first 
year in sea water, a phenomenon termed `grilsing' in the northern hemisphere; 
however, unlike typical northern hemisphere grilse which fail to reach a suitable 
size for harvest prior to maturation, Tasmanian grilse reached a viable harvest size 
of 	kg within 12 months of transfer to sea water (Jungalwalla, 1991b, a). The 
onset of maturation does, however, impose a limit on production, with a 
requirement to harvest stock before the development over austral summer 
(December — February) of undesirable changes associated with the onset of 
secondary sexual characteristics, such as uneven flesh colour, poor flesh texture 
and darkened skin (Jungalwalla, 1991b). Harvesting of fish transferred as smolts 
in spring is therefore limited to a 6 to 8 month period (Jungalwalla, 1991b). In 
1988 Saltas commenced a series of research programs aimed at extending the 
harvest period of farmed Atlantic salmon in Tasmania by developing production 
methods for non-maturing stocks and methods for early smolt transfer 
(Jungalwalla, 1991a). The introduction of non-maturing, triploid stocks has 
proven to be an effective means of extending the harvest season (Jungalwalla, 
1991b). Subsequently, the introduction of out-of-season smolts (OSS), which have 
been photo-manipulated to be able to be transferred to sea in the Austral autumn 
(March — May) has made possible a program of year round harvesting (King, 
1995) 
The success of triploid and OSS production strategies is; however, predicated 
upon the use of monosex female populations to overcome issues of maturation. 
Triploid male salmonids develop testes and secondary sexual characteristics 
(Lincoln and Scott, 1984; Krisfalusi and Cloud, 1999). Similarly, male salmonids 
have a greater tendency to enter maturation at a smaller size than females (Bye 
and Lincoln, 1981), and high proportions of precociously mature males have been 
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recorded elsewhere in mixed sex populations of photo-manipulated Atlantic 
salmon smolt (Duston and Saunders, 1992). In view of this, Saltas has maintained 
a production strategy whereby all triploids and OSS are produced as monosex 
female populations, and monosex female stocks now account for approximately 
70% of Saltas' total smolt production (H.R. King, personal communication). 
1.2 	Sex determination and sex differentiation in fishes 
The processes of sex determination and sex differentiation in fishes have been the 
subject of much discussion in the literature and a number of comprehensive 
reviews covering all aspects of fish sex determination and differentiation have 
been produced in recent years (Nakamura et al., 1998; Baroiller et al., 1999; 
Piferrer, 2001; Devlin and Nagahama, 2002). There is general agreement among 
authors as to the definitions of these terms, namely that sex determination is the 
sum of genetic or environmental processes governing sex differentiation, whereas 
sex differentiation refers specifically to developmental events whereby 
undifferentiated gonadal tissue develops to form testes, ovaries or a 
hermaphroditic gonad (Nakamura et al., 1998; Baroiller et al., 1999; Piferrer, 
2001; Devlin and Nagahama, 2002) and these definitions have been applied in the 
present study. 
In his seminal studies of medaka, Oryzias latipes, Yamamoto (synthesised in 
Yamamoto, 1969) recognised that steroid hormones play a key role in sex 
differentiation of fish, and proposed steroids as the natural inducers of sex 
differentiation. Accepting this premise, the development of cells producing sex 
steroids should precede gonadal differentiation (Nakamura et al., 1998). Although 
there is a substantial amount of data supporting this hypothesis, there is no clear 
evidence of differences between sexes in either the presence of sex steroid-
producing cells or steroid levels (Devlin and Nagahama, 2002). This may be due 
to an inability to measure steroids at sufficiently low levels (Devlin and 
Nagahama, 2002) or that the origin of the steroids is not gonadal. Molecular data 
has indicated differences between individuals, possibly reflecting sex differences, 
in steroidogenic enzyme gene activity in the brain of the zebrafish, Danio rerio 
(Trant et al., 2001). Prior to the development of steroidogenic cells in the gonad, 
both androgen and estrogen receptors may be detected, and it is through this 
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uncoupling of steroid synthesis and reception that exogenous steroids may be 
applied to manipulate sex differentiation (Devlin and Nagahama, 2002). The 
period during which exogenously applied steroids may affect sex differentiation 
has been termed the labile period, and this may be regarded as commencing prior 
to the onset of sex differentiation, and extending to a time after which gonadal 
tissue no longer displays developmental bipotency (Piferrer, 2001). The onset of 
the labile period may not be synchronous for androgens and estrogens, with both 
teleosts (Piferrer and Donaldson, 1989) and amphibians (Petrini and Zaccanti, 
1998) exhibiting sensitivity to estrogens at developmentally earlier stages than 
sensitivity to androgens, and this may be reflected in the onset of ovarian 
differentiation prior to that of testis (Laird et al., 1978; Piferrer and Donaldson, 
1989) 
Teleosts are known to have both genetic and environmental control of sex 
determination (Devlin and Nagahama, 2002). Genetic sex determination (GSD) is 
the most prevalent in the fishes, known to occur in 24 families, compared to 
environmental sex determination (ESD), in 12 families (Devlin and Nagahama, 
2002). The most common from of ESD; temperature-dependent sex determination 
(TSD), is a well recognised phenomenon among reptiles, but it remains unclear 
how widely spread this phenomenon is among the fishes. Many recent studies 
have shown some level of TSD in fishes (eg. D'Cotta et al., 2000; Goto et al., 
2000; Pavlidis et al., 2000; Kitano et al., 2001) and future studies may well 
increase the number of fish species in which TSD is known to occur. Of the . 
teleost species for which GSD has been demonstrated, various genetic systems of 
sex determination exist, including heterogametic males (XX females, XY males), 
heterogametic females (ZZ males, WZ females) and polygenic and clonal systems 
(Devlin and Nagahama, 2002). Fishes also display an extraordinary variety of 
reproductive strategies, with systems of gonochorism, progyny, protandry and 
hermphroditism recognised, and within those species that change sex, 
developmental, social and environmental cues have all been implicated as having 
roles in the onset of the changes (Devlin and Nagahama, 2002). 
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1.3 	Production of monosex female populations 
Concomitant with increased development of, and reliance on, aquaculture of 
finfish, has been an increase in the need to control and manipulate fish 
reproduction (Hunter and Donaldson, 1983; Pandian and Sheela, 1995; Piferrer, 
2001; Devlin and Nagahama, 2002). A frequent demand on culture systems has 
been for the production of monosex or sterile populations for reasons of 
production efficiency. In many species, males are preferred for reasons of faster 
growth (eg. tilapia) or enhanced marketability (eg. ornamental species ) (Pandian 
and Sheela, 1995). However, in some species, notably the commercially valuable 
European sea bass, Dicentrarchus labrax and, as noted earlier, salmonids, females 
are preferred for their reduced propensity to early maturation, with a concomitant 
growth benefit (Bye and Lincoln, 1981; Blazquez et al., 1995). 
Piferrer (2001) described the alternative methods for the production of female 
monosex populations, as 'direct' or 'indirect'. In the direct method, all female 
stocks are produced by the application of exogenous estrogens during the labile 
period (Piferrer, 2001). In contrast, the indirect method, appropriate for species 
having homogametic females, is a 2-generational process. Some females are sex 
inverted, typically by the use of exogenous androgens, to develop and mature as 
males. In a species having females homogameity, all sperm produced by these 
"neomales" will carry an X chromosome, which, when used to fertilise eggs from 
a normal female , will result in the production of all female offspring (Figure 1.1). 
The process of indirect monosex female production is therefore reliant on the 
production of neomales by sex inversion. 
Since the demonstration by Yamamoto (1969) that androgens and estrogens are 
the inducers of male and female sex differentiation respectively, numerous 
workers have investigated steroidal control of teleost sex differentiation much of 
is detailed in the comprehensive reviews by Donaldson and Hunter (1982), Hunter 
and Donaldson (1983), Pandian and Sheela (1995), Donaldson etal. (1996), 
Baroiller etal. (1999) and Devlin and Nagahama (2002). 
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Figure 1.1 	Diagram of the procedure for indirect feminisation of species 
having heterogametic males. (After Piferrer (2001)) 
The development of a successful protocol for sex control using exogenous 
steroids involves the consideration of several factors, including the choice of 
steroid, mode of delivery, dose and timing (Piferrer 2001). At least 16 naturally 
occurring and synthetic androgens have been used to masculinise fish (Pandian 
and Sheela, 1995). The most commonly used compound is the synthetic androgen 
17a-methyltestosterone (MT), preferred for reasons of efficacy, cost and slower 
clearance than natural androgens (Pandian and Sheela, 1995). Methods for 
treating fish with steroid hormones include: immersion, by either the addition of 
steroids to the culture water, or the transfer of fish to a bath containing steroids; 
the addition of steroids to the diet; the use of implants containing steroids and by 
direct injection (Pandian and Sheela, 1995; Piferrer, 2001). Immersion and dietary 
inclusion are the methods most easily applied and are suitable for the treatment of 
large numbers of animals in a commercial setting (Pandian and Sheela, 1995). The 
other methods have been found to be the most appropriate delivery methods for 
some species, such as silver carp, where immersion and dietary treatments were 
ineffective (Mizra and Shelton, 1988). Immersion treatment may be applied to 
fish at all stages of development, whereas dietary treatment is only appropriate to 
feeding stages, thus the choice of application method must be made in 
consideration of the timing of treatment (Pandian and Sheela, 1995; Piferrer, 
2001). Furthermore, the accuracy of delivery is greater for immersion than dietary 
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treatment (Pandian and Sheela, 1995) and typically immersion treatments are of 
shorter duration than dietary treatments (Pandian and Sheela, 1995; Piferrer, 
2001). The timing of steroid treatments for sex control is critical to successful 
treatment. For steroid treatment to be effective for sex control, it must be applied 
in the labile period, which may occur prior to hatching or the onset of feeding 
(Piferrer, 2001). The dose of steroid required to effect sex change is species 
specific and is a combination of steroid concentration and the duration and 
frequency of treatment (Piferrer, 2001). Excessive doses of estrogens have been 
associated with developmental abnormalities and increased mortality, and 
excessive doses of androgens have been associated with gonad malformation and 
sterility (Piferrer, 2001). Insufficient doses of steroids may result in the 
development of intersex gonads (Yamamoto, 1969; Piferrer, 2001; Devlin and 
Nagahama, 2002). 
1.4 	Estrogen and aromatase (cytochrome P450arom) 
Aromatase (cytochrome P450 a,,,„) is the enzyme responsible for the conversion of 
androgens to estrogens, and is found in all vertebrates, being highly conserved 
across vertebrate taxa (Callard et al., 1978). Due to its key role in steroidogenesis, 
and subsequent effects on development, reproduction and behaviour, a substantial 
body of work has been completed on aromatase activity and regulation across a 
range of vertebrate taxa (see reviews by Callard et al., 1978; Lance, 1997; 
Baroiller et al., 1999). 
Aromatase converts androstenedione and testosterone to estrone and estradiol (E2) 
respectively, by a 3 step process involving the synthesis of 3 intermediate 
compounds, and utilisation of 3 moles of oxygen and 3 moles of nicotinamide 
adenine dinucleotide phosphate (NADPH) for each mole of estrogen produced 
(Cole and Robinson, 1990; Brueggemeier, 2001) (Figure 1.2). The mechanism of 
the final step is unclear, but terminates with the aromatisation of the A ring of the 
steroid, by the oxidative cleavage of the bond between C-10 and C-19 and loss of 
the C-19 carbon as formic acid (Figure 1.2) (Cole and Robinson, 1990; 
Brueggemeier, 2001). 
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Figure 1.2 	Mechanism of the aromatisation of testosterone. (After 
Brueggemeier (2001)) 
Evidence from cloning studies suggests that a single protein molecule is 
responsible for all steps (Cole and Robinson, 1990). Humans carry a single 
aromatase gene, designated cypI9 , spanning 123 kilobases and with a coding 
region of 9 exons (Meinhardt and Mullis, 2002). In contrast, some teleosts, 
including goldfish, Carassius auratus (Tchoudakova and Callard, 1998; Callard et 
al., 2001) and zebrafish (Callard et al., 2001; Kishida and Callard, 2001; Tong et 
al., 2001; Trant et al., 2001) carry multiple copies of the cyp19 gene. These genes, 
termed cypl9a and cypl9b for the forms expressed predominantly in the gonad 
and brain respectively, exhibit greater homology between either the a or b genes 
between species, than between the 2 genes within a species (Tong et al., 2001; 
Dalla Valle et al., 2002). 
Aromatase activity is greatest in gonadal and brain tissue; however, other tissues 
may also have some level of activity (Callard et al., 1978; Belvedere et al., 1998; 
Silverin et al., 2000; Dalla Valle et al., 2001; Zhao et al., 2001). Within the brain, 
aromatase activity is highest in the forebrain and telencephalon (Callard et al., 
1978, 1981; Pasmanik and Callard, 1985; Andersson et al., 1988; Foidart et al., 
1995b; Gelinas et al., 1998; Melo and Edmunds, 1999; Silverin et al., 2000). In 
the ovary, aromatase activity is primarily in the granulosa layer (Devlin and 
Nagahama, 2002) and shows seasonal variation (Callard et al., 1981; Devlin and 
Nagahama, 2002). 
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In mammals, carrying a single copy of cyp19, tissue specific gene expression is 
achieved through multiple promoters, which are differentially expressed in the 
brain and gonad (Meinhardt and Mullis, 2002). In contrast, there is little overlap 
in the expression of cypl9a and cypl9b (Tchoudakova and Callard, 1998). Studies 
on goldfish indicate that there is temporal variation in the expression of cypl9a 
and cypl 9b, during development (Callard et al., 2001; Tchoudakova et al., 2001) 
and furthermore, there are distinct levels of expression of cypl9b in developing 
zebrafish (Trant et al., 2001). 
Estrogens fulfill roles as both hormones and neurotransmitters (Canard et al., 
1990) and the regulation of estrogens in both roles may be achieved through 
aromatase regulation. In Japanese quail, Coturnix japonicus, male behaviour is 
moderated by E2 synthesised in the forebrain, and Balthazart et al. (2001) 
demonstrated that aromatase activity could be regulated sufficiently rapidly to 
achieve this, by ion flux. The key role of E2 in female sex differentiation of non-
mammalian vertebrates is supported by a number of studies in which the 
disruption of E2 synthesis results in the development of male gonads (eg. Petrini 
and Zaccanti, 1998) or a male phenotype (eg. Piferrer et al., 1994; Wennstrom and 
Crews, 1995; Chardard and Doumon, 1999; Guiguen et al., 2000). In species with 
TSD, brain (Willingham et al., 2000) or gonadal (Jeyasuria and Place, 1997) 
aromatase activity is higher at temperatures known to cause female development 
than at male determining temperatures and a mechanism of sex determination 
based on temperature-dependent aromatase activity has been proposed (Richard-
Mercier et al., 1995; Jeyasuria and Place, 1998). 
1.5 	Aromatase inhibitors 
Modulation of E2 levels by reducing E2 synthesis is a strategy employed in human 
medicine for the treatment of estrogen dependent tumors (Brodie et al., 1999; 
Brueggemeier, 2001). The first compound recognised as having aromatase 
inhibitory activity was aminoglutethimide (34p-aminopheny1]-3-ethyl-piperidine-
2,6-dione) (Figure 1.3a), a compound originally developed as an anti convulsant 
(Brueggemeier, 2001). Similarly, miconazole (142,4-dichloro-13-([2,4- 
dichlorobenzyl]oxy)-phenethyl]imidazole) (Figure 1.3b), an anti-mycotic 
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Figure 1.3 	Representative 	non-steroidal 	aromatase 	inhibitors 	a) 
aminoglutethimide, b) miconazole, c) fadrozole, d) letrozole, e) 
anastrozole 
imidazole was found to inhibit aromatase activity (Mason et al., 1985). Since the 
discovery of these 'first generation' compounds in the 1970s, an extensive 
research effort has led to the development more specific and effective aromatase 
inhibitors (Al). As a result, there is now a better understanding of the structure 
and function of aromatase, which has, in turn aided the development of more 
effective Al (Seralini and Moslemi, 2001). Imidazole and triazole derivatives have 
now been developed that show a greater level of specificity than the first 
generation compounds, and these include letrozole (CGS 20267) (Figure 1.3d) 
and anastrozole (ZD 1033) (Figure 1.3e), both of which are currently used in 
clinical treatment (Demers et al., 1999; Buzdar, 2000; Seralini and Moslemi, 
2001), and fadrozole (4-[5,6,7,8-tetra-hydroimidazo-[1,5-a]-pyridin-5-y1 
benzonitrile HC1), (Figure 1.3c) used in human treatment and experimental studies 
of aromatase in a wide range of vertebrate taxa (eg. Elbrecht and Smith, 1992; 
Demers et al., 1993; Wade et al., 1994; Wennstrom and Crews, 1995; Chardard 
and Dournon, 1999; Kitano et al., 2000). 
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Figure 1.4 	Representative steroidal aromatase inhibitors 	OHA b) 
exemestane c) ATD 
In addition, a broad range of steroidal compounds, based structurally on 
androstenedione, have been investigated and synthesised for use as Al. These 
compounds include OHA (formestane, 4 androstene-4-o1-3,17-dione) (Figure 
1.4a) and exemestane (6-methylenandrosta-1,4-diene-3,17-dione) (Figure 1.4b) 
both in use clinically (Brueggemeier, 2001; Seralini and Moslemi, 2001) and 
ATD (1,4,6-androstatriene-3,17-dione) (Figure 1.4c) used in a number of animal 
studies of aromatase activity and regulation (eg. Alexandre and Balthazart, 1987; 
Foidart et al., 1995a; Antonolopou et al., 1999). 
Inhibition of enzyme function by AT may occur in a number of ways. The 
majority of non-steroidal Al are competitive inhibitors, interfering with steroid 
hydroxylation by the formation of a covalent bond between a nitrogen atom and 
the aromatase heme iron; however, this mode of action may affect other 
cytochromeP450 enzymes also possessing a heme iron (Brueggemeier, 2001; 
Seralini and Moslemi, 2001). This lack of specificity accounts for some of the 
side effects of some of the early non-steroidal Al, although subsequent 
generations of non-steroidal Al are more specific for aromatase. (Brueggemeier, 
2001). Steroidal Al may act competitively or as mechanism-based inhibitors, 
binding irreversibly to the enzyme. (Numazawa and Tachibana, 1997; Brodie et 
al., 1999; Seralini and Moslemi, 2001). Mechanism-based Al are more specific in 
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their action, but side effects of steroidal Al due to their androgenic properties have 
been reported (Seralini and Moslemi, 2001). Due to the low K m of aromatase, 
competitive Al are required at high concentrations to be effective (Cole and 
Robinson, 1990). In contrast, mechanism-based Al are effective at lower 
concentrations and furthermore, due to the low turnover rate of aromatase, the 
effect of inhibitors that irreversibly bind to the enzyme extends beyond the 
treatment period (Cole and Robinson, 1990). 
1.6 	Sex control using Al 
The development of Al has enabled the development of new approaches to 
endocrinological research. Al have been used to investigate the role of E2 as a 
neurotransmitter and modulator of bird reproductive behaviour (Alexandre and 
Balthazart, 1987; Kaplan and McGuinnis, 1989; Melo and Edmunds, 1999; Soma 
et al., 1999). Other studies using Al have dealt with the role of aromatase in the 
regulation of reproductive hormones (Pasmanik et al., 1988; Afonso et al., 1999a, 
b; Antonolopou et al., 1999; Sampath-Kumar et al., 2000). The use of Al for sex 
control has also been the subject of a number of studies, dealing with a range of 
vertebrate taxa. The female parthenogenetic whiptail lizard, Cnemidophorous 
uniparens was masculinised by the application of letrozole and anastrozole to 
developing eggs (Wennstrom and Crews, 1995) and masculinisation of the newt, 
Pleurodeles wait! was achieved by immersion treatment with fadrozole (Chardard 
and Dournon, 1999). Within the teleosts, the Japanese flounder, Paralichthys 
olivaceus and Nile tilapia, Oreochromis niloticus have been masculinised by 
dietary treatment using fadrozole (Kitano et al., 2000; Kwon et al., 2002) and the 
salmonids, rainbow trout, Oncorhynchus mykiss and coho salmon, 0. kisutch have 
been masculinised by dietary treatment with ATD (Guiguen et al., 1999) and 
immersion treatment with fadrozole (Piferrer et al., 1994) respectively. 
The use of chemotherapeutants in aquaculture is becoming increasingly more 
regulated and the development of alternative strategies to masculinisation than 
through the use of steroid hormones will be of strategic benefit to the aquaculture 
industry. Furthermore, consumers and regulators are becoming more concerned 
with the use of steroids in animal production, evidenced by a European Union 
move in 2002 to ban the use of growth promoter steroids in animal production. 
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The use of Al for the sex control of fish species in aquaculture therefore offers 
significant benefits to the aquaculture industry. 
1.7 	The present study 
The high likelihood that the production of farmed salmonids will require a 
substantial proportion of monosex female stocks both in Tasmania and other 
salmon producing regions will necessitate the continued production of neomales. 
The development of alternate methods to steroid hormones for sex inversion of 
farmed fish is therefore a strategic goal, aimed at alleviating potential future 
problems associated with the use of steroid hormones. However, in order to 
optimise the production of Atlantic salmon neomales, it is necessary to develop a 
greater understanding of the processes of sex differentiation, in particular, the role 
of E2 in sex differentiation. Al provide a means to address both of these issues. 
Accordingly, the present study set out to use Alto investigate the processes of sex 
differentiation in Atlantic salmon and to develop protocols for their use in the 
production of Atlantic salmon neomales in a commercial setting through a series 
of experiments undertaken to investigate: 
The efficacy of androgens for masculinisation of Atlantic salmon and optimise 
androgen-based masculinisation protocols for Tasmanian Atlantic salmon, 
providing baseline against which to assess the efficacy of Al for masculinisation. 
The synthetic androgens MT and 17a-methyldihydrotestosterone were applied at 
a range of doses using dietary and immersion treatments, over various treatment 
times. Previously published protocols for masculinisation using androgens has 
been largely developed for Oncorhynchus species (eg. Goetz et al., 1979; Baker et 
al., 1988; Cousin-Gerber et al., 1989; Piferrer et al., 1993; Feist et al., 1995) 
although some early studies did consider Atlantic salmon with limited success 
(Johnstone et al., 1978; Johnstone et al., 1979; Johnstone and Youngson, 1984). 
The in vitro efficacy of Al on both Atlantic salmon gonadal and brain aromatase 
by comparing E2 production by isolated follicles or brain homogenate, incubated 
with testosterone alone or with testosterone and Al. The roles of the 2 forms of 
aromatase in sex differentiation are presently unclear and recent research has 
indicated Al efficacy varies for brain and gonadal aromatase (Zhao et al., 2001) 
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The efficacy of Al for masculinisation of Atlantic salmon and the effects of the 
timing and dose of AT on sex differentiation. Atlantic salmon alevins were treated 
with Al by immersion, using a range of doses treatment times, and phenotypic sex 
and gonadal structure were examined. 
The characteristics of uptake and retention of AI, by determining tissue levels of 
Al at various times following immersion treatment. Although in vivo efficacy of 
Al may be inferred form the in vitro studies, it will also be influenced by the 
efficiency of its uptake and subsequent metabolism. 
Detailed below is the planned publication schedule for Chapters 2-5. As a result of 
this, there are elements of repetition in introductions and methods sections of 
these chapters. 
Chapter 2: Lee, P.S., King, H.R. and Panlchurst, N.W. Preliminary assessment of 
sex inversion of farmed Atlantic salmon by dietary and immersion androgen 
treatments. Nth. Am. J. Aquaculture (in press) 
Chapter 3 Lee, Pankhurst, N.W. and King, H.R. In prep. Effects of aromatase 
inhibitors on in vitro steroidogenesis in Atlantic salmon (Salmo salar) gonadal 
and brain tissue. 
Chapter 4 Lee, P.S., King, H.R. and Panlchurst, N.W. A comparison of 
aromatase inhibitors for the sex reversal of female Atlantic salmon (Salmo salar 
L.). Fish Physiol. Biochem (in press) 
King, H., Lee, P.S. and Panldiurst, N.W. Photoperiod-induced 
precocious male sexual maturation in Atlantic salmon (Salmo salar). Fish Physiol. 
Biochem (in press) 
Lee, P.S., King, H.R. and Panlchurst, N.W. In prep. Efficacy of 
aromatase inhibitors for sex inversion, and effects of aromatase 
inhibitor immersion, on production parameters of farmed Atlantic 
salmon. 
Chapter 5 Lee, P.S., PanIchurst, N.W. and King, H.R. In prep. Uptake and 
retention of aromatase inhibitors by Atlantic salmon, Salmo salar (L.) alevins. 
14 
General Introduction 
Ethical clearance for animal experimentation work undertaken for this study was 
conducted under permit No. A0007172 issued by the University of Tasmania, 
Tasmanian Animal Experimentation Ethics Committee. 
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Chapter 2 
Preliminary assessment of sex reversal of Atlantic salmon by dietary 
and immersion androgen treatments. 
Sweet Loretta Martin thought she was a woman 
But she was another man 
John Lennon & Paul McCartney 
Get Back 
	2. 	Preliminary assessment of sex reversal of farmed Tasmanian 
Atlantic salmon (Salmo salar) by dietary and immersion 
androgen treatments. 
2.1 	Introduction 
Since early demonstrations of the potency of exogenous steroid hormones to 
influence sexual development in fish, numerous studies have investigated both the 
necessary protocols for manipulating development, and some of the mechanisms 
involved (reviewed by Hunter and Donaldson, 1983; Pandian and Sheela, 1995; 
Piferrer, 2001; Devlin and Nagahama, 2002). The studies of Yamamoto (1969) 
showed that exogenous androgens masculinise differentiating individuals, 
whereas estrogens are feminising agents, and Yamamoto proposed that these 
compounds are the natural masculinising and feminising agents respectively in 
fish. The use of these compounds to produce mono-sex fish populations for 
aquaculture is now well established and is in routine use where mono-sex 
populations fulfil production needs or environmental constraints (Hunter and 
Donaldson, 1983; Piferrer, 2001). 
Both natural and synthetic steroids are effective for sex inversion, however they 
vary considerably in their efficacy (Piferrer and Donaldson, 1991, 1992; Piferrer 
et al., 1993; Piferrer, 2001). The synthetic androgens 17a-methyltestosterone 
(MT), and 17a-methyldihydrotestosterone (MDHT) have been shown to have 
greater potency than either testosterone or 11-ketotestosterone (Piferrer et al., 
1993; Pandian and Sheela, 1995), and the synthetic compounds, in particular MT, 
have been widely used both in experimental studies (e.g. Baker et al., 1988; 
Piferrer et al., 1993; Blazquez et al., 2001), and commercial production 
(Johnstone and Maclachlan, 1994) of masculinised fish. Similarly, 
ethynylestradio1-17a (EE2), a synthetic estrogen is known to be significantly more 
potent than the natural 1713-estradiol (E2) (Yamamoto, 1969; Piferrer and 
Donaldson, 1992). Devlin and Nagahama (2002) proposed that differences in 
potency reflect differences in receptor affinity, activities of steroid-receptor 
complexes and steroid metabolism. 
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The administration of steroid hormones to manipulate sexual development has 
been achieved by a number of means, reviewed by Pandian and Sheela (1995). 
Dietary administration involves the application of a solution of the steroid in a 
volatile solvent to manufactured, pelletised feed and fish are fed the treated feed 
over a period of several weeks. Typically, dietary treatments commence at or near 
the time of first feeding (Pandian and Sheela, 1995). An alternative is immersion 
treatment, where individuals are placed in an aqueous solution of the steroid for 
several hours. Unlike dietary treatments, this technique may be applied to 
individuals before hatching or feeding and the exposure each individual receives 
may be accurately determined. Immersion treatments are also easier to complete, 
and may have fewer issues of worker safety (Pandian and Sheela, 1995; Piferrer, 
2001). Regardless of the method used to apply steroids, treatment is optimal 
during the labile period, during which sex differentiation may be influenced by 
exogenous factors (Pandian and Sheela, 1995; Baroiller et al., 1999; Piferrer, 
2001; Devlin and Nagahama, 2002). 
Effective steroid doses for sex inversion vary between and within species. In 
dietary studies, Kitano et al. (2000) achieved 100% masculinisation of the 
Japanese flounder, Paralichthys olivaceus, using MT at a rate of 10 mg kg"' food, 
for 1260 °C days (DD), while a similar result was obtained for rainbow trout, 
Oncorhynchus mykiss, treated at 0.5 mg kg-1 food for 548 DD (Cousin-Gerber et 
al., 1989). Complete masculinisation of all female stocks of chinook salmon, 0. 
tshawytscha, was achieved by immersion for 120 minutes in MT at a 
concentration of 400 jig r' (Piferrer et al., 1993) or 200 lug r' MT (Baker et al., 
1988). Repeated immersion treatments were more effective for masculinisation of 
chinook salmon (Baker et al., 1988); however, masculinisation rates declined with 
repeated immersion treatments of rainbow trout (Feist et al., 1995). Within limits, 
the effects of steroid treatments may be dose dependent (Baker et al., 1988; 
Piferrer and Donaldson, 1991; Piferrer et al., 1993), but high doses have resulted 
in the production of a significant proportion of sterile individuals (Johnstone et al., 
1978; Goetz et al., 1979; Johnstone et al., 1979; Solar et al., 1984). Paradoxical 
feminisation, the phenomenon of an increased proportion of females produced 
following high doses of androgens, has also been reported in some species 
(Goudie et al., 1983; Solar et al., 1984; Piferrer and Donaldson, 1991; Piferrer et 
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al., 1993). This is attributed to the aromatisation of androgens to biologically 
active estrogens (Piferrer and Donaldson, 1991; Piferrer et al., 1993). 
The production of all female stocks of Atlantic salmon, Salmo salar (L.), is 
preferred in Tasmania, for the production of non-maturing triploids (Jungalwalla, 
1991) and because all female stocks have a reduced propensity to early maturation 
following transfer to seawater (Bye and Lincoln, 1981; Donaldson et al., 1996). 
Current production methods follow the indirect method described by Piferrer 
(2001). This method, suitable for species having homogametic females, involves 
the sex inversion of a small proportion of females, which subsequently develop as 
phenotypic males, and are used as broodstock to provide milt for crosses with 
normal females, resulting in the production of unmanipulated, all female, 
offspring. While early attempts at masculinisation of Atlantic salmon by dietary 
and immersion treatments were largely unsuccessful (Johnstone et al., 1978), later 
studies considerably improved treatment efficacy (Johnstone and Maclachlan, 
1994), however, no treatment to date has had the level of success or ease of 
application as those achieved for Oncorhynchus spp. This study aimed to develop 
more effective dietary and immersion treatment regimes for the masculinisation of 
Atlantic salmon in Tasmania, and to apply such treatments for the production of 
sex reversed males under commercial conditions. Accordingly, in the first 
experiment, a series of immersion and dietary protocols were conducted to better 
define the labile period for immersion treatment of this species, and to ascertain 
effective dietary treatment levels. Subsequently, the most successful immersion 
and dietary treatments were repeated on larger groups of fish, which were then 
ongrown to maturity for assessment of fertility. While MT was initially used as 
the established dietary treatment, non-aromatisable MHDT was preferred for 
immersion and latter dietary treatments on the basis that issues of paradoxical 
feminisation could be avoided. 
2.2 	Materials and Methods 
2.2.i Stock and Husbandry 
Experiments were conducted over two years (1991 and 1992) at Saltas Freshwater 
Operations, Wayatinah, Tasmania, using the progeny of 2+ year old Atlantic 
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salmon broodstock. Prior to transfer freshwater for final maturation, broodstock 
had been maintained at Saltas Marine Operations, Dover, Tasmania. Broodstock 
were reared in a 65m polar circle-style cage, and fed to satiation on a steam 
pelletised commercial diet (Gibsons Ltd., Cambridge, Tasmania). Sex inverted 
female fish were used to provide milt in both experiments. These stocks had been 
masculinised by dietary treatment with MT at 3 mg kg1 feed, following methods 
similar to Solar etal. (1984). Fertilised ova were incubated in commercial 
upwelling incubators at 8 °C. Once eyed, eggs were transferred to Heath vertical 
incubator trays (Maricource Inc., Tacoma, USA) and maintained at 7-10 °C until 
swim up stage. Fry were transferred to 1 m 3 tanks for first feeding and subsequent 
rearing. Immersion treatments were timed in relation to the day of median hatch 
(approximately 450 DD post fertilisation), and dietary treatments commenced at 
first feeding. Populations of parr were maintained in indoor 1 m 3 tanks receiving 
water 10-12°C, under a natural photoperiod, until sampled for gonadal 
examination, approximately eight months post-hatch. 
Experimental protocols 
Experiment 1 
Stock solutions (10 mg m1 -1 ) of MT and MDHT were prepared in 100% ethanol, 
and refrigerated until required. Feed for dietary treatments was prepared by 
diluting MT stock solution in 100% ethanol, mixing with feed at 200 ml kg -1 , and 
leaving overnight to allow evaporation of the solvent. Feed was prepared with 
either 1 mg MT kg1 or 3 mg MT kg -1 and fed to a separate groups of 6000 fry for 
a period of approximately 800 DD, commencing at the onset of feeding, at 
approximately 850 DD post-fertilisation. Bathing commenced at median hatch 
(Day 0, approximately 450 DD post-fertilisation), with baths undertaken weekly 
up to 28 days post median hatch (DPMH) or approximately 690 DD post-
fertilisation. Groups of fly received either a single bath, or two baths, 7 to 14 days 
apart as shown in Table 2.1. Bathing was undertaken in Heath trays, with the 
MDHT stock solution added to water to give a final concentration of 400 lug 
MDHT L -1 , which was recirculated through the Heath trays for 120 mm at 0.3 L s -
. Recirculation ceased at the completion of the immersion period and flow 
through resumed at 0.3 L s -1 to ensure dispersal of any remaining steroid. 
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Duplicate trays, each containing 3000 fry were used for each immersion treatment 
group. Owing to restrictions imposed by commercial considerations, only a single 
population of untreated, all female fish, derived from the same parental stocks as 
the experimental fish, was maintained as a control for both the dietary and 
immersion treatments. Such populations are known to contain a small proportion 
of genetic males (H.R. King, unpublished data), resulting from the inclusion of 
genetic male broodstock in all female production. 
Table 2.1 	Immersion (17a-methyldihydrotestosterone (MDHT)) and dietary 
treatment (17a-methyltestosterone (MT)) groups used in 
Experiment 1. 
Group 
Hormonal Treatment 
Treatment Duration 
Dietary 
MDHT Immersion 
(DPMIla) 
MT First Second 
Ab nac na na 
B 1 mg kg-1 na na 800 °C Days 
C 3 mg kg-1 na na 800 °C Days 
D na 0 120 min per immersion 
E na 0 7 120 min per immersion 
F na 0 14 120 min per immersion 
G na 7 120 min per immersion 
H na 7 14 120 min per immersion 
I na 7 21 120 min per immersion 
J na 14 120 min per immersion 
K na 14 21 120 min per immersion 
L na 14 28 120 min per immersion 
a days post-median hatch 
b untreated all female population 
c not applicable 
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Experiment 2 
To exclude the likelihood of paradoxical feminisation, MDHT was used for both 
dietary and immersion treatments in Experiment 2. A diet with 1 mg MDHT kg -1 
was prepared and fed to a single group of 6000 fry as in Experiment 1. Duplicate 
Heath trays, each containing 3000 fry, were immersed for 120 minutes in a tank 
containing MDHT at 400 jig L -1 . Baths commenced on 14 DPMH (approximately 
570 DD post-fertilization), with groups of fry receiving second bath, on either 21 
DPMH (approximately 630 DD post-fertilization) or 28 DPMH (approximately 
690 DD post-fertilization) (Table 2.2). As in Experiment 1, a single population of 
untreated, all female fish, derived from the same parental stocks as the 
experimental fish, was maintained as a control for both the dietary and immersion 
treatments. 
Fish that had been ongrown at Saltas Marine Operations were returned to 
freshwater as 2+ year fish and phenotypic males were examined for sperm duct 
morphology. 
Table 2.2 	Immersion (17a-methyldihydrotestosterone (MDHT)) and dietary 
(MDHT) treatment groups used in Experiment 2. 
Group 
MDHT Treatment 
Dietary 
Immersion (DPMH)a  
First Second Treatment Duration 
Ab nac na na na 
B 1 mg kg-1 na na 800°C Days 
C na 14 21 120 min per immersion 
D na 14 28 120 min per immersion 
a days post-median hatch 
untreated all female population 
c not applicable 
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2.2.iii Gonadal examination 
In both experiments 1 and 2, a sample of approximately 100 fish was collected 
from each group nine months post-hatch. Fish were euthenased by a blow to the 
head, and dissected for gonadal examination under a dissecting microscope. 
Individuals having oocytes present within gonad were scored as female, whereas 
all others were scored as male, thus intersex or sterile individuals may have been 
included with either male or female fish. In Experiment 2, fish remaining after 
sampling for gonadal examination were retained for a further period of 
approximately two months, until reaching a weight of approximately 45g. 
Treatment groups were marked by freeze branding, maintained in 1 m3 tanks for a 
further four months, until transfer outdoors to 4m 3 tanks, where they remained 
until smoltification and subsequent transfer to Saltas Marine Operations. Fish 
were maintained as part of a population of approximately 5000 fish in a 65 m 
polar circle style cage and reared under standard Tasmanian commercial 
conditions from arrival in September 1993, until being returned to Wayatinah in 
February 1995 for assessment of maturity, fertility and sperm duct patency. 
2.2.iv Statistical Analysis 
Alterations in sex ratio relative to untreated all female (control) groups were 
tested using a contingency Chi-squared test for each treatment group. In 
Experiment 2, differences in sperm duct patency frequency between treatment 
groups B, C and D were assessed using a Chi-squared contingency test. 
2.3 	Results 
2.3.i Experiment 1 
With the exception of a single immersion treatment on median hatch day 
(Treatment D), all dietary and immersion treatments significantly increased the 
proportion of phenotypic males (Figure 2.1). Both dietary treatments (Treatments 
B and C) resulted in complete sex reversal of the population. Single immersion 
treatments on either 0, 7 or 14 DPMH (Treatments D, G and J) resulted in 
masculinisation levels of 11, 58 and 61% respectively. Conducting a second 
immersion treatment, either 7 or 14 days after a bath at 0 DPMH (Treatments E 
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and F), significantly increased the proportion of masculinisation (61 and 54% 
males respectively) in comparison to the control population (8% males). Although 
all other treatments resulted in significant levels of masculinisation compared to 
control populations, some qualitative differences between treatments were 
apparent. A second immersion following a bath at 7 DPMH (Treatments H and I) 
resulted in increased levels of masculinisation , (77 and 79% respectively) and 
second immersion following a bath at 14 DPMH (Treatments K and L) resulted in 
increased levels of masculinisation (90 and 95% respectively) (Figure 2.1). 
0 
*** *** 
•111 	I 	I  
	
*** *** 	I 
*** 
100- 
80- 
G) 
co 60 - 
E 
c*' 40- 
20- 
A 	BC 	DEF 	GHI 	JKL 
Treatment group 
Figure 2.1 	Percentage masculinisation in immersion and dietary treatment 
groups used in Experiment 1. Refer to Table 1 for treatment details. 
Asterisks indicate a significant difference (***p<0.001) in 
proportion from the untreated, all female group (Group A). 
2.3.ii Experiment 2 
All MDHT treatments resulted in complete masculinisation of fish sampled at 
nine months post-hatch, which was significantly different from the untreated all 
female population (Figure 2.2). The incidence of sperm duct patency, was highest 
in the immersion treated fish (Treatments C and D, 92 and 84% respectively) 
(Figure 2.2) and differed significantly between treatment groups B (59%), C and 
D (x2 = 14.4, 2 di, p<0.01). 
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Figure 2.2 Percentage masculinisation and open sperm ducts in immersion and 
dietary treatment groups used in Experiment 2. Refer to Table 2 for 
treatment details. Other details as for Figure 2.1 
2.4 	Discussion 
The high levels masculinisation by dietary treatments of both MT and MDHT 
achieved in this study are consistent with, or improvements upon, the levels 
achieved previously using dietary androgens for Atlantic salmon. Johnstone et al. 
(1978), achieved 100% masculinisation of Atlantic salmon following dietary 
treatment with MT, but 17% of these fish proved to be sterile, with gonads 
comprised primarily of connective tissue. Johnstone and Maclachlan (1994) 
reported the same phenomenon at a high level in Scottish commercial hatcheries 
using a dietary treatment of 3mg MT kg -1 feed. Similar effects have been noted in 
other species treated with high doses of androgens (Goetz et al., 1979; Solar et al., 
1984; Piferrer et al., 1994a; Galbreath and Stocks, 1999; Blazquez et al., 2001). 
As neither fertility nor gonad histology were assessed in Experiment 1, it is not 
known whether a similar effect occurred in similarly treated animals here 
(treatment group B), and it is possible that animals with gonads primarily 
containing connective tissue were present, but having apparently filiform testis, 
were recorded as males. 
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The effectiveness of low dose androgens (1 mg kg-I feed) found in this study 
(Experiment 1 treatment group C; Experiment 2, treatment group B) is 
substantially higher than that found by Johnstone and Maclachlan (1994) who 
reported a masculinisation level of 46-56% in mature fish treated with 0.25-1.0 
mg MT kg -1 feed. However, this figure may have underestimated the level of 
masculinisation as the sex of immature fish was not determined. Alternatively, the 
observed differences between the present study and that of Johnstone and 
Mac lachlan (1994) may reflect the differences in treatment duration (500 DD 
compared to 800 DD) between the studies. Duration of steroid exposure has been 
previously shown to affect the degree of sex reversal in salmonids (Chevassus and 
Kreig, 1992; Piferrer and Donaldson, 1992). Increased duration of both dietary 
(Chevassus and Kreig, 1992) and immersion (Piferrer and Donaldson, 1992) 
steroid treatments resulted in increased levels of sex inversion. 
There was no evidence of paradoxical feminisation in this study, with dietary 
doses of the aromatisable androgen MT ranging from Ito 3 mg kg -1 feed for 800 
DD. Substantially higher doses than those used in this study (>25 mg kg' feed for 
330 — 1320 DD) caused some degree of paradoxical feminisation in rainbow trout 
(Solar et al., 1984), and high dose (6.4 mg L -I ) immersion treatments with MT 
was associated with the production of an increased proportion of females in coho 
salmon (Piferrer and Donaldson, 1991). This effect was not apparent with an 
equivalent dose of non-aromatisable MDHT (Piferrer and Donaldson, 1991) and 
on this basis, it has been proposed that the mechanism of paradoxical feminisation 
is by aromatisation of androgens to estrogens (Piferrer et al., 1993). While the 
doses of MT and MDHT used in this study were sufficient to induce complete sex 
reversal, there was no evidence of other effects, such as the production of intersex 
individuals, sterility and paradoxical fetninisation, reported by other workers 
(Johnstone et al., 1978; Johnstone and Maclachlan, 1994; Piferrer et al., 1994a) 
and respectively proposed to be the result of insufficient or excessive doses 
(Galbreath and Stocks, 1999). 
Results of the present study suggest that treatment by immersion is most effective 
in the period 14 to 28 DPMH, suggesting that the labile period for masculinisation 
of Atlantic salmon commences during this time. This result is consistent with 
other data for Atlantic salmon where immersion was most effective in the period 
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650-900 DD post-fertilisation (Johnstone and Maclachlan, 1994), equivalent to 
16-45 DPMH for conditions used in this study. However, these findings contrast 
with those of Baker et al. (1988) Piferrer and Donaldson (1989), Piferrer et al. 
(1993) and Feist et al. (1995) who showed in chinook salmon, coho salmon and 
rainbow trout respectively, the labile period for androgen immersion treatment 
commenced at or before hatching, but may extend to 13 DPMH. Variations in the 
labile period among different taxa are well recognised (Hunter and Donaldson, 
1983; Pandian and Sheela, 1995; Piferrer, 2001), probably reflecting interspecific 
differences in developmental rates (Devlin and Nagahama, 2002). In Atlantic 
salmon, gonadal primordia appear at 60 DD pre-hatch, while gonadal 
differentiation in Atlantic salmon continues to 600 DD post-hatch (Laird et al., 
1978). In contrast, coho salmon gonadal primordia were detected at 10 DD pre-
hatch, differentiation commenced at 270 DD post-hatch (Piferrer and Donaldson, 
1989) and differentiated gonads were discernible at 490 DD post-hatch (Goetz et 
al., 1979). This suggests that observed differences in the labile period between 
Atlantic and Pacific salmon arise from differences in the timing and duration of 
gonadal differentiation. 
The qualitative increase in masculinisation following repeated immersion 
suggests that under the rearing conditions used, double treatments may be more 
effective than single. Repeated immersion in MT has been used to produce a high 
masculinisation rate for Atlantic salmon (Johnstone and Maclachlan, 1994); 
however, this study did not compare the treatment with a single immersion. Other 
studies investigating the effects of multiple immersion treatments on sex reversal 
in salmonids have had varying results. Baker et al. (1988) found increased levels 
of masculinisation in chinook salmon following a second immersion treatment; 
however, a decrease in masculinisation was seen with additional immersion 
treatments of rainbow trout (Feist et al., 1995). Single immersion treatments of 
coho and chinook salmon have resulted in masculinisation rates of 70-100% 
(Piferrer and Donaldson, 1989, 1991; Piferrer et al., 1993; Piferrer et al., 1994b). 
It is likely that the increased effectiveness of a second immersion treatment may 
be due to maintenance of an increased tissue loading of androgen, allowing 
increased exposure of susceptible individuals over time. The results of this study 
are therefore consistent with a requirement by Atlantic salmon, in comparison to 
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Pacific salmon, of increased levels of androgens, or elevated levels of androgens 
for a longer period, for masculinisation to occur. 
The results of Experiment 2 showed that both immersion and dietary treatment of 
Atlantic salmon with MDHT are successful means of sex reversal. This is the first 
time MDHT has been reported to masculinise Atlantic salmon, and the first 
successful use of MDHT by dietary treatment. MDHT has been successfully used 
in immersion treatments of coho and chinook salmon (Piferrer and Donaldson, 
1991; Piferrer et al., 1993) and rainbow trout (Krisfalusi and Cloud, 1999) 
however, dietary treatment of channel catfish with MHDT was unsuccessful 
(Davis et al., 1990). 
The increased incidence of patent sperm ducts in immersion-treated fish, 
compared to dietary treatment is consistent with other studies. The association 
between sex reversal by dietary administration of androgens and malformations 
of the gonad has been noted by several authors (Johnstone et al., 1979; Johnstone 
and Youngson, 1984; Cousin-Gerber et al., 1989; Feist et al., 1995), while studies 
involving immersion treatments only, report few malformations. In a study 
directly comparing the effects of immersion and dietary androgen treatments in 
rainbow trout, Feist et al. (1995) found a higher incidence of patent ducts in 
immersion treated fish. While the dose and duration of dietary androgen treatment 
can affect the incidence of sperm duct patency (Cousin-Gerber et al., 1989), the 
phenomenon of impaired development of the testes in dietary treated animals may 
be a function of the developmental timing of dietary treatment, with gonads at a 
later stage of development less plastic in their growth response. 
The current reliance of hatcheries on gonad morphology to distinguish sex 
inverted male Atlantic salmon from genetic males, means that malformations of 
the sperm duct and other traits typical of dietary treated animals are necessary for 
the recognition of sex inverted broodstock, although their presence restricts the 
use of such animals to a single season (Johnstone and Maclachlan, 1994). 
Furthermore, the recognition of sex inverted males by morphological features may 
still be subject to error, as the presence of a small proportion of males in the all 
female lines used in this study indicates. The absence of a determinant of 
genotypic sex therefore not only generates a restriction on the commercial use of 
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immersion treatments for the sex inversion of Atlantic salmon, but on the quality 
of stock produced from sex inverted broodstock produced using dietary 
treatments. 
• The present study has demonstrated the effectiveness of both dietary and 
immersion androgen treatments for masculinisation of Atlantic salmon, and that 
masculinisation by immersion results in the production of a high proportion of sex 
inverted males with patent sperm ducts. Furthermore, the study has demonstrated 
the successful application of these treatments on a commercial production scale. 
This has significant implications for the Atlantic salmon farming industry in 
Tasmania, which is becoming increasingly reliant on all female stocks for year 
round production. 
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Chapter 3 
Effects of aromatase inhibitors on in vitro steroidogenesis in Atlantic 
salmon (Salmo salar) gonadal and brain tissue. 
If the brain were so simple we could understand it, 
we would be so simple we couldn't. 
Lyall Watson 
Effects of aromatase inhibitors on in vitro steroidogenesis 
	
3. 	Effects of aromatase inhibitors on in vitro 
steroidogenesis in Atlantic salmon (Salmo salar) 
gonadal and brain tissue. 
3.1 	Introduction 
The benefit to aquaculture productivity generated by using monosex populations 
has resulted in research which has elucidated much about the processes of sex 
determination and differentiation in fish reproduction (Hunter and Donaldson, 
1983; Pandian and Sheela, 1995; Piferrer, 2001; Devlin and Nagahama, 2002). 
The seminal studies of Yamamoto, (summarised in Yamamoto, 1969) showed that 
androgens and estrogens are respectively the masculinising and feminising agents 
in fish. It is through the delivery of these steroid hormones to some or all of a 
population, that monosex populations are commercially produced (Hunter and 
Donaldson, 1983; Pandian and Sheela, 1995; Piferrer, 2001). 
An alternative to the use of steroid hormones to control sex determination or 
differentiation is the use of compounds that affect steroid synthesis or release, 
particularly that of estrogens. Aromatase (cytochrome P450 aroff,) is the enzyme 
responsible for the conversion of androgens to estrogens. In fish, aromatase 
activity is greatest in the gonad and brain tissue; however, other tissues may also 
have some level of activity (Callard et al., 1978; Zhao et al., 2001; Moore et al., 
2002). Recently, studies have determined that unlike mammals, some teleost 
species, including goldfish, Carassius auratus, (Tchoudakova and Canard, 1998) 
and zebrafish, Danio rerio, (Kishida and Callard, 2001) carry multiple copies of 
the aromatase gene. Molecular studies have demonstrated differential expression 
of these genes in different tissues (Callard et al., 2001; Dalla Valle et al., 2001; 
Tchoudakova et al., 2001). Notably, different genes are predominantly expressed 
in the brain and ovary (Callard et al., 2001; Kishida and Callard, 2001). Tissue-
specific gene expression and enzyme activity also vary during development, with 
activity in brain tissue preceding that in the gonads (Kishida and Canard, 2001). 
Regulating aromatase activity has become an important strategy in human 
medicine in the treatment of estrogen dependent tumors, and a large number of 
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compounds with aromatase inhibitory activity are now recognized (Brodie et al., 
1999; Seralini and Moslemi, 2001). Aromatase inhibitors have been shown to be 
effective in studies on all major classes of non-mammalian vertebrates (e.g. 
Piferrer et al., 1994; Foidart et al., 1995; Richard-Mercier et al., 1995; Chardard 
and Dournon, 1999) with a number of studies dealing with teleosts. Antonolopou 
et al. (1995; 1999) and Afonso et al. (1999; 2000) showed aromatase inhibitors to 
affect circulating steroids, aromatase activity and response to gonadotropin in 
salmonids. Piferrer et al. (1994), Guiguen et al. (1999), Kitano et al. (1999) and 
Kwon et al. (2002) demonstrated the effectiveness of aromatase inhibitors for the 
control of sex determination in fish. In a study on goldfish Zhao et al. (2001) 
showed that the two isozymes (gonad and brain) responded differently to a range 
of aromatase inhibitors, and generally, the ovarian isozyme was more sensitive to 
the aromatase inhibitors tested, than was the brain isozyme. 
The use of the whole animal model in studies of steroidogenesis, although having 
some advantages, is resource intensive and time consuming, and can ultimately 
impact on sample sizes and statistical power (Shilling et al., 1999). Researchers of 
mammalian systems may use lower cost species, such as teleosts, in in vivo 
studies (e.g. Nigrelli, 1953; Shilling et al., 1999) to allow sufficiently robust 
studies to be carried out. An alternative approach is in vitro incubation of isolated 
tissue or homogenates, which has proven to be an informative tool for 
investigating steroidogenesis and its relationship to reproductive physiology and 
behaviour across a range of taxa. This method has been successfully applied to 
various tissue types in fishes, including gonadal (e.g. Kagawa et al., 1982; 
Pankhurst and Riple, 2000), neural (e.g. Callard et al., 1981; Gonzalez and 
Piferrer, 2002), adrenocortical (Bisson and Hontela, 2002) and mesenteric (Moore 
et al., 2002) tissue. Most studies on teleosts have focussed on gonadal physiology, 
in particular the role of, or response by, gonadal tissues to hormonal changes 
during maturation (e.g. Ueda et al., 1983; Ijiri et al., 1995; Pankhurst, 1997) or the 
process of gonadal steroidogenesis (e.g. Kagawa et al., 1982; Haddy and 
Pankhurst, 1998; Amiri et al., 1999). Neurological studies have primarily been 
concerned with the level of steroidogenic activity in relation to neuroanatomy, 
with consideration given to the role of the specific areas of the brain in 
hormonally mediated behaviour (e.g. Pasmanik and Callard, 1985) or involvement 
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of brain tissue in steroid conversion for feedback loops regulating hypothalamic 
and pituitary endocrine activity (e.g. Antonolopou et al., 1995) 
Incubation conditions, including temperature, duration and medium components 
can all influence in vitro tissue steroidogenesis (Tyler et al., 1990; Rahman et al., 
2002). The production of compounds such as steroids may increase with 
increasing incubation time (Zhao and Wright, 1985; Gonzalez and Piferrer, 2002); 
however, extended incubation can lead to the production of secondary metabolites 
that may not be measured by the assay techniques used, or result in the uptake of 
steroids secreted by the components of tissue itself (Haddy and Pankhurst, 1998). 
As enzymatic activity is strongly dependent on temperature, so incubation 
temperature affects the rate of steroidogenesis (Haddy and Pankhurst, 1998; 
Gonzalez and Piferrer, 2002). Steroidogenesis may also be enhanced by the 
provision of steroid substrates (Ijiri et al., 1995; Lokman and Young, 1995; 
Panlchurst, 1997; Rahman et al., 2002) or hormones that promote the activity of 
steroidogenic enzymes (Zhao and Wright, 1985), or disrupted by inhibitors of 
enzyme activity (Pelissero et al., 1996; Afonso et al., 1997). Consequently it is 
necessary to calibrate the performance of incubations against the major incubation 
variables involved. Optimisation of in vitro conditions ensures high levels of 
enzyme activity (Shilling et al., 1999; Gonzalez and Piferrer, 2002), and thus 
representativity of responses. 
In vitro incubation of gonadal or brain tissue provides an appropriate model for 
testing the efficacy of aromatase inhibitors (Afonso et al., 1997; Bhatnagar et al., 
2001). Measurement of aromatase activity may be achieved either indirectly, by 
measurement of estradiol (E2) synthesis (Afonso et al., 1997) or directly, by the 
measuring stereospecific loss of 10- 3H from 3H-androstenedione (Gonzalez and 
Piferrer, 2002). While the direct method is rapid, accurate and allows for kinetic 
studies of aromatase activity (Gonzalez and Piferrer, 2002), it requires the use of 
facilities equipped to deal with radioactive materials. In contrast, incubations for 
indirect determination may be conducted in locations such a hatcheries, with only 
the assay procedure requiring specialized facilities. 
Accordingly, the aims of the present study were to optimise protocols for in vitro 
incubation of Atlantic salmon, Salmo salar (L.), gonadal and brain tissue from 
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animals sampled directly at a hatchery facility, for detection of basal and steroid 
precursor-stimulated E2 synthesis, and then to use the protocol to assess the 
efficacy of several aromatase inhibitors on steroidogenesis. 
3.2 	Materials and Methods 
3.2.i 	Fish 
Vitellogenic 3+ year old female Atlantic salmon broodstock produced by Salmon 
Enterprises of Tasmania Pty. Ltd. (Saltas), at Wayatinah, Tasmania were used in 
all experiments. Broodstock were reared either at Saltas' Florentine (Experiment 
1) or Wayatinah (Experiments 2-5) facilities. Fish used in Experiment 1, 3, 4 and 
5 were maintained in 66,000 L capacity tanks, while those for Experiment 2 were 
maintained in a 25,000 L raceway. All tanks and raceways were run as flow 
through systems at natural temperature and photoperiod. Fish were fed a pelletised 
diet (Nutreco) to satiation. 
Follicle preparation and incubation 
Fish were netted from the holding tank, quickly euthenased by a blow to the head, 
and stored on ice prior to dissection. Whole fish and ovary weights were 
determined and gonosomatic index (GSI) calculated as: 
gonad weight 
GSI (%) - 	 X100 
whole body weight 
In both Experiments 1 and 2, ovaries were removed, rinsed and maintained in 
chilled complete Cortlands solution (CCS) (Wolf, 1963). Follicles were manually 
dissected from a central section from each ovary, rinsed and stored for up to one 
hour in CCS until incubation. Incubations were carried out in the incubation 
media described below, in 24 well tissue culture plates (Iwaki). Either five or ten 
follicles per well were used, as described below. Oocyte diameter was determined 
to 0.01mm from 30 follicles using digital vernier calipers. Each experiment was 
performed twice using follicles from a different fish. 
At the end of the incubation period, the culture medium was aspirated by Pasteur 
pipette, to 1.5 mL Eppendorf tubes and frozen (-18 °C) until assay: 
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3.2.iii Brain tissue preparation and incubation 
Brain tissue was dissected out, following terminal anesthesia in AQUI-STm and 
spinal transection and whole body and brain tissue weights determined. All brain 
tissue was maintained in chilled CCS during processing. Tissue was collected 
from 2-5 fish, dissected into pieces, homogenised in CCS and pooled before 
addition to culture wells. Tissue was homogenized using either a hand held teflon 
grinder or a Polytron PT 1200C homogenizer (Kinematica AG, Lucerne, 
Switzerland), added to culture plates as described below and plates gently agitated 
on either an Amersham N4201 fixed speed orbital shaker (Amersham Biosciences 
Corp., Piscataway, USA) or on an Amersham ZMD 201 variable speed orbital 
shaker during incubation at 10 °C. 
3.2. iv Experimental protocols 
Experiment 1 — Gonadal tissue incubation 
Follicles were incubated at 5, 10 or 15 °C for 6, 18 or 42 h. Incubations were 
undertaken in either CCS or CCS with the steroids 17 a-hydroxyprogesterone 
(17P) or testosterone (T) as 10 j.iL of 1 or 10 j.t.g mL -1 in ethanol to give final 
concentrations of 10 or 100 ng mL -1 . Steroid doses were selected on the basis of 
effective concentrations for similar studies on rainbow trout (Haddy and 
Pankhurst, 1998). Incubations at 10 °C and 15 °C were carried out by immersing 
the culture plates in water baths of the appropriate temperature, whereas 
incubations at 5 °C were conducted in a Contherm 1150CP incubator (Contherm 
Scientific Ltd., Petone, New Zealand). All wells without steroids received an 
equivalent volume of ethanol. There were six replicate wells for each treatment 
and 10 follicles per well, except for a treatment of 5 follicles per well, conducted 
at 10°C for 18h. 
Experiment 2— Efficacy of AI on ovarian E2 production 
Five Al were evaluated for efficacy in reducing in vitro E2 production. The 
compounds tested were: 1,4,6-androstatriene-3,17-dione (ATD, Steraloids Inc.); 
4-androstene-4-o1-3,17-dione (OHA, Sigma); 445,6,7,8-tetra-hydroimidazo-[1,5- 
a]-pyridin-5-ylbenzonitrile HC1] (fadrozole, Novartis); 142,4-dichloro-f3-([2,4- 
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dichlorobenzylloxy)-phenethyl]imidazole (miconazole, Sigma) and 34p-
aminopheny1]-3-ethyl-piperidine-2,6-dione (aminogluthetimide, Aldrich). 
Follicles were incubated in the Contherm incubator at 10°C for 18 h, in either 
CCS; CCS with the Al ATD, OHA, fadrozole, aminoglutethimide and miconazole 
added as 10 IA, of 0.01, 0.1 or lmg mL -I in ethanol to give final concentrations of 
0.1, 1 or 10 jig mL -I ; CCS with T added as 10 lit of 10 jig mU l in ethanol to give 
final concentrations of 100 ng mL -1 ; or CCS with Al and T. Al doses were 
selected to include the range of IC50 reported in studies of the effects of ATD, 
OHA, fadrozole and aminoglutethimide on teleost follicles (Pelissero et al., 1996; 
Afonso et al., 1997) and teleost (Antonolopou et al., 1995) and avian (Wozinak et 
al., 1992) brain homogenates in vitro. All wells without both T and AT received an 
equivalent volume of ethanol. There were 6 replicate wells per treatment and 5 
follicles per well. 
Experiment 3- Brain tissue incubation 
Brain tissue homogenate prepared as above was pipetted into wells to provide 20, 
50, 100, or 200 mg tissue per well. CCS was added to wells to give a total 
volume of 990 lit and the steroids 17P or T added as before. There were six 
replicate wells for each treatment. Following 18 h incubation, well contents were 
transferred to 1.5 mL Eppendorf tubes and centrifuged at 1200g for 10 min. The 
supernatant was transferred to a new 1.5 mL Eppendorf tube, and frozen (-18 °C) 
until analysis of E2 and T in 100 lit aliquots. 
Experiment 4- Solvent extraction of steroids 
Brain tissue prepared as above was added to wells as for Experiment 3. Complete 
Cortlands solution (990 lit) was then added to all wells and T or 17P added as 10 
pi., of 1 or 10 jig mL-I to give final concentrations of 10 ng mL -1 and 100 ng mL-I 
respectively. There were four replicate wells for each treatment. Tissue was 
incubated for 18 h, well contents were transferred to 1.5 mL Eppendorf tubes, and 
frozen (-18 °C) until analysis. On thawing, tube contents were transferred to clean 
20 mL glass vials, 5 mL diethyl ether added and the vial vortexed. Vials were 
allowed to stand for 5 minutes, then the aqueous phase was frozen by immersion 
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in a bath of methanol-dry ice. The organic phase was poured off into a clean glass 
vial, the solvent evaporated off under N2 and allowed to stand overnight. The 
precipitate was resuspended in 1 mL phosgel buffer by vortexing, and 200 III. 
aliquots removed for measurement of E2 and T as described in section 3.2.v. 
Experiment 5 — Efficacy of AI on E2 production by brain tissue 
Brain homogenate, at 50 mg tissue per well was added to 980 pL CCS, and T was 
added as before at 10 ng mU l . The Al OHA, miconazole, aminogluthetimide and 
fadrozole were added as before to give final concentrations of 0.1, 1.0 or 10.0 pg 
m1: I respectively. Due to significant levels of cross reactivity with the E2 RIA 
(Table 3.1), ATD was added as above, to provide final concentrations of 0.1 and 
1.0 pg mL -I only. Six replicate wells were used for each treatment and 
homogenates were incubated for 42 h. To measure differences in basal and T-
mediated E2 synthesis between homogenates incubated for 18 and 42 h, additional 
homogenates were incubated for 18 h with and without T at 10 ng m1: 1 . 
Following incubation, well contents were stored and extracted as for Experiment 
4. 
Table 3.1 	Effective E2 equivalence due to cross reactivity of Al with E2 
antibody. Values are mean ±SE (n=6). 
Ar 
AI concentration (jig 
0.1 	1.0 
) 
10.0 
pg follicle' b 
AID 10 ± 1 27 ± 1 79 ± 3 
OHA <3C 10 ± 1 29 ± 0 
miconazole <3 <3 <3 
aminoglutethimide <3 <3 <3 
fadrozole <3 <3 <3 
pg mU l 
ATD 50 ± 1 136±2 394±6 
OHA 22 ± 1 51 ± 1 144 ± 1 
miconazole <15 <15 <15 
aminoglutethimide <15 <15 <15 
fadrozole <15 <15 <15 
a see text for abbreviations 
b for incubations of 5 follicles and 1 mL medium per well 
- at or below assay detection limit of 3 pg follicle' or 15 pg mL 1  medium 
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3.2.v Steroid measurement 
T and E2 were measured by RIA, based on the methods of Panlchurst (1997), using 
reagents detailed in Panlchurst and Conroy (1987). Aliquots of unextracted 
incubation medium (100 uL) (Experiments 1, 2, and 3) or resuspended medium 
and tissue extract (200 uL) (Experiments 4 and 5) were added to duplicate 
polypropylene tubes. 3H-labelled steroid (200 4) and 200 ut antibody were 
added, tubes covered and incubated overnight. Unbound label removed by the 
addition of 200 uL ice cold dextran coated charcoal, and centrifugation 4 °C for 
10 min at 3000 rpm on a Beckman CS-6R centrifuge (Beckman Coulter Inc. 
Fullerton, USA). The supernatant was decanted to 5 mL plastic Mini Ploy-Q 
scintillation vials, 4 mL Ecolite scintillation medium (ICN Biomedical, Costa 
Mesa, USA) added, and activity measured in a Beckman LS 6500 scintillation 
counter. Assay detection limits were 30 pg mL 1 incubation medium (3 or 6 pg 
follicle -1 ) in Experiments 1, 2 and 3, and 15 pg mL -1 incubation medium in 
Experiments 4 and 5. Interas say variability was measured using aliquots of a 
pooled internal standard and was (%CV[n]) 14.8 [8] and 13.9 [12] for T and E2 
respectively. Cross reactivity of Al with the E2 RIA, was determined by 
incubating CCS spiked with 0,1, 1.0 or 10.0 mg mL -1 Al at 10°C for 18 h, and 
assaying for E2 as above (Table 3.1). 
3.2.vi Statistical Analyses 
Factorial data were analysed by one-way ANOVA. Mean comparisons were made 
using a Tukeys honestly significant difference test. Comparisons of the effects of 
follicle number on in vitro steroidogenesis (Experiment 1) and the effects of 
incubation time on brain E2 production (Experiment 5) were tested by t-tests. All 
analyses were performed using SPSS 10.1 for Windows. Heteroscedastic data 
were log transformed prior to analysis. 
3.3 	Results 
ATD cross-reacted with the E2 antibody at all levels used in Experiment 2, 
whereas OHA showed significant cross reaction at 1.0 and 10.0 pg ml.," 1 . No cross 
reactivity was detected with any of the nonsteroidal Al (Table 3.1). These values 
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represent the maximum possible contribution of the Al to the measured values, 
and do not account for losses due to metabolism of the AT or absorption by tissue. 
Due to high levels of cross reaction, data from incubations with ATD at 1.0 and 
10.0 lag mL-1 and OHA at 10.0 i_tg mL-1 were excluded from analyses. 
The fish used in Experiment 2 both had greater GSI and oocyte diameter than 
those used in Experiment 1 (Table 3.2). These values reflect more advanced 
vitellogenesis in the fish used in Experiment 2, conducted in April, compared to 
those used in Experiment 1, conducted in January. 
Table 3.2 	Fish whole weight, ovary weight, GSI and oocyte diameter for 
animals used in Experiments 1 and 2. 
Whole 	Ovary 	 Oocyte 
weight 	weight 	GSI 	diameter 
Fish # 	(kg) 	(g) 	(%)a 	( nm)b 
Experiment 1 	Fish 1 	6.95 	123 	1.8 	1.90 ±0 .05 
Fish 2 	8.00 	652 	8.1 	3.34 ± 0.11 
Experiment 2 	Fish 1 	7.18 	1121 	15.6 	4.29 ± 0.07 
Fish 2 	9.48 	1580 	16.7 	4.89 ± 0.06 
a 	 gonad weight 
GSI (%) - 	  
whole body weight 
mean ± S.E., n=30 
3.3.ii Experiment 1— gonadal tissue incubation 
Treatment of the follicles from Fish 1 with T at 10 and 100 ng mL -1 elevated E2 
levels above controls at all temperatures and incubation times, except 10 °C for 42 
h, where only Tat 100 ng mL -1 was effective (Figure 3.1). Similarly, T at 100 ng 
mL-1 stimulated higher E2 production than T at 10 ng mL -1 at all times and 
temperatures except in the 10 °C, 42 h combination. 17P at 10 ng mL i was not 
effective at stimulating E2 production any time or temperature, whereas 17P at 
100 ng mL-1 resulted in increased E2 at all times and temperatures except 10 °C 
for 6 h. Production of E2 in response to 17P at 100 ng mL -1 was less than that 
following treatment with T at 100 ng mL -1 except at 5 °C for 42 h. E2 production 
by follicles from Fish 2 was lower than for Fish 1, although in most instances, 
above the assay detection limit of 6 pg follicle -1 , and followed most trends 
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Incubation temperature (°C) 
Figure 3.1 E2 production by follicles from Fish 1, after a) 6 hours b) 18 hours 
or c) 42 hours incubation, at 5, 10 or 15 °C, with steroid precursors 
added as shown. Values are mean + SE (n=6) Within each 
time/temperature combination, values with the same superscript are 
not significantly different (p > 0.05). 
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observed in incubations of Fish 1 follicles (Figure 3.2). The addition of T at100 ng 
mL-1 increased E2 production over control levels at all temperatures and 
incubation times, and above levels attained with the inclusion of T at 10 ng mL -I 
in all temperature and times except 10 °C for 42 h. The addition of 17P at 100 ng 
mL-1 increased E2 production over control levels for incubations at 10°C for 6 or 
18 h; at 5 °C for 18 h and at 15 °C for 18 or 42 h. There was no significant effect 
of 17P added at 10 ng mL -1 . 
Addition of 17P at 100 ng mL -I increased T production over controls for all times 
and temperatures for incubations of follicles from both Fish 1 and Fish 2 (Figures 
3.3 and 3.4). The addition of 17P at 10 ng mL -1 increased T production over 
controls at 10°C and 15 °C for 18 h, and at 5 °C and 15°C for 42 h for Fish 1 
(Figure 3.3), but only at 5 °C for 18 h for Fish 2 (Figure 3.4). 
Follicular production of E2 was higher in all treatments for incubations of 5 
follicles per well than for 10 follicles per well (Figure 3.5) in both Fish 1 and 2. 
For incubations of 5 follicles per well, the addition of T at 10 or 100 ng rnL -I or 
17P at 10 or 10Ong mL-1 increased E2 production over controls, for both Fish 1 
and Fish 2. In contrast, only the addition of T at 10 or 100 ng mL -1 or 17P at 
10Ong m1: I increased E2 levels over controls for incubations of 10 follicles per 
well, for both Fish 1 and Fish 2 (Figure 3.5). T production was also higher for 
incubations of 5 follicles than 10 follicles when 17P was added at 10 or 100 ng 
m1: I for Fish 1 and Fish 2 (Figure 3.6). Production of T was increased over 
controls with 17P at 10 or 100 ng mL -1 for both 5 and 10 follicles for Fish 1, but 
only with 17P at 100 ng mL -I for Fish 2. To compare the degree of variability in 
E2 production in incubations of five or ten follicles, the coefficient of variation 
(CV) was calculated, as a measure of variability, independent of mean values. 
This value was similar to, or greater, in incubations of five follicles, compared to 
incubations of ten follicles for Fish 1, but the converse applied for Fish 2 (Table 
3.3). 
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Incubation temperature (°C) 
Figure 3.2 	E2 production by follicles from Fish 2, after a) 6 hours b) 18 hours 
or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. Other details as 
for. 	 Figure 	 3.1. 
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5 	 10 	 15 
Incubation temperature (°C) 
Figure 3.3 
	T production by follicles from Fish 1, after a) 6 hours b) 18 hours 
or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. Other details as 
for Figure 3.1. 
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Incubation temperature (°C) 
Figure 3.4 	T production by follicles from Fish 2, after a) 6 hours b) 18 hours 
or c) 42 hours incubation, at 5 °C, 10 °C or 15 °C. Other details as 
for Figure 3.1. 
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Figure 3.5 	E2 production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C. Other details as for Figure 3.1. 
Within data for each fish, for each follicle number, values with the 
same superscript are not significantly different. Asterisks indicate a 
significant difference between values for 5 and 10 follicles, tested 
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Figure 3.6 	T production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C. Other details as for Figures 3.1 and 3.5. 
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Table 3.3 	Coefficient of variation (CV) a of E2 production following 
incubation at 10 °C for 18 h, of either five or ten follicles per well. 
Steroid treatment 
follicles per well 
5 10 
Control 
T 10 ng mL -1 
37.9 
7.3 
17.8 
7.6 
Fish 1 T 100 ng mL -1 16.9 19.2 
17P 10 ng mL -1 27.7 18.0 
17P 100 ng mL -1 30.4 18.8 
Control 25.9 60.5 
T 10 ng mL -I 11.3 12.8 
Fish 2 T 100 ng mL -1 22.7 20.4 
17P 10 ng mL -1 25.6 49.9 
17P 100 ng mL-I 23.3 28.6 
S.D. a 	CV (%) = 	X 100 
mean 
Incubation at 10 °C for 18 h, allowed best discrimination between the different 
levels of T and 17P and on this basis, these assay conditions were considered as 
optimum. Increased E2 production by incubations of five follicles over ten 
follicles, with no clear concomitant increase in variability resulted in the use of 
five follicles for subsequent Al efficacy testing. 
3.3.iii Experiment 2— Efficacy ofAI on ovarian E2 production 
Incubations of follicles with fadrozole at 0.1 or 10.0 lig mU l or miconazole at 1.0 
or 10.0 fig mL -1 significantly reduced basal E2 production with respect to the 
control for Fish 1, and incubations with fadrozole at 0.1 or 10 lig mL -1 or ATD at 
0.1 pg mL-I decreased E2 production for Fish 2 (Figure 3.7). In Fish 1, there was a 
significant increase in apparent E2 levels when OHA was added at 1.01.ig 
however, this is likely to be an artifact of the cross reactivity between OHA and 
the E2 RIA (Table 3.1). 
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For Fish 1, the addition of T at 100 ng inL -1 to the incubation medium, 
significantly increased E2 production over control levels for Fish 1 (Figure 3.8), 
and the addition of fadrozole at 0.1, 1.0 and 10.01.ig mL -1 , OHA at 0.1 or 1.01.1g 
mU l or ATD at 0.1 tg mL-I all significantly decreased E2 production compared 
with incubation with T only. In contrast, for Fish 2, E2 production was 
significantly increased over controls 
in incubations with T added at 100 ng mL -I aminoglutethimide added at 0.1 or 1.0 
ng mL-I with T at 100 ng mL -1 , but no other significant differences were apparent. 
3.3.iv Experiment 3 - Brain tissue incubation 
E2 in the incubation medium was at or below detection levels of 30 pg mL -I in all 
incubations without added T (Figure 3.9). Increased levels of E2 were detected in 
treatments which received T at 100 ng mL -I ; however, this is likely to be a result 
of cross reaction of T with the E2 RIA. Panlchurst and Riple (2000) determined a 
maximum E2 equivalent of 70 pg mL-I for an addition of 100 ng T mU l using the 
same RIA protocol followed in this study. In incubations of 20 mg tissue mL-1 , 
the addition of 17P significantly increased T production over the control; 
however, this effect was not observed for incubations of greater amounts of tissue 
(Figure 3.10). There was also a decline in T production, in response to 17P, with 
increasing amounts of tissue incubated (Figure 3.10). A similar trend was evident 
in free T levels in the medium where 100 ng T mL -I was added (Table 3.4). 
Table 3.4 	T levels (mean ± SE [n=4]) in incubation media following 
incubation for 18 hours at 10 °C of 20, 50, 100 or 200 mg mL -I 
brain tissue with 100 ng T mL -I added. 
Brain tissue (mg mL-1 ) 	T (ng mL-1 ) 
20 
	
2.78 ± 0.08 
50 
	
2.00 ± 0.26 
100 
	
1.19 ± 0.07 
200 
	
0.34 ± 0.06 
58 
Effects of aromatase inhibitors on in vitro steroidogenesis 
Control 
IIIMIN 0.1 p.g Al m1: 1 
1.0 lig Al mL-1 
10.0 pig Al rn1:1 
Control 	ATD 	OHA 	ACT 	FAD 
	
MCZ 
Aromatase inhibitor (Al) 
Figure 3.7 Basal E2 production by follicles from a) Fish 1 and b) Fish 2, after 
18 hours incubation at 10 °C with Al added as shown. Other details 
as for Figure 3.1. 
* AGT — aminoglutethimide; FAD — fadrozole; MCZ — 
miconazole; ATD — 1,4,6—androstatriene-3,17-dione; OHA — 4- 
androstene-4-o1-3,17 -dione 
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Figure 3.8 	E2 production by follicles from a) Fish 1 and b) Fish 2, after 18 
hours incubation at 10 °C with T and Al added as shown. Other 
details as for Figures 3.1 and 3.7. 
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Figure 3.9 E2 levels in incubation medium from 20, 50, 100 or 200 mg m1_, -1 
brain tissue incubated for 18 hours at 10 °C. Other details as for 
Figure 3.1. 
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Figure 3.10 T levels in incubation medium from 20, 50, 100 or 200 mg m1: 1 
brain tissue incubated for 18 hours at 10 °C. Other details as for 
Figure 3.1. 
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3.3.v Experiment 4 - Solvent extraction of steroids 
In incubations of 50 mg tissue, production of E2 was significantly higher with the 
addition of 10 ng T mL-1 than for both control and 17P incubations (Figure 3.11). 
No significant differences were detected among any other treatments, and 50 mg 
was selected as a standard tissue inclusion rate for the subsequent experiment. 
Levels of T were higher than for E2, but similarly variable (Figure 3.12). No 
significant effects of tissue level or presence of 17P were detected. High 
variability of results was due to extremely high (up to 10-fold increase) levels of 
the measured steroid determined for a single well within some treatment groups. 
3.3.vi Experiment 5 — Efficacy of Al on E2 production by brain tissue 
Incubation of brain tissue homogenate with 10 ng T mL -1 increased E2 production 
significantly over incubations with no added T, after both 18 and 42 hours 
incubation (Figure 3.13). With added T, E2 production after 42 hours was 
significantly higher than at 18 hours. 
With the exception of aminoglutethimide at 1.0 jig inL -1 ' the addition of Al at all 
doses significantly decreased T-stimulated E2 production (Figure 3.14). Fadrozole 
was most effective in reducing E2 production, with addition at 1.014 mI.: 1 being 
more effective than 0.1 jig mL-1 . Miconazole was more effective at 10 jig mL -1 
than at 1.01.1g mL -1 . There is no clear trend in differences in the efficacy of 
different doses of OHA and ATD, which may be an artifact of the cross-reaction 
between the steroidal aromatase inhibitors and the E2 RIA (Table 3.1). 
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Figure 3.11 E2 levels in ether-extracted homogenate of 20, 50, 100 or 200 mg 
mL-I brain tissue incubated for 18 hours • at 10 °C. Values are 
mean+SE (n=4) Other details as for Figure 3.1. 
Figure 3.12 T levels in ether-extracted homogenate of 20, 50, 100 or 200 mg 
mL-I brain tissue incubated for 18 hours at 10 °C. Values are 
mean+SE (n=4) Other details as for Figure 3.1. 
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Figure 3.13 E2 production by brain tissue homogenate following 18 or 42 h 
incubation with or without added T. Other details as for Figure 3.1. 
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3.4 	Discussion 
Although trends in response to treatment were similar, there were up to 4-fold 
differences in basal steroid production between individuals in both Experiments 1 
and 2. Pankhurst et al. (1996) reported similar variation in E2 production in 
incubations of rainbow trout follicles, while individual variation in studies of the 
follicles of marine fish was considerably lower (Pankhurst, 1997; PanIchurst and 
Riple, 2000). The high level of variability amongst salmonids may be a function 
of individual variation in gonadal steroidogenic activity associated with the 
extended period of E2 production in these species (Fitzpatrick et al., 1986; King 
and Panlchurst, 2003). Individual variability in circulating E2 levels of female fish 
in the study population increases throughout vitellogenesis, reaching a maximum 
in March (King and Pankhurst, 2003). Follicles from individuals sampled in 
January (Experiment 1) and March (Experiment 2) may thus have had highly 
variable basal levels of steroidogenesis, reflected in the observed results. In 
conjunction with increased levels of variation between individuals is the seasonal 
trend of increasing follicle size and mean circulating E2 levels from October to 
March (King and PanIchurst, 2003) The greater GSI and follicle diameter for 
samples used in Experiment 2 is consistent with more advanced stage of 
vitellogenesis of fish, compared to those in Experiment 1, and basal E2 levels 
were generally higher in Experiment 2 than for comparable incubation conditions 
in Experiment 1. This agrees with in vitro studies of the follicles of Japanese eel, 
Anguilla japonica (Ijiri et al., 1995), rainbow trout, Oncorhynchus mykiss 
(Carragher and Sumpter, 1990), amago salmon, Oncorhynchus rhodurus (Kagawa 
et al., 1983), where increased vitellogenic state and follicle size were associated 
with increased levels of E2 production. However, the comparison of basal E2 and 
follicle size between individuals in Experiment 1 contrasts with these findings, for 
reasons that remain unclear. It should be noted however that maximum oocyte 
size does not always coincide with maximum aromatase activity or circulating E2 
levels (Sampath-Kumar et al., 2000) and that steroidogenic activity in vitro may 
not always represent the situation in vivo, where circulating steroids levels are the 
net result of secretion and metabolism and not steroidogenic activity of tissues per 
se. 
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Stimulation of E2 and T production by follicles by the addition of T or 17P 
respectively was apparent after 6 h of incubation and this effect continued for up 
to 42 h. This is similar to the findings of Pankhurst and Riple (2000) and Haddy 
and Pankhurst (1998) in incubations of follicles of greenback flounder, 
Rhombosolea tapirina and rainbow trout respectively, and confirms that follicular 
enzyme systems were functional under the range of incubation periods tested. 
Conversion of 17P by follicle preparations confirmed activity of 17- 
hydroxysteroid-dehydrogenase and 17a-hydroxylase (Lemmen et al., 2002), but 
follicular E2 production in response to T generally exceeded the response to 
equivalent doses of 17P. The capacity of follicles to more efficiently utilize T as a 
substrate for E2 production than 17P has been ascribed to the greater number of 
reaction steps necessary for the conversion of 17P to E2 and the greater possible 
range of products from 17P conversion (Haddy and Pankhurst, 1998). There was 
also a clear dose response to the added steroid substrates in the present study, 
consistent with the findings by Afonso et al. (1997) for coho salmon, 
Oncorhynchus. kisutch, and suggesting that substrate may be a limiting factor for 
in vitro steroid production by follicles. 
Discrimination of the effects of treatment on E2 levels was generally poorer after 
42 h incubation, due to increased variability between replicates and reduced 
absolute E2 levels in the incubation medium. These results are consistent with the 
findings of Haddy and Panlchurst (1998) and Pankhurst and Riple (2000). Haddy 
and Pankhurst (1998) showed that decreased levels of free steroids after 18 h 
static incubation of rainbow trout follicles was concomitant with increased 
production of glucuronides and uptake of steroids from the medium by follicles. 
Discrimination of treatment effects in the present study was less clear after 18 h 
incubation at 5 °C than at either 10 or 15 °C, with only high doses of steroids 
consistently eliciting a significant response. Increased incubation temperature, 
within limits, increases aromatase activity (Zhao et al., 2001; Gonzalez and 
Piferrer, 2002) and the differences observed in the present study may reflect this. 
After 6 h incubation, E2 production consistently increased with the addition of T 
at 100 ng mL -1 whereas the effects of low doses of T and 17P were equivocal. 
Doses of 100 ng 	T or 17P were effective in increasing E2 production during 
incubation of greenback flounder follicles for 6 h (Panlchurst and Riple, 2000) and 
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rainbow trout follicles for 3 h (Haddy and Pankhurst, 1998). Discrimination of 
differences in T production by follicles in the present study was less dependent on 
incubation conditions, as the effect of 10 ng 17P mL -1 was marginal, whereas 100 
ng 17P mU l was always effective in increasing T. A similar trend in the effects of 
dose of 17P was evident in the incubation of greenback flounder follicles 
(Pankhurst and Riple, 2000) and reflects the capacity of follicular enzyme systems 
to deal with high levels of 17P. 
Despite a higher degree of variability between replicates, there were significantly 
higher levels of both E2 and T production by incubations of five follicles than 
incubation of ten follicles in the present study. This effect was consistent for both 
individuals tested, despite differences in follicle size. Factors in the medium or 
access to the medium may be limiting to follicle steroidogenesis for larger 
numbers of follicles. In a seasonal study, Kagawa et al. (1983) removed yolk from 
large follicles prior to incubation, to accommodate the required number of 
follicles in the assay, with no evidence of diminished steroidogenic activity. As 
steroid synthesis by follicles occurs in the thecal and granulosa layers (Kagawa et 
al., 1982), it is likely to be a function of surface area, unlike metabolic 
requirements that vary with volume, thus metabolic requirements may limit 
steroidogenesis over extended incubation for incubations of ten follicles. In 
addition, Haddy and Pankhurst (1998) showed significant uptake of steroids by 
follicles in vitro and a similar result was obtained by Piferrer and Donaldson 
(1994) for eggs and newly hatched coho salmon alevins. Thus follicles represent 
an effective steroid sink, and the reduction of steroids in the medium in 
incubations of 10 follicles may be due to this process. 
The use of pooled brain tissue in the present study prevented comparison of brain 
steroidogenic activity between individuals; however, considerable variability 
between replicate wells was apparent in Experiment 4. Several studies have 
shown aromatase activity to be anatomically localized to the preoptic regions and 
the telencephalon in the teleost brain (Callard et al., 1981; Pasmanik and Callard, 
1985; Andersson et al., 1988; Gelinas et al., 1998; Callard et al., 2001; Melo and 
Ramsdell, 2001). Thus incomplete removal, or poor homogenisation of the 
forebrain in the present study, could explain the heterogeneity of enzyme activity 
in the homogenate. E2 production by brain tissue responded to T in the incubation 
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medium, with the effect continuing for up to 42 h of incubation. However, no 
comparison can be drawn with other studies as the 3H-androstenedione 
determination method used by other workers (Andersson et al., 1988; 
Antonolopou et al., 1995; Zhao et al., 2001) excludes the capacity to measure 
aromatization levels in the absence of additional substrate. 
The results of increasing E2 synthesis by brain homogenate after 42 h incubation 
contrasts with the decline in E2 synthesis with extended incubation of follicles; 
however, such differences are likely to be a result of the extraction of steroids 
from tissue in addition to the incubation medium. There was no evidence of 
increased levels of E2 production with incubation of increasing amounts of brain 
tissue, and yields of T declined with increasing mass of tissue incubated, after 18 
h incubation, most likely as a result of the uptake of steroids from the medium by 
tissue. In contrast, Gonzalez and Piferrer (2002) showed an increase in weight-
corrected aromatase activity with increasing levels of homogenised tissue; 
however, this occurred over short (30 minute) incubation, and was less apparent 
beyond this. Under similar incubation conditions to the present study, Haddy and 
Pankhurst (1998), showed uptake of steroids by follicles after 18 h incubation, 
although this occurred to a lesser extent than in the present study. Such 
differences may reflect differential capacity of the brain and follicular tissue to act 
as steroid sinks. Other studies of aromatase activity of brain tissue using 3H-
androstenedione (e.g. Callard et al., 1978; Pasmanik and Callard, 1985; 
Andersson et al., 1988; Zhao et al., 2001; Gonzalez and Piferrer, 2002) routinely 
extract steroids from the homogenate. 
Levels of E2 production achieved in Experiment 2 and 5 with gonadal and brain 
tissue respectively incubated with T, equate to approximately 0.5-0.8 fmol 
hr'. These estimates are orders of magnitude lower than levels recorded for other 
teleost species, determined using the 3H-androstenedione method (Pasmanik and 
Callard, 1985; Andersson et al., 1988; Melo and Ramsdell, 2001). This may 
reflect reduced sensitivity of the methods used in the current study, due to the 
reliance on measuring the synthesis end product, which may be influenced by 
factors such as reduced rates of steroid synthesis or increased steroid uptake by 
follicles, during extended static incubation (Haddy and Panlchurst, 1998); and the 
use of T as a substrate, which has been shown to be a poorer substrate than 
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androstenedione for teleost aromatase (Zhao et al., 2001). There was no evidence 
of greater aromatase activity in brain than gonadal tissue in the present study in 
contrast to results reported in other studies (Tchoudakova and Callard, 1998; Zhao 
et al., 2001; Gonzalez and Piferrer, 2002), although the extended incubation times 
used in the present study are likely to confound any differences in enzyme 
kinetics. In addition, the use of large follicles will reduce the synthesis rate, per 
unit weight, in comparison to that of homogenates of immature ovaries due to the 
relatively lower amount of steroidogenically active follicular tissue. 
Al reduced E2 biosynthesis by both follicular and brain tissue in the present study 
although there were some differences in efficacy between tissue types. This may 
be due to the expression of different isoforms of aromatase in brain and gonad of 
Atlantic salmon, as occurs in goldfish (Tchoudakova and Callard, 1998) and 
zebrafish (Kishida and Callard, 2001) which may be differentially sensitive to Al 
(Zhao et al., 2001). Aminoglutethimide was ineffective in follicles, but 
significantly reduced E2 production by brain homogenates. This contrasts to the 
findings of Zhao et al. (2001) who found no difference in aminoglutethimide 
efficacy on brain or ovarian homogenates, although efficacy in both was low. The 
results of the present study concur with those of Chardard and Dournon (1999) 
who found no effect of aminoglutethimide on aromatase activity of newt, 
Pleurodeles waltl, gonad, but contrast with Pelissero et al. (1996) who showed 
that aminoglutethimide reduced the aromatase activity of micro somes from 
rainbow trout ovarian homogenates. These differences may reflect the different 
systems used, with microsomal preparations reported to have higher aromatase 
activity than homogenates (Gonzalez and Piferrer, 2002), and higher sensitivity to 
AI, than cellular preparations (Bhatnagar et al., 2001). Miconazole was effective 
at high doses 	lmg L -1 ) on brain and follicular tissue, consistent with the 
findings of Chardard and Dournon (1999), who showed that immersion of 
developing newts in miconazole at 1 mg L . ' resulted in a significant decline in 
gonadal aromatase activity. However, in the present study, miconazole was 
ineffective in follicle preparations in the presence of added T. Miconazole is a 
competitive inhibitor (Seralini and Moslemi, 2001), and reduced efficacy in the 
presence of added T may reflect relatively low affmity for the aromatase enzyme. 
Fadrozole displayed the highest efficacy of all AI, over the concentrations tested, 
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in both follicular and brain tissue. This supports previous fmdings that fadrozole 
was an effective in vitro inhibitor of aromatase activity in coho salmon follicles 
(Afonso et al., 1997) when used at concentrations of 2.2 and 22 mg 
Furthermore, treatment of developing newts with fadrozole by immersion 
(Chardard and Dournon, 1999) and of Atlantic salmon parr by implantation, 
(Antonolopou et al., 1995) resulted in reduced aromatase activity in gonadal and 
brain tissues respectively. Wozinak et al. (1992) also showed fadrozole to be a 
more potent inhibitor of brain aromatase than either ATD or OHA. 
Notwithstanding the potential for cross reaction of ATD and OHA with the E2 
assay to underestimate the extent of aromatase inhibition, both ATD and OHA 
were effective on gonadal and brain tissue. This supports previous work on these 
compounds on Atlantic salmon in vivo and in vitro by Antonolopou et al. (1995) 
who found brain aromatase activity was reduced by both ATD and OHA. 
Similarly, Zhao et al. (2001) and Moore et al. (2002) showed OHA to be a potent 
inhibitor of goldfish brain gonadal and mesenteric aromatase respectively. The 
relatively high efficacy of fadrozole, ATD and OHA is to be expected from these 
compounds as "second generation" aromatase inhibitors (Brodie et al., 1999; 
Seralini and Moslemi, 2001). Such compounds have been developed specifically 
for increased potency and specificity (Brodie et al.., 1999; Seralini and Moslemi, 
2001). 
The results of the present study show that effective methods for the in vitro 
assessment of aromatase activity in both gonadal and brain tissues of Atlantic 
salmon are feasible. The methods provide an approach to enable relatively simple 
assessment of the efficacy of compounds affecting steroidogenesis in these 
tissues, and are suitable for use in standard laboratory or hatchery facilities. Use 
of these methods to screen several aromatase inhibitors has shown that fadrozole, 
ATD and OHA are potent inhibitors of S. salar gonadal and brain aromatase 
activity, while miconazole is less potent but still effective, and aminoglutethimide 
is effective on brain aromatase only. These data do not discount the possibility 
that Atlantic salmon may possess more than one functional form of aromatase. 
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of farmed Atlantic salmon. 
But love is blind and lovers cannot see 
The pretty follies that themselves commit; 
For if they could, Cupid himself would blush 
To see me thus transformed to a boy. 
William Shakespeare 
The Merchant of Venice, Act II Scene 6 
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4. 	Efficacy of aromatase inhibitors for sex inversion of farmed 
Atlantic salmon. 
4.1 	Introduction 
The commercial production of sex inverted females ("neomales") for the indirect 
production of all female stocks (Piferrer, 2001) has traditionally been achieved 
through the use of steroid hormones, and a substantial research effort has been 
directed to the optimisation of their use (Chapter 2 see also reviews by Pandian 
and Sheela, 1995; Baroiller et al., 1999; Piferrer, 2001; Devlin and Nagahama, 
2002). Masculinisation of salmonids has been achieved following both chronic 
and acute (Piferrer, 2001) application of androgens, typically by dietary 
(Johnstone et al., 1978; Goetz et al., 1979; Solar et al., 1984) or immersion 
(Johnstone et al., 1978; Goetz et al., 1979; Baker et al., 1988; Piferrer and 
Donaldson, 1991; Piferrer et al., 1993) treatments respectively, and these methods 
are currently in routine use in commercial production systems. However, a shift in 
public attitudes and policy against the use of hormones for animal production, 
exemplified by a ban by the European Union in 2002 on the use of growth 
promoter hormones in animal production, may necessitate the development of 
alternative methods for sex inversion of farmed fish. One such avenue is the use 
of compounds that inhibit or otherwise modulate normal endocrine processes. 
Compounds that interfere with steroid synthesis or steroid receptors have been 
used in a number of studies of teleost reproductive and developmental 
endocrinology, mainly as tools to elucidate the role of steroid hormones in sex 
differentiation (eg. Guiguen et al., 1999; Kitano et al., 2001; Kwon et al., 2002) 
and maturation (eg. Afonso et al., 1999; Antonolopou et al., 1999). Specifically, 
aromatase (cytochrome P450.n,) inhibitors (Al); compounds which inhibit the 
conversion of androgens to estrogens, have been used to investigate the key role 
of estrogens in teleost sex differentiation (Piferrer et al., 1994c; Nakamura et al., 
1998; Guiguen et al., 1999; Kitano et al., 1999; Kwon et al., 2002; Lee et al., 
2002) and consequently as a non-hormonal alternative for sex manipulation of a 
number of teleost species, including coho salmon, Oncorhynchus kisutch, 
(Piferrer et al., 1994c) rainbow trout, 0. mykiss (Guiguen et al., 1999), Japanese 
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flounder, Paralichthys olivaceus (Kitano et al., 2000) and tilapia, Oreochromis 
niloticus (Guiguen et al., 1999). As is the case for steroid hormones, the 
administration of Al for sex inversion of fishes has been successfully achieved via 
the diet (Guiguen et al., 1999; Kitano et al., 2000) and by brief immersion 
(Piferrer et al., 1994c). 
The development of an effective treatment regime using exogenous compounds is 
dependent on optimising the treatment variables of timing, dose and frequency 
(Piferrer, 2001). Non-steroidal, competitive Al are required in relatively high 
concentrations due to the low K m of aromatase (Cole and Robinson, 1990) and 
their successful application via immersion for sex inversion, has been at 
concentrations of 0.3-10 mg L -I (Piferrer et al., 1994c; Chardard and Dournon, 
1999). In contrast, there are no data on effective doses for immersion treatment 
with mechanism-based steroidal aromatase inhibitors, which bind irreversibly to 
the enzyme; however, these compounds are known to be effective at 
concentrations several orders of magnitude lower than competitive inhibitors 
(Cole and Robinson, 1990; Seralini and Moslemi, 2001). Steroid hormones 
themselves are effective for the sex inversion of salmonids when applied by 
immersion at doses as low as 0.08 mg L1 (Piferrer et al., 1993) and steroidal Al 
may be effective at similar concentrations. "First generation" (Seralini and 
Moslemi, 2001) Al, such as aminoglutethimide (34p-aminopheny1]-3-ethyl-
piperidine-2,6-dione) have relatively low efficacy (Buzdar, 2000; Seralini and 
Moslemi, 2001) whereas the effectiveness of "second generation" compounds, 
such as fadrozole (4-[5,6,7,8-tetra-hydroimidazo-[1,5-a]-pyridin-5-ylbenzonitrile 
BC!]) may be 500 times higher (Cole and Robinson, 1990; Brodie et al., 1999; 
Brueggemeier, 2001). 
In numerous studies of the masculinisation of fishes using androgens, various 
abnormalities in gonadal development have been observed, which could 
compromise fertility and/or the use of masculinised individuals in commercial 
production. In some gonochorists, steroid hormone treatments have resulted in 
individuals with "intersex" gonads (Yamamoto, 1969), comprising significant 
proportions of both testicular and ovarian tissue, (eg. Piferrer et al., 1993; 
Blazquez et al., 1995). This is thought to arise from insufficient dosage or an 
inability of the gonad to respond to the exogenous hormones (Devlin and 
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Nagahama, 2002). The development of gonads with a predominance of connective 
tissue (eg. Johnstone et al., 1978; Goetz et al., 1979; van den Hurk and Slof, 1981; 
Solar et al., 1984; Piferrer et al., 1994b; Blazquez et al., 2001) is seen as a result 
of excessive steroid treatment and has been proposed to be due either to 
incompatibility between exogenous steroids and internal processes, or 
pathological effects of steroids on the developing gonad (Devlin and Nagahama, 
2002). The production of neomales with blocked or otherwise malformed sperm 
ducts is most frequently observed following dietary androgen treatment (Chapter 
2 Feist et al., 1995). The fertility of neomales may thus be compromised on a 
number of levels, although few studies have attempted to quantify this, possibly 
due, in part, to the time needed for individuals to reach maturity. Some studies 
have reported comparable fertility of sex inverted and normal males (Johnstone et 
al., 1979; Piferrer et al., 1994c), whereas others demonstrated reduced neomale 
fertility due to the need to manually extract milt (Geffen and Evans, 2000), or 
poor sperm production and quality (Kiranlcumar and Pandian, 2002). 
Some non-steroidal Al, including aminoglutethimide and fadrozole, are also 
known to cause side effects in humans, due to their effects on the function of 
cytochrome P450 enzymes other than aromatase (Buzdar, 2000; Brueggemeier, 
2001; Seralini and Moslemi, 2001) and some steroidal Al, including ATD (1,4,6- 
androstatriene-3,17-dione) and OHA (4-androstene-4-o1-3,17-dione), may cause 
side effects due to their androgenic properties (Seralini and Moslemi, 2001). In 
animal studies, miconazole (142,4-dichloro-13-([2,4-dichlorobenzyl]oxy)- 
phenethyl]imidazole) a first generation non-steroidal Al, was toxic to larval newts 
when used at a concentration of 0.5 mg L -1 for several weeks (Chardard and 
Doumon, 1999) but no toxic side effects have been reported for the second 
generation Ms fadrozole, ATD and OHA, across a range of vertebrate taxa 
(Elbrecht and Smith, 1992; Piferrer et al., 1994c; Richard-Mercier et al., 1995; 
Wennstrom and Crews, 1995; Kitano et al., 2000). The development of a suitable 
administration protocol for Al should therefore not only consider efficacy, but 
toxic or other side effects, and adjust the dose and frequency of application 
accordingly. 
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Although several Al have been demonstrated to be effective on Atlantic salmon 
aromatase in vitro (Chapter 3), their effectiveness on Atlantic salmon alevins in 
vivo is not known. The present study was conducted to assess the in vivo efficacy 
of Al for Atlantic salmon, with the strategic aim of developing a commercially 
appropriate protocol for their use in the production of Atlantic salmon neomales. 
The study was conducted in 2 phases over consecutive years, with the initial phase 
designed to screen several Al for efficacy and toxicity, and the latter phase aimed 
at investigating the effects of dose and treatment timing on the efficacy of the 
most promising Al. All five Al previously shown to be effective on either brain or 
gonadal aromatase in vitro (Chapter 3) were investigated, although fadrozole was 
not available for the first phase of the study. Atlantic salmon alevins were treated 
with aromatase inhibitors by immersion, for reasons of both controlled dosage 
(Pandian and Sheela, 1995) and the increased likelihood of generating individuals 
with patent sperm ducts (Chapter 2 Feist et al., 1995). In the screening phase, non-
steroidal Al were tested at a maximum dose of 12.5 mg L-1 , a dose based on the 
methods of Piferrer et al. (1994c), and the steroidal All were tested at a maximum 
dose of 500 p.g L -1 , based on the demonstrated effective dose for androgens 
(Chapter 2). Initially, single or repeated immersion treatments were conducted, at 
times shown to be effective for androgen treatment (Chapter 2). Based on the 
studies of Duston and Saunders (1992), an artificial photoperiod was applied to 
animals throughout the 10 months of each phase of the study, to induce elevated 
levels of precocious maturation, enabling the assessment of sperm quality and 
fertility of neomales. In order to better evaluate the commercial effectiveness of 
Al, production parameters, including growth and mortality, were also followed 
over each phase of the study. 
4.2 	Materials and Methods 
4.2.i Stock and Husbanthy 
Experiments were conducted at Saltas' two hatcheries, at Wayatinah, Tasmania 
on the Derwent and Florentine Rivers (respectively "Wayatinah" and 
"Florentine"). Both hatcheries, utilise intensive recirculation systems for the 
production of fry (<0.5 g) and natural river waters for the production of parr and 
smolts. Experiments were conducted over two years (2000/01 and 2001/02) using 
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the progeny of 2+ year old Atlantic salmon broodstock. Neomales were used to 
provide milt in both experiments. These stocks had been masculinised by dietary 
treatment with 17a-methyldihydrotestosterone (MDHT) at 1 mg kg"' feed, for 800 
°C days (DD), based on daily water temperature and following methods similar to 
Solar et al. (1984). 
Milt was collected from neomales by removal and maceration of the testes, 
dilution of the homogenate with milt extender solution (Appendix Ia), and 
refrigeration until use. Fertilisation was achieved by combining the eggs of 6 
female fish, dividing this into 4 containers, and adding the milt from a single 
neomale, together with milt activator solution (Appendix lb) to each container. 
Fertilised eggs from a total of approximately 24 female fish fertilised by up to 8 
neomales were maintained in a single upwelling incubator, at 8°C. Eyed eggs 
were transferred to mesh sided boxes (110mm x 150mm x 30mm), with 500 
individuals per box. In a first experiment, transfer occurred at the onset of 
hatching and in a second experiment, transfer was undertaken several days before 
the expected commencement of hatching. Boxes were maintained at 8.0 ± 0.1 °C 
in Heath vertical incubator trays (Maricource Inc., Tacoma, USA), in two separate 
recirculation systems, with a maximum of 6 boxes per tray, until the swim up 
stage. Immersion treatments were timed in relation to the day of median hatch, at 
approximately 450 DD post-fertilisation. 
Fry were subsequently transferred to indoor 1 m3 fibreglass tanks (Figure 4.1) and 
reared at 10-12 °C under a photoperiod of 8 hr L:16 hr D, from August until 
December. Tanks were supplied with water from the Florentine facility 
recirculation system. In September 2001, all tanks were treated with 200 ppm 
formalin to control an infection of the freshwater protozoan parasite Costia 
(=khthyobodo) sp. in the hatchery. All tanks experienced elevated mortality 
levels at the time of the infection and immediately post-treatment. In December, 
fish were transferred to 4 m 3 fibreglass tanks, located outdoors at Saltas' 
Wayatinah facility (Figure 4.2). Tanks received river water at natural 
temperatures, which ranged from 6 to 17 °C (Figure 4.3) and fish were subject to 
natural photoperiod until fmal sampling in June. The photoperiod regime used for 
experiments (Figure 4.4) was based on a model which had previously been shown 
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Figure 4.1 	Arrangement of six 1m3 tanks used for first feeding of juvenile 
Atlantic salmon, indoors at Saltas' Florentine facility. 
Figure 4.2 	Four m3 tanks used for ongrowing of Atlantic salmon parr, 
outdoors at Saltas' Wayatinah facility. 
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Figure 4.3 Mean weekly water temperature for a) December 2000 to June 
2001 and b) December 2001 to June 2002 in outdoor tanks at 
Wayatinah. 
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to relate photoperiod and growth to the incidence of male maturation in Atlantic 
salmon parr (Duston and Saunders, 1992) 
4.2.ii Immersion protocol 
Immersion treatments were undertaken in stainless steel trays (35 cm x 15 cm x 
10 cm), containing 750 ml water, with treatments added as detailed below. Stock 
solutions of the Al and MDHT were prepared in 100% ethanol, and added to the 
immersion trays in a volume of 2 ml per tray, with control trays receiving only 
ethanol. Two mesh boxes, each with 500 alevins, were placed in each tray (Figure 
4.5), left for 2 hours then returned to the Heath trays. 
Figure 4.5 	Atlantic salmon alevins undergoing immersion treatment in mesh 
boxes, in stainless steel containers. 
4.2.iii Experiment 1:2000-01 
Four Al were used: ATD (Steraloids Inc.) ; OHA (Sigma); miconazole (Aldrich) 
and aminogluthetimide (Sigma). Maximum doses of 12.5 mg L -1 and 500 lig L -1 
were respectively used for non-steroidal Al miconazole and aminoglutethimide 
and steroidal AT ATD and OHD. A 5-fold dilution series from the maximum dose 
was used in order to assess the extent of any toxic effects of the Al. Thus, ATD 
and OHA were used at concentrations of 4, 20, 100 and 500 pig L -1 , while 
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miconazole and aminoglutethimide OHA were used at concentrations of 0.1, 0.5, 
2.5, 12.5 mg L -1 . In addition, MDHT (500 pg L -1 ) was used as a positive control. 
For each level of AT or MDHT, groups of 1000 alevins were treated either once at 
14 DMPH, or twice, at 14 and 28 DMPH. 
4.2.iv Experiment 2:2001-02 
Two Al were used: ATD and fadrozole (Novartis), each at two doses. ATD and 
fadrozole were tested at doses that had previously been shown to be partially 
effective in sex reversal, in Experiment 1 and Piferrer et al. (1994c) respectively. 
Higher doses were also used to assess whether efficacy could be increased with 
- increased dose. Thus ATD was used at doses of 0.5 and 5 mg L 1 , and fadrozole 
was used at doses of 10 and 50 mg L -1 . In addition, MDHT (500 pg ) was used 
as a positive control. For each dose of Al or MDHT, groups of 1000 alevins were 
treated twice, either at 7 and 14 DMPH ("Early" immersion treatment), or 14 and 
21 DMPH ("Late" immersion treatment). Immersion treatments were repeated at 
shorter intervals than in Experiment 1, as reduced interval time has been shown to 
increase steroid uptake in alevins (Piferrer and Donaldson, 1994). The timing of 
immersion treatments was made earlier than in Experiment 1 to further assess the 
effects of developmental stage on Al efficacy. 
4.2.v Population assessment 
Assessment of sex ratios in all experimental groups was conducted in June, at the 
completion of the following spawning season, 10 months after the treatment of 
alevins with AL One hundred fish were sampled from each treatment group. Fish 
were euthenased in Aqui-STM and examined externally for signs of maturity. 
Sperm duct patency was assessed by applying gentle abdominal pressure and 
checking for signs of expressed milt. A sample of 25 individuals (Experiment 1) 
or all individuals (Experiment 2) was weighed and standard length of each fish 
determined. Gonads from all individuals were dissected out and phenotypic sex 
was determined by visual observation of the gonad. Representative samples of 
testes and ovaries were retained from 5 individuals from each treatment group, 
fixed in Bouins fixative and processed for histological examination. Where 
phenotypic sex could not clearly be determined from visual examination of the 
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gonads, gonads were fixed in Bouins fixative and sex determined histologically. 
In the absence of any recognisable gonadal tissue, animals were recorded as 
sterile. Gonads from 25 individuals were weighed for determination of 
gonosomatic index (GSI), calculated as: 
gonad weight 
GSI (%) = 	 X100 
whole body weight 
4.2.vi Sperm quality 
Where present, five mature males with patent sperm ducts were collected from 
each treatment group and milt was obtained from these by insertion of a 
polypropylene pipette tip into the vent and application of gentle abdominal 
pressure. Expressed milt was refrigerated in the tips until required. Sperm quality 
was assessed by applying a small amount of milt to a microscope slide, adding 10 
Ill of sperm activator and recording sperm activity (Table 4.1) every 15 seconds, 
until no activity was observed. Parameters used for comparisons of sperm activity 
between treatment groups were the proportion of motile sperm observed 30 sec 
after the addition of activator and the duration of sperm activity. Male fertility was 
estimated using groups of 100 eggs, collected from a single female that had 
ovulated 3-7 days previously. Eggs were placed in 120 ml plastic vials, 250 IA of 
milt and 50 ml sperm activator were added, the vials gently swirled, and allowed 
to stand for 2 minutes. After standing, eggs were rinsed twice with fresh water, 
incubated at 8 °C for 15 hours and embryos fixed in clearing solution (1:1:1 v/v 
methanol:acetic acid:water). Embryos were examined at 10 X magnification, 
Table 4.1 	Sperm motility criteria used in sperm activity assessment. 
Score 	 Criteria 
0 	No motile sperm 
1 	Less than 25% sperm motile 
2 	25-50% sperm motile 
3 	50-75% sperm motile 
4 	Greater than 75% motile 
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fertility determined as the proportion of eggs that had undergone first cell 
division. Sperm quality and fertility of Al treated neomales were compared with 
that of precociously mature males of the same age from a mixed sex population. 
4.2. vii Histological procedures 
Tissue was fixed in Bouins fixative for 24-72 hours, then transferred to 70% 
ethanol. Standard histological techniques, similar to those outlined by Hinton 
(1990) were employed. Samples were dehydrated in an alcohol series and 
toluene, and embedded in paraffm in a Tissue-Tek VIP 4617, using the infiltration 
regime given in Appendix Ha. Seven micron sections were cut on a Leitz Wetzlar 
1512 microtome fitted with disposable blades (Feather S35), and stained with 
Mayer's haematoxylin and Young's eosin, with Scott's tapwater substitute used as 
a blueing agent (Appendix Ilb). Sections from gonads of some representative 
males (n=7) and females (n=5) from Experiment 2 were used for the 
determination of spermatocyte and ooctye size. The largest diameter of 20 
spermatocytes or 10 ooctyes was measured for each individual using images 
captured with a Leica DC 300F videocamera at 100 and 400X magnification 
respectively, and measurements were made using Leica IM 50 image analysis 
software. 
4.2.viii Statistical Analyses 
Morphometric, mortality and fertility data were analysed by one-way ANOVA, 
and mean comparisons made using a Tukeys honestly significant difference 
(HSD) test. Comparisons of masculinisation rates were made by contingency Chi-
squared tests between each treatment group and the appropriate control, but the 
differences in the frequency of intersex and sterile animals among groups was not 
tested as some of these individuals were only able to be detected in histological 
samples which were considered to be unrepresentative of the population. Sperm 
activity data were analysed by Mann-Whitney U-test for comparisons of activity 
30 sec after activator addition, and by ANOVA for duration of activity. All 
analyses were performed using SPSS 10.1 for Windows. Percentage data were 
arcsine transformed prior to analysis. 
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4.3 	Results 
4.3.i 	Experiment 1:2000-01 
Although there were differences in mortality rates between groups of alevins 
during the period from treatment to first feeding (Table 4.2), elevated mortality 
showed no relationship with Al type or dose, and coincided with events of 
reduced water flow affecting one of the rearing systems. On this basis, only 
animals treated at the highest dose were retained for subsequent study. The 
differences in mortality following first feeding (Table 4.3) arose either because of 
difficulties in establishing feeding (control, double immersion, and 
aminoglutethimide, single immersion tanks), or reduced flow for extended 
periods (MDHT, single immersion and aminoglutethimide, double immersion 
tanks), both of which elevated mortality rates. Mortality data for each treatment 
were not collected following transfer to 4 m3 tanks; however, total mortality in 
these tanks from transfer in December 2000 to final sampling in May 2001 was 
less than 1%. 
Table 4.2 	Percent mortality (mean ± range a) of Atlantic salmon alevins 
immersion treated in different doses of the aromatase inhibitors 
AID, OHA, miconazole and aminoglutethimide. 
Aromatase 
inhibitor 
Immersion 
regime 
(DPMHY 0 
Dose (gg 
4 	20 	100 500 
14 21.7±0.6 
Control 
14,28 24.4±10.4 
14 16.5±7.4 	23.6±4.0 	26.4±7.6 23.3±7.4 
ATD 
14, 28 17.4±3.6 	19.0±1.6 	24.5±3.0 19.4±5.6 
14 20.0±2.8 	22.5±15.0 	16.6±6.0 16.3±1.0 
OHA 
14, 28 25.9±2.2 	21.0±10.4 	16.6±6.4 18.2±2.8 
Dose (mg L -1) 
0 0.1 	0.5 	2.5 12.5 
miconazole 
14 15.4±3.2 	18.9±3.4 	19.3±10.6 17.6±6.4 
14, 28 22.8±0.4 	60.2±79.6 	17.6±2.0 21.3±1.4 
aminoglutethimide 
14 21.3±7.0 	23.4±6.4 	20.3±2.6 22.6±17.2 
14, 28 16.7±3.4 	62.5±75.0 23.7±12.6 14.5±3.8 
a data from duplicate rearing trays 
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Table 4.3 	Production parameters for Atlantic salmon, immersion treated in either MDHT or the aromatase inhibitors ATD, OHA, 
miconazole or aminoglutethimide. 
Treatment Immersion regime 
(DPMH)a 
First feeding 
mortality (')/0)b'e 
Weight (g)de 
(mean±SE) 
Length (mm) d'e 
(mean±SE) 
CF d'e'l 
(mean±SE) 
GSI (%)d '" 
(mean±SE) 
Control 14 17.2 110.03 ± 7.36' 198.47 ± 4.27"Y 1.35 ± 0.01 0.11 ±0.01 
14, 28 39.4 98.69 ± 6.74' 194.23 ±4.33 1.29 ± 0.01 0.31 ± 0.17 
MDHT 14 98.6*** ND ND ND ND 
5001.ig L-1 14,28 14.8*** 95.53± 11.09"'Y 186.04 ± 6.81'Y'z 1.37 ± 0.02 3.19 ± 0.58 
ATD 14 20.1 92.36 ± 6.48'Y 187.46 ± 4.33 x 'Y'z 1.35 1 0.02 0.14 ± 0.01 
500pg L-1 14, 28 28.7*** 109.35 ± 6.93' 200.23 ± 4.24'Y 1.31 ± 0.02 0.22 ± 0.11 
OHA 14 16.8 86.32 ± 6.02''"Y'z 187.13  1.26 1 0.01 0.14 ± 0.01 
500gg L-1 14, 28 16.3*** 60.9613.18 z 168.87 ± 2.83 z 1.24 ± 0.01 0.16 ± 0.00 
miconazole 14 14.1 67.71 ± 4.15Y' 171.90 ± 353Z 1.29 ± 0.02 0.15 ± 0.01 
10 mg L-1 14, 28 21.7*** 79.39 ± 183.31 ±4.4O 1.22 ± 0.01 0.15 ±0.01 
aminoglutethimide 14 32.3*** 106.82 1 7.08' 201.13 ±4.S8 1.26 ± 0.01 0.12 ± 0.01 
10 mg L -1 14, 28 83.7*** 112.80 ± 7.76' 204.00 ± 4.59' 1.28 1 0.01 0.13 ± 0.01 
a DPMH - days post-median hatch 
cumulative mortality from first feeding (September 2000) to December 2001 
Asterisks indicate difference in mortality rate from appropriate controls (* 0.01<p<0.05; ** 0.001<p<0.01; *** 0.001<p) 
d data collected in May 2001 
'values sharing the same superscript are not significantly different (p>0.05) 
"CF = 100 x weight (g) / (fork length (mm)) 3 x 1000 
g GSI (%) = gonad weight/ total weight x 100 
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Weight and fork length of OHA, double immersion treated and miconazole, single 
immersion treated fish were significantly lower than controls, and but not 
different to other fish treated with the same Al (Table 4.3). There were no 
significant differences in condition factor. GSI was significantly higher in the 
MHDT treated group, reflecting the increased frequency of mature males in that 
group (Figure 4.6). 
There was a significantly higher proportion of males in fish treated with MDHT 
and ATD single and double immersion, than in control groups (Figure 4.6). 
Maturation levels among males were 75, 46 and 46% for MHDT and ATD single 
and double immersion treated fish respectively, and patent sperm ducts were 
observed in 86, 83 and 67% of the mature fish in those same groups (Figure 4.7). 
Females, mature and immature males displayed similar distributions of body 
weight, fork length and condition factor (Figure 4.8 a-c), whereas differences in 
GSI were apparent between mature and immature males (Figure 4.8 d). Due to the 
low number of male fish present in samples at 9 months post-hatch, statistical 
analyses were not performed on these data. 
Histological examination of representative male and female gonads (n = 50) from 
all treatment groups agreed with the assignation of sex based on visual 
examination in 94% of cases. Most testes were comprised of spermatogonia 
arranged in clusters (Figure 4.9), however some specimens also contained 
secondary spermatocytes (Figure 4.10 a,c inset). Ovaries consisted of 
perinucleolar oocytes with surrounding somatic cells (Figure 4.11) and were 
structurally similar in control and Al treated populations. In those individuals 
where sex was unable to be determined visually (n=18), gonads from two 
individuals were ovotestes, with both gamete types mixed throughout the gonad 
(Figure 4.10 a,b) In another two cases the gonads were comprised primarily of 
spermatogonia, with clusters of small numbers of oocytes also present in addition 
to areas of sterile tissue ("mostly male", Figure 4.12a). The presence of small 
numbers of oocytes in a predominantly male gonad has been frequently observed 
in 2+ year old mature sex inverted male Atlantic salmon (P.S. Lee and H. R. King, 
unpublished observations). On this basis, and giving consideration to the likely 
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Figure 4.7 	Proportions of sperm duct status of mature fish, expressed as a 
percentage of mature sex inverted male fish produced by 
immersion in either MDHT or ATD in Experiment 1. See text for 
abbreviations. 
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Figure 4.8 	Percent frequency of pooled data (N = 356) of: a) whole weight; b) 
fork length (FL); c) condition factor and d) GSI, for fish from 
Experiment 1. 
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Figure 4.9 
	
Sections of testis showing spermatocytes (Sp), from individuals 
treated with a) MDHT b)ATD c) aminoglutethimide and d) 
miconazole. Note sterile connective tissue (St) in b). 
Scale bar =50 
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Figure 4.10 Sections of ovotestis, from individuals treated with a) and b) 
miconazole c) aminoglutethimide, showing oocytes (Oo), male 
gonadal tissue (d ), spermatogonia (Sp) and secondary 
spermatocytes (Ssc). Detail of male gonadal tissue in inset. Other 
details as for Figure 4.9. 
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Figure 4.11 Sections of ovaries, from a) control b) aminoglutethimide c) 
miconazole and d) OHA treated individuals. Inset shows detail of 
oocyte (Oo) and surrounding follicular cells (F). Other details as 
for Figure 4.9. 
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Figure 4.12 Sections of gonads containing a small cluster of oogonia (Oo) 
amongst testis (cf ) and sterile connective tissue (St) from a) 
MDHT treated and b) Control individuals. Inset shows 
spermatogonia in detail. Other details as for Figure 4.9. 
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assignation of similar fish as males based solely on visual examination, this and 
subsequent mostly male individuals were included as males in the data set. In 
distinguishing the gonads of intersex individuals from the mostly male gonads 
described above, the key criterion was the presence of oocytes located throughout 
testis tissue (Figure 4.10), rather than in an isolated cluster (Figure 4.12a). The sex 
of the remainder of individuals determined by histological examination was: male 
(10); female (3); and sterile (1). Of the three representative gonad samples where 
histological determination of sex differed from visual assessment, two that had 
been visually assigned as male were intersex, and one visually assigned as female 
was mostly male. 
Sex inverted males, obtained by immersion in either ATD or MDHT displayed no 
difference in either sperm activity 30 sec after activator addition (x 2=3.98, 3 d.f., 
p>0.05), activity duration (F3,16=1.49, p>0.05) or fertility (F3,16 =1.68, P>0.05), 
from normal precocious males (Table 4.4). 
Table 4.4 	Sperm activity parameters and fertility of sex inverted and normal 
male fish in Experiment 1. See text for abbreviations 
Treatment 	 Sperm activity a 	Duration of 	Fertility 
at 30 sec 	sperm activity 	(%) 
(mean[rangep 	(sec) 
Control 	 2.8[3] 	54.0 ± 11.2 	69.3 ± 7.8 
MDHT, double immersion 	2.0[2] 	54.0 ± 11.2 	74.8 ± 4.9 
ATD, single immersion 2.4[3] 	72.0 ± 22.4 	68.3 ± 4.8 
ATD, double immersion 	1.4[3] 	63.0 ± 25.3 	66.7 ± 6.9 
a Defined in Table 4.1 
4.3.ii Experiment 2:2001 -02 
There was no effect of either AT dose or timing of immersion treatment on 
survival to 10 months post-hatch over the course of the experiment (Table 4.5). 
Increased mortality prior to first feeding in fry treated with ATD at 5 mg U 1 and 
fadrozole at 10 mg I: on 14 and 21 DPMH (Table 4.5) was the result of fungal 
infection which affected trays in one system. Increased mortality following first 
feeding was the result of the Costia sp. infection and treatment discussed 
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Table 4.5 	Production parameters for Atlantic salmon, immersion treated in either MDHT or the aromatase inhibitors ATD or fadrozole in 
Experiment 2. Details as for Table 4.3. 
All androgen 
dose 
Immersion 
regime 
(DPMH) 
First feeding Post-hatch 
mortality 
mortality (%) 
(%) 
Weight (g) 
(mean±SE) 
Length (mm) 
(mean±SE) 
CF 
(mean±SE) 
GSI (%) 
(mean±SE) 
Control 
MDHT 
0.5 mg 1: 1 
ATD 
0.5 mg 1,1 
ATD 
5 mg 1: 1 
fadrozole 
10 mg L -1 
fadrozole 
50 mg 1: 1 
7,14 
	
17.9 
	
23.4 
	
65.85 ± 2.32 
	
178.3 ± 2.1" 
14,21 
	
13.4 
	
22.3 
	
65.97 ± 2.11 
	
179.5 ± 1.7' 
7,14 
	
21.4 
	
22.3 
	
67.64 ± 2.62 
	
177.9 ± 2.1 Y ' z 
14,21 
	
15.2 
	
33.0*** 
	
65.23 ± 2.72 
	
176.0 ± 2.3" 
7,14 
	
21.3 
	
18.9* 
	
70.41 ± 3.17 
	
177.5 ± 2.5" 
14,21 
	
15.2 
	
23.8 
	
69.78 ± 2.77 
	
179.2 ± 2.2" 
7,14 	16.9 	 19.3* 	60.90 ± 2.54 	170.8 ± 2.2Y 
14,21 	20.1*** 	24.3 	65.38 ± 3.53 	172.6 ± 2.8 Y 'z 
7,14 	20.3 19.9 67.17 ± 2.43 
	
176.6 ± 2.1" 
14,21 	17.6* 
	
18.9 
	
68.74 ± 2.04 
	
180.8± 1.7z 
7,14 	17.0 	32.3*** 	63.30 ± 2.20 
14,21 	16.2 	28.4*** 	65.15 ± 2.38 
	
1.13 ± 0.02 	0.25±0.08 Y ' z 
1.11 ± 0.01 	0.78±0.35 Y 'z 
1.15 ± 0.01 
	
1.02±0.40 Y'z 
1.14 ± 0.01 
	
1.57±0.43 Y ' z 
1.19 ± 0.01 
	
1.48±0.47 Y ' z 
1.16 ± 0.01 
	
0.86±0.31 Y'z 
1.16 ± 0.01 
	
1.26±0.41 Y'z 
1.19 ± 0.02 
	
1.60±0.42 z 
1.25 ± 0.10 	0.14±0.01 
1.13 ± 0.01 	0.16±0.02 Y 
0.17±0.01" 
0.16±0.01Y 
175.4± 
	
1.13 ± 0.01 
177.8± 
	
1.12 ± 0.01 
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previously. As in Experiment 1, total mortality in the 4 m 3 tanks from transfer in 
December 2001 to final sampling in May 2002 was less than 1%. 
Mean fork length of fry treated with ATD at 5 mg L -1 on 7 and 14 DPMH was 
significantly lower than that of fry treated with fadrozole at 10 mg Con 14 and 
21 DPMH (Table 4.5). GSI was significantly higher in the group treated with 
ATD at 5 mg L-1 on 14 and 21 DPMH than in animals treated with Fadrozole at 
10 mg L-1 on 7 and 14 DPMH or 14 and 21 DPMH, or at 50 mg L-1 on 14 and 21 
DPMH, reflecting the low frequency of mature males in the fadrozole treated 
animals (Figure 4.13 ). There were no significant differences in either weight or 
condition factor between the treatment groups.. 
There was a significantly higher proportion of males in fish treated with MDHT 
and ATD, regardless of dose and timing of immersion, than in control groups 
(Figure 4.13). Furthermore, the proportion of males in fish treated with MDHT at 
7 and 14 DPMH was lower than those treated at 14 and 21 DPMH, whereas the 
proportion for fish treated with ATD at 500 i.ig L -1 at 7 and 14 DPMH was greater 
than at 14 and 21 DPMH. Maturation levels were 39 and 47 % for MHDT , 67 
and 62 % for ATD at 500 i.tg L -1 and 59 and 72% for ATD at 5 mg L-1 , for 
immersion at 7 and 14 or 14 and 21 DPMH respectively (Figure 4.14). Patent 
sperm ducts were observed in 87, 96, 88, 80, 87, 90% of the mature fish in those 
same groups (Figure 4.14). Analysis of pooled data for female, mature and 
immature male fish (Figure 4.15) showed that mature males had significantly 
lower weight (45.7 g) and FL (155.5 mm) and significantly higher CF (1.18) than 
either immature males (weight = 69.9 g, FL = 180.2 mm, CF = 1.14) or females 
(weight = 70.1 g, FL = 181.0 mm, CF = 1.14) (weight F2,1156 = 78.0, p<0.001; FL 
F2,1156 = 133.8, p<0.001; CF F2,1156 = 9.8, p<0.001). GSI of mature males (4.24 %) 
was higher than that of females (0.13 %), which was higher than immature males 
(0.07 %) (F2,678= 4397, p<0.001). Histological determination of phenotypic sex of 
representative samples agreed with visual assessment in all cases (n = 50). There 
were 47 individuals in which sex could not be determined visually, with 
histological examination determining them to be: male (22 including mostly male 
(4)); female (14) and intersex (7). The four gonad types described above: testis 
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Figure 4.13 Percentage masculinisation following immersion with MDHT or 
Al. See text for abbreviations. For each level of androgen or 
aromatase inhibitor treatment, different superscripts indicate 
significant difference (p<0.05) between early and late immersion 
treatments. Asterisks indicate significant difference in male 
frequency from control populations (** 0.001<p<0.01; 
***p<0.001). 
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Figure 4.14 Proportions of sperm duct status of mature fish, expressed as a 
percentage of mature sex inverted male fish produced by 
immersion in either MDHT or ATD in Experiment 2. 
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Figure 4.15 Percent frequency of pooled data of: a) whole weight; b) fork 
length (FL); c) condition factor and d) GSI, for fish from 
Experiment 2. 
103 
Efficacy of aromatase inhibitors for sex inversion 
(Figure 4.16) ; ovotestis (Figure 4.17); ovaries (Figure 4.18); and mostly males 
(Figure 4.19) were structurally similar between treatment groups, and to those 
described for Experiment 1. Within the groups treated with Al, large areas of 
sterile tissue were present in some ovotestis with (Figure 4.18) . Oocyte size 
(mean diameter ±S.E.) of individuals was in the range of 134.7±7.8 to 160.0±7.8 
pm, with spermatocyte size in the range of 7.4±0.1 to 10.6±0.4 p.m. Sperm 
activity 30 sec after activator addition (x2=3.98, 3 d.f., p>0.05), activity duration 
(F3 , 1 6 =1.49, p>0.05) or fertility (F3,16 =1.68, p>0.05) of sex inverted males, 
obtained by immersion in either ATD or MDHT did not differ to that of normal 
precocious males (Table 4.6). 
Table 4.6 	Sperm activity parameters and fertility of sex inverted and normal 
male fish from Experiment 2. See text for treatment details and 
abbreviations. 
AI/androgen 
dose 
Immersion 
regime 
(DPMH) 
Sperm 
activity' at 30 
sec 
(mean[rangep 
Duration of 
sperm 
activity (sec) 
(mean ± SE) 
Fertility (°/0) 
(mean ± SE) 
Control na 1.6 [2.0] 36.0 ± 6.0 66.5 ± 3.6 
MDHT early 1.6 [3.0] 33.0 ± 5.6 63.8 ± 2.3 
0.5 mg I.,"' late 2.2 [3.0] 39.0 ± 7.6 72.8 ± 2.9 
ATD early 2.8 [2.0] 48.0 ± 5.6 74.0 ± 3.6 
0.5 mg L -1 late 3.8 [1.0] 54.0 ± 3.7 75.6 ± 2.4 
ATD early 2.4 [3.0] 42.0 ± 5.6 71.9 ± 2.5 
5 mg E l late 2.0 [2.0] 33.0 ± 3.0 69.6 ± 2.8 
a Defined in Table 4.1 
104 
Efficacy of aromatase inhibitors for sex inversion 
A 
Sp 
B 
Sp 
1\ 
Sp 
I\ 
, 
D 
Sp 
I 
Figure 4.16 Sections of testis from a) control or individuals treated with, b) 
ATD, c) fadrozole and d) MDHT. Other details as for Figure 4.9. 
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Figure 4.17 Ovotestis from individuals treated with a) and b) fadrozole at 10 
mg L-1 c) ATD at 5 mg L. Note extensive areas of sterile 
connective tissue (St) in addition to male gonadal tissue d. Detail 
of male gonadal tissue with primary spermatocytes (Psc) and 
spermatogonia (Sp) shown in insets. Other details as for Figures 
4.9 and 4.12. 
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Figure 4.18 Sections of ovaries from individuals treated with a) ATD at 
5mg 1: 1 b) ATD at 0.5mg U' c)and d) MDHT. Other details as for 
Figure 4.9 
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Figure 4.19 Sections of gonads containing predominantly testis tissue (di ), with 
a cluster of oocytes (Oo). Animals treated with a) and d) ATD, b) 
and c) MDHT. Other details for Figures 4.9 and 4.11. Insets shoe 
detail of male gonadal tissue, including secondary spermatocytes 
(Ssc) in a), and spermatogonia (Sp) in a)-d). 
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The persistence of a small proportion of males in the control all female population 
may arise from the use of genetic males during spawning, alternatively there may 
have been movement of fish between the 1 m 3 tanks. At the conclusion of both 
experiments there were a small number of males with blocked sperm ducts present 
in the control populations. While the spontaneous development of these cannot be 
ruled out, it is possible that they came from an adjacent tank. Jump screens were 
used during Experiment 2 to prevent transfer between tanks; however, the 
relatively high incidence of females in the Control (Late) tank, again including 
some males with blocked sperm ducts, indicated that some mixing may have 
occurred. 
4.4 	Discussion 
The present study represents the first achievement of masculinisation of salmonids 
following immersion treatment with ATD. Furthermore, masculinisation rates of 
greater than 50% following immersion treatment with ATD were comparable to 
levels achieved with MDHT in the same study, and demonstrate the commercial 
viability of immersion treatment with ATD for salmonid masculinisation. ATD 
had previously been shown to be an effective masculinising agent for rainbow 
trout, Oncorhynchus mykiss, when it was administered chronically, via the diet 
(Guiguen et al., 1999). In their study of the efficacy of ATD applied acutely for 
the masculinisation of developing chickens, Elbrecht and Smith (1992) induced a 
male pattern of gonadal development with a single, 2 mg dose. In contrast, similar 
acute treatment with ATD was ineffective in masculinising turtles with 
temperature-dependent sex determination (Wibbels and Crews, 1992; Pieau et al., 
1994). 
The poor efficacy of fadrozole in the present study is in contrast to the results of 
previous in vitro efficacy experiments (Chapter 3) and in vivo studies on a range 
of taxa (Elbrecht and Smith, 1992; Piferrer et al., 1994c; Wennstrom and Crews, 
1995; Chardard and Dournon, 190; Kitano et al., 2000; Kroon and Liley, 2000; 
Kitano et al., 2001; Kwon et al., 2002). Using similar techniques to those in the 
present study, Piferrer et al. (1994c) achieved 22% masculinisation of chinook 
salmon, 0. tshawytscha, and although the difference in masculinisation rates 
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between the present study and that of Piferrer et al. (1994c), may be a result of 
interspecific differences, the failure of fadrozole to induce masculinisation in the 
present study, even when applied at times that were effective for another Al, 
suggests that other factors may have contributed the observed results. Fadrozole 
has increased aqueous solubility under acidic conditions (Ackermann and Kaiser, 
1989), and aqueous solubility negatively correlates with drug uptake rate (Hunn 
and Allen, 1974). This may mean that bath conditions in immersion studies may 
influence uptake. Ammonia and carbon dioxide excretion by alevins during 
bathing would tend to reduce bath pH, and although bath pH was not measured in 
the present study, the density of alevins in immersion treatments was more than 
10-fold higher than in the study by Piferrer et al.(1994c), raising the possibility 
that different immersion conditions between studies might affect results. 
Notwithstanding the results of the present study, previous successful studies have 
achieved only moderate levels of masculinisation of chinook salmon (Piferrer et 
al., 1994c) and newts, Pleurodeles wait! (Chardard and Dournon, 1999), 
following immersion treatment with fadrozole. In contrast, higher levels (>95%) 
of masculinisation have been achieved using fadrozole applied directly to the 
developing eggs of the parthenogenetic whiptail lizard Cnemidophorous 
uniparens (Wennstrom and Crews, 1995), and the chicken (Elbrecht and Smith, 
1992). Furthermore, complete masculinisation following dietary administration of 
fadrozole has been reported in the Japanese flounder, Paralichthys olivaceus, 
(Kitano et al., 2000, 2001) and Nile tilapia, Oreochromis niloticus (Kwon et al., 
2002). Such differences in efficacy may be a consequence poor uptake from an 
aqueous solution, possibly as a result of the effects of pH on aqueous solubility as 
discussed above. The characteristics of fadrozole uptake and their relevance to its 
efficacy in the present study are discussed further in Chapter 5. 
The frequency of application may have also affected the efficacy of fadrozole in 
the present study, as there is a quantifiable relationship between treatment 
frequency, drug half life and tissue levels (Notari, 1980; Grahame-Smith and 
Aronson, 1984). Due to a low Km and turnover rate of aromatase, competitive 
inhibitors, such as fadrozole, are required in higher concentrations, and have a 
shorter effective half-life, than mechanism-based inhibitors which bind 
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irreversibly to aromatase, such as ATD (Cole and Robinson, 1990; Seralini and 
Moslemi, 2001). Taking these observations into account, the efficacy of fadrozole 
may be improved by reducing stocking density during immersion treatment, 
reducing the inter-bath interval to less than 7 days and applying more than 2 
treatments. However, should the efficacy of fadrozole be improved by this 
approach, the need to repeatedly handle alevins over a relatively short time period 
may still limit its attractiveness in a commercial setting 
OHA is an effective inhibitor of salmonid aromatase in vitro (Chapter 3, 
Antonolopou et al., 1995; Shilling et al., 1999) and masculinises developing 
amphibian gonads (Yu et al., 1993; Petrini and Zaccanti, 1998); however, it was 
neither an effective masculinising agent of Atlantic salmon in the present study 
nor effective in reducing aromatase activity when administered in vivo to juvenile 
Atlantic salmon (Antonolopou et al., 1995). This may be due to a compensatory 
increase in aromatase production as proposed by Antonolopou et al. (1995). 
Alternatively, it may result from rapid glucuronation of OHA, as occurs in 
humans (Cole and Robinson, 1990). Additionally, poor efficacy of OHA in the 
present study may be related to poor uptake, discussed in detail in Chapter 5. The 
low efficacy of the miconazole and aminoglutethimide is consistent with the 
relatively poor efficacy in previous in vitro studies (Chapter 3) and with the 
findings of Chardard and Dournon (1999) in their studies on the newt. 
Masculinisation by MDHT in Experiment 1 is at a comparable levels to previous 
studies, as is the reduction in efficacy of androgens applied prior to 14 DPMH 
(Chapter 2). The relatively low levels of masculinisation of animals treated at 14 
and 21 DPMH in Experiment 2 is in contrast with previous studies (Chapter 2). 
The reasons for this are unclear, and it may be a reflection of annual variability of 
the stocks. Importantly, notwithstanding the relatively low incidence of sex 
inversion achieved with MDHT in Experiment 2, commercially acceptable levels 
of masculinisation of were achieved with ATD. 
Previous work (Chapter 2) showed no difference in the efficacy of androgens 
applied in dual immersion treatments separated by either 7 or 14 days; however, 
in the present study there was an increase in masculinisation from 13 to 24% 
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when ATD was applied at a 7 (Experiment 2) rather than a 14 (Experiment 1) day 
interval. Such differences may reflect differences in the mode of action of these 
compounds, or differences in uptake and clearance rates. The turnover of steroid 
hormones in salmonids is rapid, with an estimated half life of 48 hours in alevins 
(Piferrer and Donaldson, 1994), and shorter periods in fry and juveniles 
(Johnstone et al., 1978; Johnstone et al., 1983; Piferrer and Donaldson, 1994), 
thus by 7 or 14 days, only 1-10% of the initial steroid uptake would remain. 
(Grahame-Smith and Aronson, 1984). Provided clearance is not complete, 
repeated doses of a drug increase tissue levels and hence efficacy; however, to be 
optimally effective, the interval between doses should be equal to or less than the 
drug half life (Notari, 1980; Grahame-Smith and Aronson, 1984). This was borne 
out in the study of Piferrer and Donaldson (1994) who showed E2 efficacy was 
improved when the inter-bath interval of coho salmon alevins was reduced from 7 
to 2 days. In contrast, the efficacy of Al such as ATD that irreversibly bind to 
aromatase, is extended beyond the period of clearance, as aromatase has a slow 
turnover rate (Cole and Robinson, 1990), and the optimum inter-treatment interval 
is therefore likely to be substantially longer than for steroids. The influence of the 
timing of immersion treatments with ATD on uptake and retention of ATD is 
discussed further in Chapter 5. 
The masculinisation of Atlantic salmon achieved with ATD in the present study 
supports the hypothesis that the onset of ovarian differentiation in fishes is 
dependent on the presence of estrogens (Yamamoto, 1969; Piferrer et al., 1994c; 
Nagahama, 2000; Piferrer, 2001), or a sufficiently high estrogen:androgen ratio 
(Bogart, 1987), and that the differentiation of gonadal tissue to testis occurs in the 
absence of estrogens (Kwon et al., 2002). The improved efficacy of AID when 
used at 7 compared to 14 DPMH contrasts with results obtained with MDHT in 
the present and previous (Chapter 2) studies, and suggests differences in their 
roles in masculinisation. These data suggest that the presence of E2 at a time soon 
after hatch is a key factor in the onset of female sex differentiation, whereas 
androgens exerts a masculinising effect at a later time, which extends beyond the 
period of first feeding. Similar evidence of asynchrony between the onset of 
feminisation and masculinisation in fishes was shown by Piferrer and Donaldson 
(1989) who determined that the sensitivity of coho salmon to estrogen preceded 
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that for androgens by several days, and by Nagahama (2000) who showed that in 
tilapia the levels of several steroidogenic enzymes increased prior to ovarian 
differentiation, but not until after differentiation of the testis. Petrini and Zaccanti 
(1998) also showed an earlier response to exogenous estrogens than to androgens 
in the toad Bufo bufo. Although the study of Piferrer et al. (1994c) involved the 
addition of fadrozole or androgens at a time of sensitivity to both estrogens and 
androgens, the relatively poor masculinisation rate attained with fadrozole alone 
compared to levels obtained with fadrozole and androgens in combination, raises 
the possibility that the earlier addition of fadrozole may have improved its 
efficacy. In the present study, the increase in efficacy of ATD when used in late 
immersion treatments at a dose of 5 mg L -1 , compared to 0.5 mg L -1 suggests an 
additional role for ATD. ATD has androgenic properties (Wozinak et al., 1992; 
Seralini and Moslemi, 2001) and this increased efficacy is possibly due to its 
androgenic effects. The potential for ATD to induce masculinisation through 
action as an androgen was also noted by Guiguen et al. (1999), who achieved 
complete masculinisation of rainbow trout using a dose of 50 mg kg"' ATD in the 
diet, (an order of magnitude higher than typical dietary androgen doses for 
salmonids). Notwithstanding a demonstrated reduction in aromatase activity 
following ATD treatment, Guiguen et al. (1999) noted that "We cannot exclude a 
superimposed androgenic effect concomitantly to the decrease in estrogen 
production, since ATD has a steroidal structure". It remains possible that the 
labile period for feminisation (and hence maximum sensitivity to Al) extends 
earlier than 7 DPMH in Atlantic salmon, and the efficacy of both ATD and 
fadrozole may be improved with earlier application. Masculinisation by non-
steroidal Al administered in the diet has been demonstrated for species in which 
the labile period for E2 sensitivity occurs after the onset of feeding, including 
tilapia (Kwon et al., 2002) and flounder (Kitano et al., 2000), but it has not been 
reported for salmonids. Similarly, dietary administration of tamoxifen, an E2 
receptor antagonist, caused masculinisation of Japanese flounder (Kitano et al., 
2001) but not rainbow trout (Guiguen et al., 1999). These examples support the 
premise that on the model of sex determination discussed previously, the period of 
maximum efficacy of non-steroidal AT would be expected to coincide with the 
time of sensitivity to exogenous E2, while the efficacy of androgenic steroids and 
steroidal Al may extend beyond this period. The comparison of an effective non- 
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steroidal Al applied by immersion during the labile period, and by the diet would 
provide a useful test of this hypothesis. 
The artificial photoperiod regime used in both Experiments 1 and 2 in the present 
studies was successful at inducing up to 70% precocious male maturation 
• reducing the time requirement to achieve gonadal function from 3 years to 9 
months. The high level of sperm quality and fertility of neomales obtained by 
treatment with all doses of ATD concurs with the fmdings of Piferrer et al. 
(1994c). Regrettably, few studies of Al have continued to the point of male 
maturation to allow more detailed comparisons. The effects of masculinisation by 
MT on the fertility of neomales have varied, with studies on rainbow trout 
reporting either comparable fertility to normal males despite the need to macerate 
gonads to extract milt (Johnstone et al., 1979) or a significant decline in fertility 
(Geffen and Evans, 2000). The fertility of Siamese fighting fish declined with 
increasing of MT, due in part to reduced sperm motility and sperm count 
(Kirankumar and Pandian, 2002), whereas Geffen and Evans (2000) found no 
specific traits of the sperm from sex-reversed rainbow trout could account for 
declining fertility. The fertility of sex-reversed males is also compromised with 
high doses of androgens, affecting gonadal development (Johnstone et al., 1978; 
Goetz et al., 1979; Krisfalusi and Cloud, 1999). The need to minimise any 
deleterious effects of steroid hormones has been a consideration in the 
development of a strategy of minimum intervention for sex control (Piferrer, 
2001), but the use of aromatase inhibitors for masculinisation may alleviate some 
of the fertility problems associated with androgens. 
Treatment with Al and MDHT did not affect the production parameters of growth, 
condition factor or GSI. Similarly, the growth and gonadal development of 
chinook salmon was unaffected following immersion treatment of alevins with 
fadrozole (Piferrer et al., 1994c). In contrast, varying effects on gonad growth and 
maturation were found in juvenile Atlantic salmon treated with Al (Antonolopou 
et al., 1995) and gonad size was reduced in chinook salmon following repeated 
immersion treatment with MT (Goetz et al., 1979). Other workers have reported 
both positive and negative effects of steroid hormones on the growth of fishes 
(Pandian and Sheela, 1995; Blazquez et al., 2001; Piferrer, 2001). Piferrer (2001) 
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described 2 response types in growth whereby a Type A response is characterised 
by a dose dependent increase in growth rate up to a threshold dose and a declining 
growth rate at higher doses. The data for androgens clearly fit this model, as the 
administration of androgens to teleosts has both positively (Goetz et al., 1979; 
Baker et al., 1988; Riley et al., 2002) and negatively (Blazquez et al., 1995; 
Kirankumar and Pandian, 2002) affected growth. The basis for the increase in 
growth is proposed to be a result of stimulation of GH/IGF axis by androgens 
(Riley et al., 2002). In contrast, the Type B response is characterised by the lack 
of, or a negative effect on growth with increasing dose, typified by the growth 
response following treatment with E2 (Johnstone et al., 1978; Goetz et al., 1979; 
Piferrer, 2001). The absence of an effect on growth by all Al used in the present 
study suggests a Type B response, despite the reported weak androgenic 
properties of the steroidal AI, ATD and OHA (Seralini and Moslemi, 2001). 
The patterns of mortality in the present study showed no relationship to Al 
treatment, and aside from those due to equipment failures, mortality rates of Al 
treated fish were generally similar to those of controls. No toxic effects of AT have 
been reported for fishes in either dietary (Guiguen et al., 1999; Kwon et al., 2002) 
or immersion (Piferrer et al., 1994c) treatments, despite the use of high doses of 
these compounds in some studies (Guiguen et al., 1999). In contrast, fadrozole 
and miconazole have been reported to be toxic to developing European pond 
turtles (Pieau et al., 1994) and newts (Chardard and Dournon, 1999). Although 
this may solely reflect interspecific variation, differences in dose or duration of 
exposure, AT action may also contribute to these observations. The doses of 
miconazole of 0.25-0.5 mg I.," 1 used by Chardard and Dournon (1999) were 
considerably lower than those used in the present study; however, treatment 
duration was extended, and mortalities occurred after 3 days of exposure. 
Similarly, mortalities in European pond turtles treated in ovo occurred following a 
fourth injection of fadrozole (Pieau et al., 1994). Miconazole, an antimycotic 
imidazole, may inhibit a number of P450 enzymes (Seralini and Moslemi, 2001), 
and although fadrozole is known to have fewer side effects, it may also inhibit 
other pathways (Demers et al., 1993). The results of the present study suggest that 
toxic side effects will not be an issue at the doses and treatment frequency used 
here. 
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The incidence of 67-90% sperm duct patency in sex inverted males obtained 
through immersion treatment with Al is comparable to that of 86-96% in MDHT-
treated fish in the present study, and previous results of 84-92% for fish treated 
with MDHT by immersion (Chapter 2), and higher than that of 59% in fish treated 
with dietary MT or MDHT (Chapter 2). Other studies of salmonids have found 
that the masculinisation of salmonids by androgens via the diet resulted in a high 
proportion of neomales with blocked or malformed ducts (Johnstone et al., 1978; 
Johnstone and Youngson, 1984; Feist et al., 1995) whereas immersion treated 
males had proportionally greater open ducts (Feist et al., 1995). Johnstone and 
Maclachlan (1994) found low incidence of patent ducts in males, regardless of 
treatment mode; however, in that study, immersion treatment was continued at 
weekly intervals, from hatch to 1 month after first feeding. Regrettably, in the 
only study of sex inversion of sahnonids by dietary administration of Al, only 
data on juvenile fish was published (Guiguen et al., 1999). Collectively, these data 
indicate that, despite working through apparently different mechanisms, both Al 
and androgens produce neomales with a high incidence of patent sperm ducts, 
when applied by immersion. 
Treatment of Atlantic salmon alevins in the present study with either ATD or 
MDHT resulted in the production of individuals with fully developed testes and 
high fertility. Histologically the testes of neomales were, in most instances, 
identical to those of normal males and to those of sex inverted female salmonids 
described previously (Krisfalusi and Cloud, 1999). Testis tissue was packed with 
spermatogonia arranged in lobules (Piferrer et al., 1994a; Krisfalusi and Cloud, 
1999) and spermatogonial size was similar to that of diploid, masculinised, coho 
salmon gynogens (Piferrer et al., 1994a). The onset of meiosis within the testis, 
indicated by the presence of secondary spermatocytes in some individuals, is 
consistent with the onset of maturation (Path-1o, 1995; Nakamura et al., 1998), 
reflected in spermiation in a high proportion of sex inverted males. The testis of 
some individuals contained significant areas of connective tissue, similar to that 
described for sex reversed males treated with androgens (Johnstone et al., 1978; 
Goetz et al., 1979; van den Hurk and Slof, 1981; Blazquez et al., 1995; Krisfalusi 
and Cloud, 1999), although few individuals in the present study had gonads 
comprised solely of connective tissue, of the type described by Goetz et al. (1979) 
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Blazquez et al. (1995 ), Krisfalusi and Cloud (1999) and van den Hurk and Slof 
(1981). This is typically associated with high doses of, or extended treatment 
with, androgens. 
Gonads having both male and female gametic tissue, as observed following Al 
treatment in the present study, have also been previously reported as developing 
in a number of gonochoristic fish species following steroid treatment (Johnstone 
et al., 1978; Blazquez et al., 1995). These intersex individuals (Yamamoto, 1969) 
are most frequently associated with intermediate doses or timing of androgens 
(Johnstone et al., 1978; van den Hurk and Slof, 1981; Baker et al., 1988; Blazquez 
et al., 2001). The persistence of ovarian tissue in the testis of males, also observed 
in Al treated fish in the present study, is a frequent occurrence for sex reversed 
Atlantic salmon males produced by dietary androgen treatment (H.R. King, 
unpublished data). Ovarian structure was similar to that which had been 
previously described for salmonids (Piferrer et al., 1994a), with synchronous 
oocytes in the perinucleolar stage, and a lamellar structure of ovaries evident in a 
number of specimens. 
Based on the results of the present study, an effective commercial regime, 
utilising a minimum intervention strategy recommended by Piferrer (2001) has 
been developed for the masculinisation of Atlantic salmon. Dual immersion of 
alevins in ATD at a concentration of 0.5 mg I: 1 commencing no later than 7 
DPMH will provide a commercially effective rate of masculinisation. Efficacy 
may be further improved by reducing the inter-bath interval. If the hypothesis that 
it is the reduction of estrogen causing masculinisation following Al treatments is 
correct, then treatment with Al could be improved by application during the 
period of maximum sensitivity to E2. This remains to be determined for Atlantic 
salmon, but is probably earlier than 7 DPMH. 
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Uptake and retention of aromatase inhibitors by Atlantic 
salmon alevins following immersion treatments. 
Nothing endures but change. 
Heraclitus 
Uptake and retention of aromatase inhibitors 
	
5. 	Uptake and retention of aromatase inhibitors by 
Atlantic salmon alevins following immersion 
treatments. 
5.1 	Introduction 
The responsible and cost-effective use of drugs in aquaculture relies on the 
implementation of treatment regimes that optimise efficacy and dose. A number 
of readily controlled variables relating specifically to the administration of the 
drug may be considered in the development of such a regime, including drug 
selection, dose, frequency and mode of treatment (Allen and Hunn, 1986; Piferrer, 
2001). Additionally, operational considerations such as worker safety, ease of 
implementation, environmental issues and marketing consequences may also be 
taken into consideration. Many of these issues are addressed in the "minimum 
intervention approach" proposed by Piferrer (2001) specifically for the 
development of protocols for steroid hormone treatment of new finfish species in 
aquaculture. However, the principles of this approach including the determination 
of the appropriate treatment period and progressive reduction in dosage and 
treatment duration over repeated experiments, could readily be applied to any 
drug treatment in aquaculture, to yield the desired outcomes of high effectiveness, 
while minimising treatment duration, dosage, cost, environmental impact, 
operator risk and side effects(Piferrer, 2001). 
Drug treatment of fishes is primarily undertaken via either the feed, by immersion 
treatment or by injection. Although the latter method is widely used for some 
vaccine administration, particularly for high value species such as salmonids, 
mass treatment by the former two methods is preferred for reasons of cost, ease of 
delivery and worker safety (Pandian and Sheela, 1995). Dietary treatment may be 
undertaken over weeks or months, but due to differential feed intake between 
members of a population, may result in variable doses between individuals 
(Pandian and Sheela, 1995). In contrast, immersion treatment is usually relatively 
brief (< 1 day) (Pandian and Sheela, 1995; Piferrer, 2001) and offers significant 
advantages over dietary delivery in relation to precision of dose and surety of 
delivery of similar doses across a treatment group (Pandian and Sheela, 1995). 
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Treatment by immersion relies on the uptake of drugs by fishes via gills and skin 
and, as most drugs are not taken up by active membrane transport, their uptake is 
a direct function of lipid solubility (Hunn and Allen, 1974; Allen and Hunn, 
1986). Larval fish may also accumulate high levels of lipid soluble compounds in 
yolk or oil reserves, effectively extending exposure to the treatment agent beyond 
the immersion period (Piferrer and Donaldson, 1994). 
Data on drug uptake and retention are essential for the development of an 
optimum treatment protocol and can contribute to the implementation of a 
minimum intervention strategy for treatment. Steroid hormones, widely studied 
for the control of sex differentiation of fishes, are taken up by the diet (Hishida, 
1965; Johnstone et al., 1983) or via the gills in immersion treatment (Piferrer and 
Donaldson, 1994; Specker and Chandlee, 2003). Although immersion treatment 
may be applied to all developmental stages of fish, including pre-hatching, the 
efficiency of uptake does change with developmental stage treatment (Piferrer and 
Donaldson, 1994; Specker and Chandlee, 2003), and this should be taken into 
consideration in the development of a treatment protocol. Knowledge of drug 
pharmacokinetics is necessary for the development of a multi-dosage regime, as 
the optimum timing of subsequent doses will be a function of drug half-life 
(Notari, 1980). Additionally, clearance data are necessary for cultured animals 
intended for human consumption. 
The application of treatments for the manipulation of sex differentiation is one 
area of fish endocrinological research and production where drugs are routinely 
used. Historically, steroid hormones were used for studies of sex manipulation, 
having been identified by Yamamoto (1969) as the agents responsible for fish sex 
differentiation. More recently, an alternative approach to the control of sex 
inversion in fishes has been developed using drugs that interfere with either 
steroid synthesis or cellular reception of steroids. To date, sex inversion has most 
successfully been achieved using aromatase inhibitors (Piferrer et al., 1994; 
Guiguen et al., 1999; Kitano et al., 2000; Kwon et al., 2002). 
Aromatase inhibitors (Al) block the synthesis of estrogens from androgens, 
through action on the aromatase (cytochrome P45 0,,, m) enzyme, and are used 
extensively in human medicine for the treatment of estrogen—dependent tumors 
127 
Uptake and retention of aromatase inhibitors 
(Brodie et al., 1999; Brueggemeier, 2001). Many aromatase inhibitors have been 
developed, and these may be categorised by mode of action, into two main 
groups. Mechanism-based or suicide Al are compounds structurally based on 
androstenedione, and which bind irreversibly to the aromatase enzyme complex 
(Cole and Robinson, 1990; Numazawa and Tachibana, 1997; Brodie et al., 1999; 
Brueggemeier, 2001; Seralini and Moslemi, 2001). A second class of compounds, 
competitive Al, bind reversibly with aromatase in dynamic competition with 
natural substrates (Cole and Robinson, 1990; Brueggemeier, 2001; Seralini and 
Moslemi, 2001). Competitive AI may be steroidal or non-steroidal in nature, 
(Brueggemeier, 2001) with non-steroidal imidazole and triazole derivatives 
showing the greatest clinical efficacy (Cole and Robinson, 1990; Santen et al., 
1990; Buzdar, 2000; Brueggemeier, 2001; Seralini and Moslemi, 2001). In 
addition to the many human studies, competitive and mechanism-based Al have 
been shown to be effective in reptiles (Richard-Mercier et al., 1995; Wennstrom 
and Crews, 1995), amphibians (Petrini and Zaccanti, 1998; Chardard and 
Doumon, 1999), birds (Elbrecht and Smith, 1992; Foidart et al., 1994) and fishes 
(Piferrer et al., 1994; Guiguen et -a1.-,- 1999). 
Based on their molecular structure, different Al would have a predicted range in 
lipid solubility and hence potential uptake capacity by alevins. In particular, the 
uptake of compounds carrying a charge would be expected to be poor, while in 
general, that of steroidal compounds should be relatively high. Both fadrozole and 
OHA displayed poor efficacy for sex inversion of Atlantic salmon (Chapter 4), 
which contrasted markedly with high in vitro efficacy (Chapter 3) and this 
anomaly may be due to poor uptake and/or retention of these compounds by 
alevins. The high efficacy of ATD in vitro was supported by moderate in vivo 
efficacy, although optimisation of the treatment protocol could further increase 
efficacy and potentially enable dosage to be reduced. Determining the levels of 
uptake, and retention profiles for ATD, OHA and fadrozole, following their 
administration to Atlantic salmon alevins by immersion would provide data to 
address both of these issues. 
The technique of direct measurement by gas or liquid chromatography (GC and 
LC respectively) in combination with mass spectrometry (MS) may be applied to 
the measurement of a wide range of compounds in biological materials (Throck, 
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1985), although detection levels may limit the application of this method in some 
instances. Ackermann and Kaiser (1989) developed a method for the 
determination of fadrozole in plasma and urine using GC/MS which enabled 
detection of fadrozole to a lower limit of 0.2 p.g mL -l in extracted samples. 
However, the authors also noted problems in the chromatography, in particular the 
occurrence of 'ghost' peaks, where a proportion of the sample was retained in the 
column and eluted with subsequent samples. On this basis, LC was preferred for 
the present study. The technique of tandem mass spectrometry (MS/MS) was 
developed to enable the detection of compounds against a complex 
chromatographic background (Throck, 1985) and therefore applicable to less 
purified samples. It relies on the use of two mass spectrometers operating in 
series, with only selected ions from the first spectrometer passed on to the second. 
The selection and subsequent analysis of only those ions arising from the target 
compound, results in a final spectrum of limited molecular species, and 
consequently higher sensitivity than standard MS (Throck, 1985). 
Radioimmunoassay (RIA) is a highly sensitive means for the determination of a 
range of compounds, in pg quantities, from animal tissues or fluids (eg. Crain et 
al., 1995; Navarro et al., 1995; Panlchurst and Riple, 2000; Lokman et al., 2002) 
and its use is well established in endocrinological research. Heterologous RIA 
relies on displacement of labeled tracer by compounds that have enough structural 
similarity to the homologous ligand to cross-react with the antibody. This method 
has been applied to measure compounds where specific antibodies or labeled 
tracers are not available and a level of sensitivity in excess to that achievable with 
chromatography is required (e.g. Crain et al., 1995; Navarro et al., 1995). The 
steroidal structure of both ATD and OHA and low dosage regime used for these 
Al (Chapter 4) made analysis by RIA appropriate for these compounds. 
Accordingly, alevins from Experiments 1 and 2 in the study described previously 
(Chapter 4) were sampled at the completion of immersion treatment and for up to 
7 days post-immersion. Tissue levels of ATD or OHA were determined by 
heterologous RIA based on a testosterone assay and tissue levels of fadrozole 
were determined by LC MS/MS. 
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5.2 	Materials and Methods 
5.2.i Stock and Husbandry 
Experiments were conducted at Saltas' two hatcheries, at Wayatinah, Tasmania 
on the Derwent and Florentine Rivers (respectively "Wayatinah" and 
"Florentine"). Both hatcheries, utilise intensive recirculation systems for the 
production of fry (<0.5 g) and natural river waters for the production of parr and 
smolts. Experiments were conducted over two years (2000/01 and 2001/02) using 
the progeny of 2+ year old Atlantic salmon broodstock. Sex inverted female fish 
("neomales") were used to provide milt in both experiments. These stocks had 
been masculinised by dietary treatment with 17a-methyldihydrotestosterone 
(MDHT) at 1 mg kg-I feed, for 800 °C days (DD), following methods similar to 
Solar etal. (1984). Fertilisation and incubation was conducted as described 
previously (Chapter 4). 
5.2.ii Immersion protocol 
Immersion treatments were undertaken as described previously (Chapter 4 
5.2.iii Aromatase inhibitor uptake and retention 
Alevin samples were collected for studies of Al uptake and retention, 
commencing at the completion of the immersion period, and at 4.5, 9, 24, 72, 168 
and 240 hr post-immersion. Six individuals were collected with forceps, blotted 
dry on a paper towel, and placed either as a group (Experiment 1) or singly 
(Experiment 2) in Eppendorf tubes and frozen (-18 °C) until analysis. Samples 
were thawed, separated where necessary, and individuals were homogenised 
separately in Eppendorf tubes using a hand-held teflon tissue grinder. Individuals 
from Experiment 1 that could not be separated intact were discarded. 
5.2.iv Experiment 1: 2000-01 
Of the four Al used, as described in Chapter 4, tissue levels were determined only 
for : 1,4,6-androstatriene-3,17-dione (ATD) and 4-androsten-4-o1-3,17-dione 
(OHA). For each dose of Al, groups of 1000 alevins were treated either once, at 
14 DMPH, or twice, at 14 and 28 DMPH. 
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5.2.v Experiment 2:2001-02 
Two AT were used: ATD and 445,6,7,8-tetra-hydroimidazo-(1,5-a)-pyridin-5-yl] 
benzonitrile HC1 (Fadrozole), at 500 lig L -1 and 5 mg L-1 , and at 10 and 50 mg L -1 
respectively. For each dose of Al, groups of 1000 alevins were treated twice, 
either at 7 and 14 DMPH ("Early" immersion treatment), or 14 and 21 DMPH 
("Late" immersion treatment). 
5.2.vi ATD and OHA assay 
ATD and AOD levels in tissue were determined by heterologous R1A based on 
the displacement of T by the AT in a T RIA system. Fish in 1.5mL Eppendorf 
tubes were homogenised with a hand held teflon grinder in 500 uL ethyl acetate, 
the tubes were then centrifuged at 1200 g, for 10 minutes, 150 III, aliquots of the 
supernatant added to duplicate polypropylene tubes and left overnight to allow 
evaporation of the solvent. Extracts were assayed for T using the methods of 
PanIchurst (1997), detailed in Chapter 3. Cross reactivity of ATD and OHA with 
the T antiserum were 0.64 and 0.13% respectively and minimum detection levels 
were 0.03 ng fish -1 and the minimum detection level of T in controls was 0.03 pg 
Interassay variability was measured using aliquots of a pooled internal 
standard and was (%CV[n]) 14.5[12] and 12.4[9] for assays for Experiments 1 
and 2 respectively. Assay performance characteristics are described in the results. 
5.2. vii Fadrozole assay 
Fadrozole levels were determined by LC MS/MS, following extraction based on 
the methods of Ackermann and Kaiser (1989). Fish were homogenised using a 
hand-held teflon grinder, in 800uL 0.01M HC1, and 100 uL of 500 ng mL-1 
miconazole, used as an internal standard. Tube contents were then transferred to a 
20 mL glass scintillation vial with 4 mL diethyl ether, 2mL pH 10 buffer 
(Ackermann and Kaiser, 1989), vortexed and allowed to stand for 5 minutes. The 
homogenate was then frozen in a dry ice/methanol bath, the organic phase 
transferred to a clean 20 mL glass scintillation vial, lmL 0.1M HC1 added, 
vortexed and allowed to stand for 5 minutes. The homogenate was again frozen in 
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a dry ice/methanol bath, the organic phase discarded and the aqueous phase 
transferred to a 2 mL glass vial and frozen (-18 °C) before assay by LC MS/MS. 
Fadrozole levels were determined using a Waters Xterra MS C18 5 micron 
column (2.1mm x 150mm.) on a Waters Alliance HPLC, coupled to a Finnigan 
LCQ mass spectrometer fitted with an Atmospheric Pressure Chemical Ionization 
(APCI) source. The HPLC was operated isocratically with a mobile phase of 
methanol and 2% acetic acid (9:1 v/v) at a flow rate of 0.4 mL min -I . The APCI 
conditions were: nitrogen sheath gas 35 psi; source current 5 IAA; capillary 
temperature 150 °C; vaporiser temperature 470 °C. Sample volume was 100 pt 
and trap fill time was 150 msec. Samples were analysed by selection reaction 
monitoring of product ions from the protonated molecular ions. For fadrozole, the 
fragmentations m/z 	m/z 224—+82 and m/z 224---÷156 were monitored 
using an isolation width of 4 daltons and collision energy of 20%. For miconazole 
the product ions at m/z 159 &161 from the molecular ion cluster starting at m/z 
415 were monitored; the isolation window was centred at 417 with a width of 8 
daltons, and the collision energy was 23%. 
Standard curves were constructed for each run, using untreated fish spiked with 
100 uL fadrozole in 0.01M HCI, to produce concentrations of 500, 250, 125 and 
25 ng fish-I and the minimum detection level was 25 ng fish -I .Three replicate fish 
were used for each concentration of fadrozole. A separate standard curve was 
constructed for the determination of residual levels of fadrozole in bath water after 
immersion. 
5.2.viii Statistical analyses 
Aromatase inhibitor uptake and retention data failing Cochrans test for 
homoscedasticity were logo + 1 transformed and analysed by one way ANOVA 
for each sampling period. Mean comparisons were made by a Tukeys honestly 
significant difference test using harmonic mean sample size for analyses where 
sample sizes were uneven (Day and Quinn, 1989). Regression curve slopes of Al 
standard curves and extract serial dilution were compared using t tests (Zar, 
1984). All analyses were performed using SPSS 10.1 for Windows. 
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5.3 	Results 
5.3.i 	RIA validation 
Standard curves in the range 100 — 3200 pg mL-I and 200 — 12800 pg mL -1 were 
constructed for ATD and OHA respectively. The slopes of standard curves were 
not different to serially diluted extract for either ATD (t4=0.170, p>0.05, Figure 
5.1a) or OHA (t5=0.027, p>0.05, Figure 5.1b). 
5.3.ii Fadrozole assay validation 
Chromatographs produced following the LC MS/MS analysis (Figure 5.2) had a 
single, well formed peak, with no evidence of sample retention in the column as 
reported previously for fadrozole determination using gas chromatography 
(Ackermann and Kaiser, 1989). Two measures of the amount of fadrozole could 
be obtained from the data, total area under the fadrozole curve, and the ratio of 
areas of the fadrozole and internal standard (miconazole) curves. Standard curves 
constructed using alevins spiked with fadrozole showed less variability when the 
ratio data were used (Figure 5.3) and this was subsequently used in all 
calculations. 
5.3.iii Experiment I: 2000-01 
Tissue levels of ATD increased significantly with increasing dose (Figure 5.4a); 
however, the proportion of ATD taken up from the bath declined with increasing 
dose from 100% uptake for treatment at 4, 20 and 100 lig L -1 to 62% for treatment 
at 500 lig L-1 (Table 5.1). Within 4.5 hr of the completion of the first immersion 
treatment, tissue levels in alevins treated at a dose of 4 jig L-1 had declined to 
those of controls, whereas all other doses were significantly different to each other 
and controls (Figure 5.4a). After 9 hr, alevins treated at 5001.1g L -1 had higher 
tissue levels than all other treatments, whereas there was no difference between 
tissue levels in alevins treated at 20 or 100 ps L -1 , and treatment at 4 ug L-1 did 
not elevate tissue levels above control levels (Figure 5.4a). As only a single 
control sample was available at 24 hr post-treatment, this was excluded 
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Table 5.1 
	Uptake and tissue levels (mean ± S.E.) of the AT ATD and OHA by 
Atlantic salmon alevins, following 120 min immersion in solutions 
of AI at 4, 20, 100 or 500 lAg 
Al dose 
1St bath - 14 DPMH 2" bath -28 DPMH 
Tissue level 
(ng fish" 1 )" 
Uptake from 
bath (%) 
Tissue level 
(ng fish-1) a 
Uptake from 
bath (%) 
Control 1.2 ±0.3 0.7 ±0.1 
ATD 4 jig L-I 5.4 ± 0.6 100b 2.0 ±0.1 36 
ATD 20pg E l 31.6 ± 3.7 100b 4.9 ± 1.0 24 
ATD 100 ptg E l 92.5 ± 7.1 100b 13.1 ± 0.2 14 
ATD 500 Kg 1.. -1 275.1 ± 10.7 62 18.6 ± 2.3 4 
Control 0.1 ± 0.0 0.6 ± 0.1 
OHA 4 lig E l 6.3 ± 0.7 100b 3.4 ± 0.5 81 
OHA 20 .t.g 1., -1 16.1 ± 2.4 91 9.1 ± 0.7 48 
OHA 100 lig 1., -1 24.4 ± 2.3 28 13.9 ± 1.2 15 
OHA 500 Kg L-1 34.3 ± 3.6 8 23.6 ± 2.8 5 
a mean ± S.E, n=3-6 
b calculated value >100% 
from analysis. Tissue levels at this time were different among all Al doses. At 3 
days post-treatment, there were no differences between treatment at 4 or 20 lig 1: 1 
and controls, whereas tissue levels were still significantly elevated in alevins 
treated at 500 and 100 pg 1_,-1 (Figure 5.4a). After 7 days, only alevins treated at 
500 pig L -1 had tissue levels above controls. Regardless of dose, tissue levels 
declined by approximately 50%, within 9 hours and 90% within 24 hours of the 
immersion treatment (Figure 5.4a). 
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Tissue levels of ATD immediately following the second immersion at 28 DPMH 
were significantly higher than controls for all doses; however, levels were an 
order of magnitude lower than those achieved following the first immersion 
treatment (Figure 5.4a). This was also reflected in reduced uptake rates, ranging 
from 36% for 4 ug LI to 4% for a dose of 500 j.ig 	(Table 5.1) .Tissue levels in 
alevins treated at 500 pg 	were no different from those treated at 100 [ig 
(Figure 5.4a). After 4.5 hours, tissue levels in alevins treated at 4 ptgl.," 1 were not 
different to controls; however, tissue levels were different among all other doses. 
There were differences in tissue levels between all doses at 9 hours post-
treatment, whereas after both 24 hours and 3 days, only those alevins treated at 
100 or 500 ug 	had tissue levels higher than controls (Figure 5.4a). As with the 
first treatment, only alevins treated at 500 	had elevated tissue levels 7 days 
after treatment (Figure 5.4a). 
Trends in the uptake and retention of OHA were similar to those of ATD; 
however, uptake rates and tissue levels were substantially lower than those for 
ATD, particularly following the first immersion treatment (Figure 5.4b). Uptake 
rates declined with increasing concentrations of OHA from 100% for 4 i.tg 	to 
8% for 500 lig 	Immediately following immersion, tissue levels of OHA in all 
alevins exposed to OHA were higher than controls, with levels in alevins treated 
at 500 fig 	higher than those treated at 20 or 4 pg 	but not 100 ug 	and 
there was no difference in tissue levels between alevins treated at 100 or 201.tg 
I . Similarly, after 4.5 and 9 hours, and 3 days , there were differences between all 
treatment groups, except 4 pig 	and controls (Figure 5.4b). Tissue levels in all 
treatment groups differed 24 hr post-treatment; however, as for ATD, no 
comparisons were possible with controls due to low sample size (n=1) (Figure 
5.4b). After 7 days, only those animals treated with OHA at 500 lig had tissue 
levels higher than controls (Figure 5.4b). 
Tissue levels following the second immersion treatment with OHA were lower 
than for the first treatment, but not to the same degree as occurred for ATD 
(Figure 5.4b) with uptake rates of 81% for a dose of 4 pig 	to 4% for 500 lig 
Alevins treated at 500 pig 	has tissue levels higher than all other doses, whereas 
there was no difference in tissue levels between alevins treated at a dose of 20 or 
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100 pg L -1 and treatment at 4 1.1g L -1 did not elevate tissue levels above controls 
(Figure 5.4b). After 4.5 hr, there was no difference in tissue levels between 
alevins treated at 100 or 500 pg L - 1, although these levels were higher than for all 
other treatments. At 9 hours post treatment, tissue levels in alevins treated at 20 
pg L-1 had declined to those of controls and alevins treated at 4 pg L -1 , whereas 
tissue levels were significantly higher in alevins treated at 100 and 500 lig 
After 24 hr and 3 days, only alevins treated at 100 or 500 pg L -1 had tissue levels 
greater than those of controls, and by 7 days post-treatment tissue levels were only 
elevated in the 500 pg L -1 treatment (Figure 5.4b). 
5.3.iv Experiment 2: 2001-02 
Uptake of ATD immediately following immersion did not differ with dose, but 
exceeded control levels for all immersion treatments. Consequently the uptake 
rate following treatment with ATD at 5 mg L-1 was substantially lower than that 
for treatment at 0.5 mg L -1 (Table 5.2). For the early immersion regime, treatment 
with ATD at 0.5 or 5 mg L -1 at 7 DPMH elevated tissue levels of ATD above 
control values immediately after immersion and at 4.5, 9 and 24 hr post-treatment, 
and differences due to dose only occurred at 4.5 hr (Figure 5.5a). At 3 days post-
treatment, a dose of 5mg L -1 increased tissue levels above controls, but a dose of 
0.5 mg L -1 did not and after 7 days there were significant differences between 
both doses of ATD and controls (Figure 5.5a). Immediately following a second 
immersion treatment at 14 DPMH tissue levels of alevins treated with a dose of 
0.5 or 5 mg L -1 were greater than controls; however, after 4.5hr, there was no 
difference between alevins treated at 0.5 mg L -1 and controls, but treatment at 5 
mg I.," 1 maintained elevated tissue levels. At 9 hr post-treatment, tissue ATD 
levels differed between both doses of ATD and controls whereas after 24 hr, ATD 
treated alevins had increased tissue levels of ATD, but this did not differ between 
doses (Figure 5.5a). After 7 days, tissue levels began to increase in alevins treated 
at 5 mg L -1 , and these remained higher than both alevins treated at a dose of 0.5 
mg L -1 and controls, up to 10 days post-treatment, where animals treated at 0.5 mg 
L-1 had tissue ATD levels elevated above controls at 7 and 10 days, but not 3 days 
post-treatment (Figure 5.5a). Tissue levels in alevins treated at a dose of 0.5 mg L" 
declined to approximately 50% of initial levels after 7 days for both the first and 
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Figure 5.5 	Tissue levels of ATD in Atlantic salmon alevins, following 120 
minutes immersion in solutions of ATD at 0.5 or 5 mg 1: 1 at a) 7 
and 14 DPMH (arrows) or b) 14 and 21 DPMH (arrows) Values are 
mean ± S.E. I Other details as for Figure 5.4. 
'Control n=3; ATD treatments n=6 
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second immersion treatments, whereas alevins treated at a dose of 5 mg L -1 
showed no decline, and appeared to be increasing up to 10 days after the second 
treatment. 
Table 5.2 	Percentage uptake and tissue (mean ± S.E.) levels of the AT ATD 
by Atlantic salmon alevins, following 120 min immersion in 
solutions of ATD at 0.5 or 5.0 mg L-1 , at either 7 and 14 or 14 and 
21 DPMH. 
Al dose 
1 st bath —7 DPMH 2"d bath —14 DPMH 
Tissue level 	Uptake from 
(ng fish-1) a 	bath (')/0) 
Tissue level 	Uptake from 
(ng 	a 	bath CYO 
Control 
ATD 0.5 mg L-1 
ATD 5.0 mg L-1 
16.3±2.4 
	
150.1±23.6 	35% 
123.0±10.7 	3% 
23.±3.3 
171.0±14.1 	38% 
167.2±20.1 	4% 
1 st bath — 14 DPMH rd bath — 21 DPMH 
Control 
ATD 0.5 mg L-1 
ATD 5.0 mg L-1 
58.5±6.3 
189.7±25.6 	32% 
175.1±29.0 	3% 
42.1±3.5 
135.1±10.0 	17% 
116.1±4.7 	1% 
a mean ± S.E., control n=3; ATD 0.5 and 5 mg L -1 n=6 
Immersion treatment utilising the "late" treatment regime resulted in similar tissue 
levels as the second treatment of the early regime, also conducted at 14 DPMH; 
however, subsequent trends in retention were different (Figure 5.5b). Tissue levels 
of ATD in alevins treated with ATD at 0.5 or 5 mg L -1 declined to approximately 
50% of initial levels 7 days post-treatment. Tissue levels were greater than 
controls, but not different between ATD treated groups immediately after 
treatment; however, after 4.5 hr, alevins treated at 0.5 mg L -1 had lower levels 
than those treated at 5 mg L -1 , but higher than controls (Figure 5.5b). At 9 hr post-
treatment, treatment at 5mg L -1 resulted in higher tissue levels than either 
treatment at 0.5 mg L -1 or controls, whereas after 24 hr both ATD treated groups 
were higher than the controls (Figure 5.5b). After 3 days, alevins treated at 5 mg 
L-1 had higher tissue levels than alevins treated at 0.5 mg L -1 and controls and by 
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7 days post-treatment, there were differences between all treatment groups (Figure 
5.5b). 
Following the second immersion treatment of the late treatment regime, the trend 
in retention was similar to that of the early regime, in that tissue levels of ATD 
treated alevins stayed at or above uptake levels (Figure 5.5b). Both ATD treated 
groups maintained similarly higher tissue levels than controls immediately after 
treatment and for 4.5, 9, 24 hr and 3 days post-treatment (Figure 5.5b). At 7 days 
post-treatment tissue levels in alevins treated at 5 mg L -1 were higher than those 
treated at 0.5 mg 1., -1 which were higher than controls, whereas after 10 days, there 
was do differences between the ATD treated groups, but both had levels greater 
than controls (Figure 5.5b). 
Uptake of fadrozole was less than 5% for all immersion periods and doses (Table 
5.3). In contrast to the data for ATD, the trends of retention of fadrozole by 
alevins were similar for both first and second immersion treatments, for both early 
and late regimes (Figure 5.6). In all cases, tissue levels declined after immersion, 
reducing to approximately 50% of uptake levels by 3 days post-treatment. Tissue 
levels in alevins treated with fadrozole remained greater than control levels up to 
3 days- post treatment, with levels in animals treated at 50 mg 1: 1 greater than 
those in alevins treated at 10 mg L-1 (Figure 5.6). In the early treatment groups, 7 
days after both the first and second immersion treatments, only animals treated at 
50 mg 1.,-1 had elevated tissue levels, whereas in the late group, this was only the 
case following the second bath (Figure 5.6). 
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Table 5.3 	Percentage uptake and tissue (mean ± S.E.) levels of the AT 
fadrozole by Atlantic salmon alevins, following 120 min 
immersion in solutions of fadrozole at 10 or 50 mg 1,-1 at either 7 
•and 14 or 14 and 21 DPMH. 
1 st bath — 7 DPMH 2" bath — 14 DPMH 
Uptake Uptake 
Tissue level from bath Tissue level from bath 
(ng 	a CYO (ng fish') a (%) 
NDb ND 
210.0 ± 12.6 2% 629.2 ± 42.4 7% 
1974.3 ±4 
945.4 ± 40.2 3% 43.8 5% 
Al dose 
control 
fadrozole 10 mg L' 
fadrozole 50 mg 
1 st bath — 14 DPMH 	rd bath — 21 DPMH 
control 	 ND 	 ND 
330.3 ± 54.9 4% 172.2 ± 10.7 2% 
996.3 ± 96.1 2% 861.6 ± 49.3 2% 
fadrozole 10 mg L I 
fadrozole 50 mg I.,"' 
a mean ± S.E. n=3 
b ND not detected 
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Figure 5.6 	Tissue levels of fadrozole in Atlantic salmon alevins, following 120 
minutes immersion in solutions of fadrozole at 10 or 50 mg U 1 at 
a) 7 and 14 DPMH (arrows) or b) 14 and 21 DPMH (arrows) 
Values are mean ± S.E. 1 Other details as for Figure 5.4. 
'Control n=3; fadrozole treatments n=6 
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5.4 	Discussion 
The assay methods developed as part of the present project provide methods for 
determining tissue levels of ATD, OHA and fadrozole at biologically significant 
levels. The use of a heterologous RIA provides an effective means of determining 
biologically significant levels of both ATD and OHA in the tissues of alevins; 
however the inability of the assay to distinguish the AT from native androgens, 
may limit the capacity to better elucidate steroidogenic processes post-immersion. 
Levels of native androgens in control fish in the present study of ca. 8 pg T 
equivalents fisfi l (data not shown) were similar to those reported in salmonid 
alevins of a similar age (Feist et al., 1990; Feist and Schreck, 1996) and androgen 
levels of rainbow trout and coho salmon alevins declined for up to 40 days post-
hatch (Feist et al., 1990; Feist and Schreck, 1996), indicating that the potential for 
interference with the assay by native androgens is low. Nonetheless, the addition a 
separation step following the extraction of steroids in ethyl acetate may provide a 
means of determining the presence of androgens and Al, separately, using the T 
RIA. 
The use of HPLC for fadrozole separation is a significant change from previous 
studies, where the use of gas chromatography was associated with some problems, 
including 'ghosting' (Ackermann and Kaiser, 1989; Schneider et al., 1996). 
Similar problems were not apparent with HPLC separation in the present study. 
Although the level of sensitivity of the fadrozole assay used in the present study 
was less than that of Ackermann and Kaiser (1989), significant levels of fadrozole 
were detectable in the tissues of single alevins up to 7 days after immersion 
indicating suitability of the assay for such studies. 
The uptake and retention data for Atlantic salmon alevins treated with Al by 
immersion are similar to those obtained by Piferrer and Donaldson (1994) for 
coho salmon, Oncorhynchus kisutch immersed in solutions of T and E2. These 
data confirm the capacity of alevins to incorporate substantial levels of steroidal 
compounds and retain these in the tissues well beyond the immersion period, as 
proposed by Hunter and Donaldson (1983), and demonstrated for T and E2 by 
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(Piferrer and Donaldson, 1994). The retention of steroids for a significant period 
following immersion treatment was proposed as a major factor in the efficacy of 
short duration immersion treatments (2 h) for sex control of salmonids (Piferrer 
and Donaldson, 1994). 
Clearance rates of steroidal AT were similar to those reported previously for 
steroids in larval fish (Hishida, 1965; Piferrer and Donaldson, 1994; Specker and 
Chandlee, 2003), with a half life of approximately 24-50 h for steroidal Al. 
Catabolic byproducts of the Al were not quantified; however, glucuronation of 
OHA in the liver is known to be a major route of its catabolism in mammals (Cole 
and Robinson, 1990; Brueggemeier, 2001) and fish are known to be capable of 
both glucuronation and conjugation of steroids (Fostier et al., 1983; Yeoh et al., 
1996). The glucuronated form of the steroidal AT would not have been available to 
the RIA (Haddy and Pankhurst, 1998) and so this cannot be excluded, although E2 
excretion by larval medaka, Oryzias latipes, was predominantly in the free form 
(Hishida, 1965). Both OHA and ATD show similar rates of clearance, suggesting 
a similar process to be responsible for their elimination. Regardless of the nature 
of their clearance, the efficacy of both AID and OHA as mechanism-based 
aromatase inhibitors would continue beyond their clearance, due to the slow 
turnover of aromatase (Seralini and Moslerni, 2001). 
At concentrations of 4 - 5001.tg 	the uptake of steroidal Al in the present study 
was dependent on the concentration in the medium. This is also the case for the 
uptake of steroids by coho salmon (Piferrer and Donaldson, 1994) and summer 
flounder, Paralithys dentatus, (Specker and Chandlee, 2003). However, there was 
no difference in the in the uptake of AID following the first immersion at a dose 
of either 5 or 0.5 mg 	suggesting that the levels attained represented maximum 
concentrations for a 2 h immersion. This suggests that any further increases in 
uptake would require extending immersion time rather than increasing the Al 
concentration. The tissue level of AID of 275 ng fish' achieved in Experiment 1 
equates, on the basis of estimated alevin weight of 150 mg (H.R. King, 
unpublished data), to approximately 6.5 nmol g -I , comparable to levels of E2 
achieved in coho salmon by Piferrer and Donaldson (1994) of 25 nmol 
Notably, although similar immersion protocols were used in both studies, tissue 
levels of steroids determined by Piferrer and Donaldson (1994) were based on 
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retained radiolabel following immersion with labeled steroid, and were recognised 
by those authors as being an upper estimate, as they potentially included 
metabolites. In their study of the uptake of E2 by summer flounder juveniles after 
48 h incubation, Specker and Chandlee (2003) recorded E2 levels of 1.1 nmol 
600% higher than in the immersion solution of 0.2 nM (approximately 50 lig U'), 
indicating a concentrating of E2 in the tissues. Similar analysis of the data for 
salmonids from the present study and that of Piferrer and Donaldson (1994) 
indicates that tissue concentrations of ATD and E2 reached 400 and 1700% of 
bath concentrations of 500 and 400 pg L1  respectively. The capacity to 
concentrate steroidal compounds to such high levels may be a feature of 
salmonids, made possible by the large yolk size of alevins. The uptake of aqueous 
drugs by alevins occurs primarily across the gills (Allen and Hunn, 1986), at a rate 
determined by physical processes (Hunn and Allen, 1974), and steroids appear to 
accumulate primarily in the yolk (unpublished observations, cited in Piferrer and 
Donaldson, 1994). Thus in salmonids the yolk acts as both a steroid 'sink' during 
immersion, and a reservoir, providing extended delivery of steroid-like 
compounds, post-immersion. 
The reduced level of uptake of ATD between immersion treatments on 14 and 28 
DPMH in Experiment 1 in the present study is consistent with the role of yolk as a 
reservoir for Al, as yolk loss occurred over that time. The absence of similar 
differences in Experiment 2 may reflect the earlier developmental state of alevins 
at the time of treatment and the smaller inter-treatment interval, with a smaller 
loss of yolk over the period between treatments. Although no studies have 
quantified the uptake of steroids by alevins at different stages of development, the 
studies of Piferrer and Donaldson (1994) and Specker and Chandlee (2003) 
compared alevins or larvae respectively with subsequent developmental stages. In 
contrast to the results of the present study, uptake rates by coho salmon fry after 4 
h immersion, were greater than for alevins, whereas maximum concentrations 
(C.) of T and E2 after extended immersion were greatest in alevins (Piferrer and 
Donaldson, 1994). However, as discussed previously, the data of Piferrer and 
Donaldson (1994) may reflect differences in steroid metabolism between alevins 
and fry rather than differences in uptake over time. Summer flounder larvae 
retained higher concentrations of E2 than juveniles after 4 h immersion; however, 
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there was a significant increase in tissue levels in juveniles after 24 h immersion, 
and the authors postulated unidentified processes not related to body lipid levels 
to be regulating E2 uptake in juveniles (Specker and Chandlee, 2003). Thus 
developmental stage of animals has a clear influence on the uptake of steroids, not 
only in relation to physical uptake capacity but in metabolic processing of 
steroids, and this should be considered in the development of an immersion 
protocol. 
Reducing the inter-bath interval from 14 to 7 days resulted in changes to the 
patterns of uptake and retention of ATD in the present study. Tissue levels 
following the second immersion treatment were greater than those after the first; 
however, this resulted from elevated tissue levels before treatment, as net uptake 
was similar (approximately 200 ng fish -1 ) for each immersion treatment. This 
contrasts with an increase in uptake of E2 by coho salmon alevins following a 
second treatment 48 h after the first which was ascribed to either the induction of 
hormone receptors or saturation of hormone metabolising enzymes (Piferrer and 
Donaldson, 1994). To achieve similar effects with ATD, the inter-bath interval 
would probably need to be reduced to near the estimated half life (approximately 
24 h), as recommenced by Piferrer and Donaldson (1994). 
The substantial difference in uptake between ATD and OHA in Experiment 1 may 
explain in part the relative efficacy of these compounds in vivo. Piferrer and 
Donaldson (1994) estimated the immersion time to achieve Cm ax of T and E2 by 
coho salmon alevins to be in approximately 20 and 50 h respectively. On this 
basis it is unlikely that maximum uptake of Al would have been reached in 2 h, so 
the observed differences in alevin content in the present study are likely to reflect 
differences in the uptake rate. Lipid solubility is a major determinant of drug 
uptake across fish gills (Hunn and Allen, 1974). Therefore, differences in the lipid 
solubility between ATD and OHA may result in differential uptake rates. OHA 
has a highly electronegative hydroxyl group on C-4, making the molecule more 
polar, and less lipid soluble (Stryer, 1981) than ATD. Although there are no data 
available on effective tissue levels in fish for the AT tested, in vitro data indicate 
increased efficacy of AT with increasing dose (Chapter 3), and dose dependence of 
steroids for sex inversion has also been demonstrated (Devlin and Nagahama, 
2002). On this basis, the efficacy of OHA could possibly be improved by 
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increasing the effective dose, either through increased concentration in the bath or 
by extending the duration of immersion. Alternatively, administration via the feed 
may be a more effective means of delivery. 
Although tissue levels of fadrozole exceeded those of ATD, efficacy was poor, 
suggesting levels may have been insufficient for aromatase inhibition. 
Competitive inhibitors, such as fadrozole, are required at high concentrations, due 
to the low Km of aromatase (Cole and Robinson, 1990). The relatively low tissue 
levels achieved in the present study may have been due to poor uptake efficiency 
of fadrozole which was an order of magnitude lower than that of ATD. Under 
conditions of low pH, fadrozole monohydrochloride is more water soluble 
(Ackermann and Kaiser, 1989), and therefore less available for uptake by alevins 
(Allen and Hunn, 1986). Carbon dioxide is a major waste metabolite produced by 
fishes and although neither carbon dioxide concentrations nor pH were 
determined during immersion treatments, carbon dioxide excretion during 
immersion treatment would be expected to reduce bath pH. The capacity for 
alevins to affect bath pH was potentially greater in the present study than in that 
of Piferrer and Donaldson (1994) since alevins were held at a substantially higher 
density of 1300 fish L -I compared to 20 fish L1 , and this in turn may account for 
the differences in sex inversion frequency between the two studies. Modifying the 
immersion methods by extending immersion time, increasing immersion 
treatment frequency, reducing fish density and adding a pH buffer to the 
immersion solution may all contribute to enhanced uptake of fadrozole and hence 
increased tissue levels. However, whether such measures will increase the 
efficacy of fadrozole for sex inversion of Atlantic salmon is uncertain. 
The maintenance of elevated tissue levels of ATD in the present study following a 
second treatment at a dose of 5 mg L -I compared to the decline after the first 
treatment, may reflect saturation of hormone metabolising enzymes by ATD. 
Piferrer and Donaldson (1994) proposed a similar mechanism to account for 
enhanced E2 uptake by coho salmon alevins following repeated immersion 
treatment. It is also possible that native androgens, including T, may be elevated, 
although no data on potential feedback mechanisms to account for this were 
collected in the present study. Sustained high tissue levels of ATD may be the 
underlying cause of the increased efficacy of high doses of ATD in comparison to 
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low doses, administered at 7 and 14 DPMH. Steroidal Al are known to exert 
androgenic effects when present in high concentrations (Seralini and Moslemi, 
2001) and androgen efficacy increases after 14 DPMH (Chapter 2), thus the 
increase in the efficacy of ATD could have resulted from both the aromatase 
inhibitory, and androgenic properties of ATD. These data add further evidence to 
the premise that there is asynchrony between estrogen and androgen sensitivity 
with androgen sensitivity later in development (Chapter 4, Piferrer and 
Donaldson, 1989; Petrini and Zaccanti, 1998). 
Treatment of Atlantic salmon alevins by immersion in solutions of Al represents a 
viable and commercially appropriate method of delivering some of these 
compounds; however, consideration needs to be given to factors influencing the 
lipid solubility of each AI and methods adjusted accordingly. The uptake of 
molecules having lower lipid solubility, such as OHA may be enhanced by 
extending the immersion period or increasing dose. For compounds such as 
fadrozole, where solubility is influenced by pH, buffering the immersion solution 
may overcome poor uptake. Although adequate levels of sex inversion were 
attained in the present study using an inter-bath interval of 7 days, reducing this to 
3 days may further improve Al uptake and efficacy. 
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6. 	General Discussion 
6.1 	The present study 
The routine use of androgens for sex reversal is well established in the 
commercial production of a number of cultured fish species (Hunter and 
Donaldson, 1983; Pandian and Sheela, 1995; Piferrer, 2001; Devlin and 
Nagahama, 2002); however, the literature regarding the masculinisation of 
salmonids is, with a few notable exceptions (Johnstone et al., 1978; Johnstone 
and Youngson, 1984; Johnstone and Maclachlan, 1994), dominated by studies 
on Oncorhynchus spp. The present studies were conducted to develop a more 
complete understanding of the process of sex differentiation in Atlantic 
salmon, Salmo salar and to evaluate aromatase inhibitors (Al) as a means of 
masculinisation. 
6.2 	Sex differentiation in Atlantic salmon 
The successful use of Al for sex inversion (Chapter 4) supports the hypothesis 
that the process of female sex differentiation in lower vertebrates is dependent 
on the presence of estrogens (Nagahama, 2000; Devlin and Nagahama, 2002). 
By implication, male sex differentiation is a default state, initiated in the 
absence of estrogens but able to be induced by androgens (Chapters 2 and 4, 
Nagahama, 2000; Devlin and Nagahama, 2002) and this has some 
implications for potential mechanisms of genetic sex determination in fishes. 
In mammals, the expression of a male phenotype depends on the presence of 
the Sry gene (Devlin and Nagahama, 2002), the product of which is known to 
bind to the promoter regions of aromatase and other genes (Haqq et al., 1993). 
No functional Sty gene has been found in fish (Nagahama, 2000; Devlin and 
Nagahama, 2002); however, the gene Ftz-F 1 is believed to have a role in 
regulating aromatase transcription in fish (Watanabe et al., 1999) although 
there is no evidence of male-specific expression in fish (Nagahama, 2000). 
The demonstration in the present study that the labile period for the induction 
of sex inversion by the inhibition of estrogen synthesis (Chapter 4) precedes 
that for masculinisation by androgens (Chapter 2) supports the results of a 
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previous study on coho salmon Oncorhynchus kisutch (Piferrer and 
Donaldson, 1989). A similar asynchrony was found for the production of 
steroidogenic enzymes during the development of tilapia, with the presence of 
enzymes being detected in females several days before males (Nakamura et 
al., 2000) and this has been proposed to reflect the relative timing of the onset 
of differentiation of ovaries and testis (Piferrer, 2001). It should be noted that 
evidence from the present study for the existence of an estrogen sensitive 
period of development in Atlantic salmon is inferred from data of estrogen 
synthesis inhibition, and needs to be confirmed by E2 immersion treatment 
during development. In general, the timing of the labile period in Atlantic 
salmon determined from the present study is later than that of coho salmon 
(Piferrer and Donaldson, 1989) and this is consistent with studies of gonadal 
ontogenesis suggesting that gonadal differentiation in Atlantic salmon 
commences later than in Oncorhynchus spp. (Laird et al., 1978; Goetz et al., 
1979; Piferrer and Donaldson, 1989). 
6.3 	Sex inversion with Al 
All Al investigated in the present study demonstrated a level of aromatase 
inhibitory activity (Chapter 3) and in vitro efficacy which largely agreed with 
the findings of mammalian studies (Cole and Robinson, 1990; Buzdar, 2000; 
Brueggemeier, 2001; Seralini and Moslemi, 2001), confirming the high 
degree of conservation of steroidogenic enzyme structure across vertebrate 
taxa (Callard et al., 1978). In consequence, third and fourth generation Al, 
such as letrozole and anastrozole, which have very high efficacy against 
mammalian aromatase (Brueggemeier, 2001; Seralini and Moslemi, 2001), are 
likely to be similarly effective against salmon aromatase and may have 
applications for masculinisation of fishes in the future. 
Although the Al used in the present study were effective against both brain 
and gonadal aromatase (Chapter 3), there were indications of a differential 
response, suggesting that in Atlantic salmon, as in other fish species (Canard 
et al., 2001; Tchoudakova etal., 2001; Tong etal., 2001; Trant et al., 2001), 
more than one aromatase isozyme may be present. Furthermore, the 
differential efficacy of AT in preparations of brain and gonadal tissue is 
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consistent with the findings of Zhao et al. (2001) who demonstrated 
differences in efficacy of Al against goldfish, Carassius auratus, brain and 
gonadal aromatase. As a result of the effectiveness of all AT against both brain 
and gonadal tissue, the present study did not permit distinction between the 
roles of brain and gonadal aromatase in female sex differentiation. Future 
studies may be able to utilise differential response of the aromatase isozymes 
to Al, to differentiate their roles in this process. 
The induction of commercially significant levels of masculinisation using Al 
by immersion (Chapter 4) is the first such demonstration for fish, and, along 
with the study of Piferrer et al. (1994) demonstrates the feasibility of the 
production of functional, fertile salmonid neomales without the use of steroid 
hormones. Although masculinisation was achieved in the present study using 
a steroidal AT with androgenic properties at high concentrations (Seralini and 
Moslemi, 2001), the data in relation to treatment timing (Chapter 4) are 
consistent with the hypothesis the effectiveness of ATD is due primarily to E2 
synthesis inhibition rather than androgenic effects. However, the efficacy of 
Al other than ATD for sex inversion was not consistent with their efficacy 
against Atlantic salmon aromatase in vitro (Chapter 3) or their efficacy for sex 
inversion in other species (Piferrer et al., 1994; Chardard and Dournon, 1999; 
Guiguen et al., 1999; Kwon et al., 2002). Fadrozole and OHA were highly 
effective in vitro in the present study and effective in masculinising the 
developing gonads of birds (Elbrecht and Smith, 1992), amphibians (Petrini 
and Zaccanti, 1998; Chardard and Doumon, 1999), reptiles (Wennstrom and 
Crews, 1995) and fishes (Piferrer et al., 1994; Kitano et al., 2000) but neither 
was effective in the present study. These results may be explained by the low 
rates of uptake of both of these compounds by alevins during the standardised 
immersion treatment protocol used in this study (Chapter 5). Immersion for 2 
h was shown to be an effective, commercially appropriate method of 
administering steroid hormones for sex control in salmonids (Goetz et al., 
1979; Baker et al., 1988; Piferrer and Donaldson, 1989, Chapter 2) but its 
effectiveness is clearly contingent upon the high lipid solubility of the 
compounds used and hence their rapid uptake across the gills of alevins 
during the brief treatment period (Hunn and Allen, 1974; Allen and Hunn, 
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1986). Although potential differences in lipid solubility between ATD, OHA 
and fadrozole could only be inferred from differences in their structure in the 
present study, the results presented in Chapter 4 are consistent with the 
proposal by Allen and Hunn (1986) that uptake rates depend on lipid 
solubility. As discussed in Chapter 5, modification to the immersion protocol 
in terms of dose, duration or water pH may provide a means of addressing 
issues of poor uptake, although the effectiveness of these measures would 
need to be demonstrated. 
As proposed by Piferrer (2001), factors for consideration in the application of 
steroids for sex inversion include: the choice of compound, treatment method 
and dose, and these may equally be applied to the choice of Al for sex 
inversion, provided relevant data are available to predict their effects. The 
results of the in vitro component of the present study (Chapter 3) indicate that 
there is considerable variation in the efficacy of AT for Atlantic salmon, 
consistent with differences in efficacy in mammalian systems (Cole and 
Robinson, 1990; Brueggemeier, 2001). However, it was also demonstrated 
that in vitro efficacy did not necessarily translate to efficacy for sex inversion 
(Chapter 4), necessitating the application of additional data on AT uptake to be 
considered when interpreting the results of studies of Al for sex inversion 
(Chapter 5). Additionally, data on the lipid solubility of Al may be used to 
predict uptake rates (Hunn and Allen, 1974; Allen and Hunn, 1986) 
6.4 	Commercial implications 
Utilising the methods developed for the masculinisation of Oncorhynchus spp. 
(Goetz et al., 1979; Baker et al., 1988; Piferrer and Donaldson, 1989; Piferrer 
et al., 1994), the present study has established commercially appropriate 
protocols for the production of Atlantic salmon neomales using androgens and 
AI. The success of immersion for the administration of both categories of 
masculinising agents has enabled the production of neomales with patent 
sperm ducts, providing further evidence that sperm duct patency is a function 
of the timing of treatment. Blocked sperm ducts significantly impair 
production efficiency, and the high incidence of patent sperm ducts and high 
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fertility in neomales produced using AT in the present study is a significant 
factor for consideration in the potential commercial application of Al. 
Based on the results of the present study, non-steroidal Al do not appear to be 
suitable for sex inversion of Atlantic salmon. In general, the structure of non-
steroidal AT would be expected to be associated with lower lipid solubility 
than steroidal compounds, and therefore result in lower uptake rates by alevins 
(Allen and Hunn, 1986), making non-steroidal Al unsuited to use in 
immersion treatments. Furthermore, since AT were most effective when 
applied during the estrogen sensitive period, non-steroidal AT would not be 
suited for application via the diet, as this would commence well after the 
optimum window for estrogen treatment. 
The recommended use of any new compound in commercial aquaculture must 
take into consideration several factors. Compounds used in animal production 
require approval from national or international regulatory authorities. These 
authorities may take into consideration issues such as the current use in 
humans of a particular drug, and determine its use accordingly. Currently, a 
number of Al are the preferred treatment for breast cancer (Seralini and 
Moslemi, 2001) and this may affect the approval for their use in aquaculture. 
However, commercial usage of a drug also necessitates its ready availability. 
Of the Al used in the present study, AID is available, but its longevity in the 
marketplace is unclear as it has no application in human medicine. Fadrozole 
and OHA are no longer used in human medicine, however, OHA is available 
commercially. 
Provided specific guidelines are met, steroid hormones are readily available 
and approved for use in aquaculture in Australia and these presently represent 
a cost effective means of masculinisation in salmonids. Future potential 
regulatory changes aside, the public perception of the use of steroids in animal 
production may be the greatest impediment to their use in the future. Indirect 
feminisation provides a robust method for the production of all female stocks 
that are completely untreated, with masculinisation agents only used for 
broodstock production (Piferrer, 2001). The commercially significant level of 
masculinisation of Atlantic salmon was achieved in the present study using a 
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steroidal Al, AID and it is therefore possible that potential negative 
regulatory or marketing issues associated with the use of steroids may not be 
alleviated by this approach for the production of neomales. Based on uptake 
data for both steroids and steroidal AI, a reasonable argument may be 
mounted that the quantities taken up by alevins during immersion treatment 
are low, (approximately 0.2 lig ATD, Chapter 5; or 0.8 i.tg T, Piferrer and 
Donaldson (1994)), and that once taken up, these compounds have a half life 
of approximately 48 h (Hishida, 1965; Piferrer and Donaldson, 1994; Specker 
and Chandlee, 2003, Chapter 5). The compounds would therefore not be 
detectable at spawning, 3 years after treatment. Additionally, AT may offer the 
perceived benefit to the public of having a specific mode of action, in contrast 
to steroid hormones, which effect processes other than sex differentiation. The 
release of steroid hormones or other aquaculture drugs, into the environment 
is also an issue for consideration. This may be addressed by the use of 
immersion treatment for AT or androgens for sex inversion. Unlike dietary 
treatment, immersion treatment involves relatively small quantities of water, 
which may be appropriately disposed of at the completion of the treatment. 
6.5 	Future studies 
Although the present study addresses_ some issues of teleost sex 
differentiation, there is much about the processes of sex differentiation that 
still remains unclear. Studies of the type undertaken by Kitano et al. (1999; 
2001), Guiguen et al. (1999) and Nagahama (2000) which combine molecular 
techniques with Al or steroid receptor antagonists would complement the 
present work and address issues such as the nature of control of cyp19 
expression. 
The existence of asynchronous labile periods for androgens and estrogens in 
salmonids has potential implications for the timing of the expression of sex 
determining genes. If, as occurs in mammals, cyp19 activity in genetic males 
is suppressed at the promoter level by the products of a male determining gene 
(Devlin and Nagahama, 2002), expression of this gene, is likely to commence 
in the period immediately post-hatch in Atlantic salmon. Molecular studies at 
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this time may be a means of further investigating this model, and ultimately 
may elucidate the sex determining gene(s) in Atlantic salmon. 
The differential sensitivity of brain and ovarian aromatase isozymes to Al 
(Zhao et al., 2001) and E2 receptor antagonists (Kishida and Callard, 2001) 
may also provide an avenue of further research into sex differentiation. If 
compounds can be found that significantly differentiate between the 2 
isozymes, they may be used evaluate the relative contributions to sex 
differentiation of estrogens of gonadal and neural origin. 
The possibility remains that future regulatory controls or market pressures 
may prevent the use of steroidal Al for sex inversion, and methods for sex 
inversion using non-steroidal AT may become necessary at that time. Further 
studies are needed to improve the efficacy of non-steroidal Al for sex 
inversion and such studies may address the issues of dose, treatment duration 
and bath pH discussed previously. Although the development of a steroid-free 
method for masculinisation of salmonids may be achieved using Al, 
alternative approaches to sex control, such as the use of environmental 
manipulation may ultimately prove to be the preferred approach. Numerous 
recent studies have demonstrated a role for temperature in sex determination 
of fishes (Kitano et al., 1999; D'Cotta et al., 2000; Goto et al., 2000; Pavlidis 
et al., 2000; Fujioka, 2001; Felip et al., 2002; Kwon et al., 2002). The 
potential for thermal regulation of sex determination in Atlantic salmon 
remains to be explored. 
6.6 	Concluding remarks 
Borrowing from the quote from Yamamoto (1969) cited at the beginning of 
this chapter, science has gone a long way to unfolding and controlling the 
processes of sex differentiation in fish in the nearly 50 years since 
Yamomoto's seminal studies on sex differentiation in medaka commenced. 
Such advances have undoubtedly provided aquaculturists with a number of 
highly efficient tools with which to 'control nature'. 
The ongoing need to produce monosex or sterile populations of farmed 
Atlantic salmon in Tasmania, and farmed finfish elsewhere, is likely to remain 
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high as producers continue to maximise production efficiencies and minimise 
risks. The challenge is therefore to apply the increasing knowledge of sex 
determination and differentiation to develop tools for use in aquaculture, that 
not only satisfy production requirements, but which are sensitive to the needs 
of an increasingly better informed and proactive public. For its part, the 
aquaculture industry also needs to address the issues of public perception of 
the use of steroids and other compounds in aquaculture by making clear the 
quantities of compounds involved, and explaining the benefits of indirect 
• treatment protocols for the production of untreated fish for consumption. 
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Appendices 
Appendix I Atlantic salmon milt extender and activator solutions 
Appendix Ia Extender solution for Atlantic salmon milt 
Distilled water2 L 
KC1 	14.40g 
NaC1 	3.84g 
NaH2PO4.H20 0.80 g 
MgSO4.7H20 0.48 g 
CaC1 0.48 g 
NaHCO3 2.00 g 
glucose 2.00 g 
Appendix lb Activator solution for Atlantic salmon milt 
Distilled water2 L 
NaC1 	10.00 g 
tris-methylamine 	1.34 g 
glycine 	0.88g 
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Appendix II Histological procedures 
Appendix Ha Infiltration regime — Tissue Tek VIP 4617 
Step Solvent Time Step Solvent Time 
No. No. 
1 70% ethanol 60 min 8 100% ethanol 60 min 
2 80% ethanol 60 min 9 toluene 60 min 
3 85% ethanol 60 min 10 toluene 60 min 
4 90% ethanol 60 min 11 paraffin 30 min 
5 95% ethanol 60 min 12 paraffin 30 min 
6 100% ethanol 60 min 13 paraffin 30 min 
7 100% ethanol 60 min 14 paraffin 30 min 
Appendix lib Haematoxylin and eosin staining procedure 
Step Solvent/stain Time Step Solvent/stain Time 
No. No. 
1 xylene 2 min 11 tap water 20 dips 
2 xylene 2 min 12 Young's eosin 150 sec 
3 100% alcohol 20 dips 13 tap water 10 dips 
4 100% alcohol 20 dips 14 70% alcohol 20 dips 
5 100% alcohol 20 dips 15 100% alcohol 20 dips 
6 70% alcohol 20 dips 16 100% alcohol 20 dips 
7 tap water 20 dips 17 xylene 20 dips 
8 Mayer's haemalum 5 min 18 xylene 20 dips 
9 tap water 20 dips 19 xylene 20 dips 
10 Scott's tapwater 
substitute 
30 sec 20 Mountant: DPX 
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